Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page i
Clinical Procedures in Laser Skin Rejuvenation
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page ii
SERIES IN COSMETIC AND LASER THERAPY Published in association with the Journal of Cosmetic and Laser Therapy
Already available 1. David Goldberg. Fillers in Cosmetic Dermatology. ISBN: 1841845094 2. Philippe Deprez. Textbook of Chemical Peels. ISBN: 1841844950 3. C William Hanke, Gerhard Sattler, Boris Sommer. Textbook of Liposuction. ISBN 1841845329
Of related interest 1. Robert Baran, Howard I Maibach. Textbook of Cosmetic Dermatology, 3rd edition. ISBN: 1841843113 2. Anthony Benedetto. Botulinum Toxin in Clinical Dermatology. ISBN: 1842142445 3. Jean Carruthers, Alistair Carruthers. Using Botulinum Toxins Cosmetically. ISBN: 1841842176 4. David Goldberg. Ablative and Non-Ablative Facial Skin Rejuvenation. ISBN: 1841841757 5. David Goldberg. Complications in Cutaneous Laser Surgery. ISBN: 1841842451 6. Nicholas J Lowe. Textbook of Facial Rejuvenation. ISBN: 1841840955 7. Shirley Madhere. Aesthetic Mesotherapy and Injection Lipolysis in Clinical Practice.ISBN: 1841845531 8. Avi Shai, Howard I Maibach, Robert Baran. Handbook of Cosmetic Skin Care. ISBN: 1841841793
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page iii
Clinical Procedures in Laser Skin Rejuvenation Edited by
Paul J Carniol MD FACS Cosmetic Laser and Plastic Surgery Summit, NJ USA
Neil S Sadick MD FAAD FAACS FACP FACPh Sadick Aesthetic Surgery and Dermatology NewYork, NY USA
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page iv
© 2007 Informa UK Ltd First published in the United Kingdom in 2007 by Informa Healthcare,Telephone House, 69–77 Paul Street, London EC2A 4LQ. Informa Healthcare is a trading division of Informa UK Ltd. Registered Office: 37/41 Mortimer Street, London W1T 3JH. Registered in England and Wales number 1072954. Tel: +44 (0)20 7017 5000 Fax: +44 (0)20 7017 6699 Website: www.informahealthcare.com All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher or in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. A CIP record for this book is available from the British Library. Library of Congress Cataloging-in-Publication Data Data available on application ISBN-10: 0 415 41413 X ISBN-13: 978 0 415 41413 5 Distributed in North and South America by Taylor & Francis 6000 Broken Sound Parkway, NW, (Suite 300) Boca Raton, FL 33487, USA Within Continental USA Tel: 1 (800) 272 7737; Fax: 1 (800) 374 3401 Outside Continental USA Tel: (561) 994 0555; Fax: (561) 361 6018 Email:
[email protected] Distributed in the rest of the world by Thomson Publishing Services Cheriton House North Way Andover, Hampshire SP10 5BE, UK Tel: +44 (0)1264 332424 Email:
[email protected] Composition by C&M Digitals (P) Ltd, Chennai, India Printed and bound in India by Replika Press Pvt Ltd
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page v
Contents
List of contributors Note on outcomes 1 Laser safety William Beeson 2 Evaluation of the aging face Philip J Miller 3 Carbon dioxide laser resurfacing, Fractional resurfacing and YSGG resurfacing Dee Anna Glaser, Natalie L Semchyshyn and Paul J Carniol 4 Erbium laser aesthetic skin rejuvenation Richard D Gentile 5 Complications secondary to lasers and light sources Robert M Adrian 6 Nonablative technology for treatment of aging skin Amy Forman Taub
vii x
11 Management of vascular lesions Marcelo Hochman and Paul J Carniol
125
1
12 Laser treatment for unwanted hair Marc R Avram
135
11
17
14 Treatment of leg telangiectasia with laser and pulsed light Mitchel P Goldman
157
15 Photodynamic therapy Papri Sarkar and Ranella J Hirsch 45
16 Adjunctive techniques I: the bioscience of the use of botulinum toxins and fillers for non-surgical facial rejuvenation Kristin Egan and Corey S Maas
173
181
51
69
8 Treatment of acne scarring Murad Alam and Greg Goodman
89
10 Laser treatment of pigmentation associated with photoaging David H Ciocon and Cameron K Rokhsar
139
31
7 Lasers, light, and acne Kavita Mariwalla and Thomas E Rohrer
9 Nonsurgical tightening Edgar F Fincher
13 Non-invasive body rejuvenation technologies Monica Halem, Rita Patel, and Keyvan Nouri
103
111
17 Adjunctive techniques II: clinical aspects of the combined use of botulinum toxins and fillers for non-surgical facial rejuvenation Stephen Bosniak, Marian Cantisano-Zilkha, Baljeet K Purewal and Ioannis P Glavas 18 Adjunctive techniques III: complementary fat grafting Robert A Glasgold, Mark J Glasgold and Samuel M Lam Index
191
205
219
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page vi
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page vii
Contributors
Robert M Adrian MD FACP Center for Laser Surgery Washington, DC USA Murad Alam MD Departments of Dermatology, Otolaryngology, and Surgery Northwestern University Chicago, IL USA Marc R Avram MD Department of Dermatology New York Presbyterian Hospital-Weill Medical College at Cornell Medical Center New York, NY USA William Beeson MD AAFPRS AACS Beeson Aesthetic Surgery Institute Carmel, IN USA Stephen Bosniak † MD Marian Cantisano-Zilkha MD Manhattan Eye, Ear and Throat Hospital New York, NY USA Paul J Carniol MD Cosmetic Laser and Plastic Surgery Summit, NJ USA David H Ciocon MD Department of Dermatology Albert Einstein College of Medicine New York, NY USA
Kristin Egan MD Department of Otolaryngology UCSF San Francisco, CA USA Edgar F Fincher MD PhD The David Geffen School of Medicine at UCLA and Moy-Fincher Medical Group Los Angeles, CA USA Richard D Gentile MD Facical Plastic and Aesthetic Laser Center Youngston, OH USA Dee Anna Glaser MD Dermatology Department St Louis University St Louis, MO USA Mark J Glasgold MD Department of Surgery Robert Wood Johnson Medical School University of Medicine and Dentistry of New Jersey Piscataway, NJ USA Robert A Glasgold MD Department of Surgery Robert Wood Johnson Medical School University of Medicine and Dentistry of New Jersey Piscataway, NJ USA
Prelims Carniol-8028.qxd
viii
8/23/2007
10:37 AM
Page viii
List of contributors
Ioannis P Glavas MD Oculoplastic Surgery Manhattan Eye, Ear and Throat New York, NY USA
Kavita Mariwalla MD Department of Dermatology Yale School of Medicine New Haven, CT USA
Mitchel P Goldman MD LaJolla Spa LaJolla, CA USA
Philip J Miller MD FACS Department of Otolaryngology New York University School of Medicine and The NatraLook ProcessTM and East Side Care New York, NY USA
Greg Goodman MD Department of Dermatology Minash University Melbourne Australia Monica Halem MD Department of Dermatology Miller School of Medicine University of Miami Miami, FL USA Ranella J Hirsch Skin Care Doctors Cambridge, MA USA Marcelo Hochman MD The Facial Surgery Center Charleston, SC USA Samuel M Lam MD Willow Bend Wellness Center Lam Facial Plastic Surgery Center and Hair Restoration Institute Plano,TX USA Corey S Maas MD Department of Otolaryngology UCSF and The Maas Clinic San Francisco, CA USA
Keyvan Nouri MD Department of Dermatology Miller School of Medicine University of Miami Miami, FL USA Rita Patel MD Department of Dermatology Miller School of Medicine University of Miami Miami, FL USA Baljeet K Purewal MD Department of Opthalmology Lutheran Medical Center Brooklyn, NY USA Thomas E Rohrer MD Department of Dermatology Boston University School of Medicine and Skin Care Physicians of Chestnut Hill Chestnut Hill, MA USA Cameron K Rokhsar MD FAAD FAACS Department of Dermatology Albert Einstein College of Medicine New York, NY USA
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page ix
List of contributors Neil S Sadick MD Sadick Aesthetic Surgery and Dermatology New York, NY USA Papri Sarkar MD Department of Dermatology Harvard Medical School Boston, MA USA
ix
Natalie L Semchyshyn MD Dermatology Department St Louis University St Louis, MO USA Amy Forman Taub MD Advanced Dermatology Northwesten University Department of Dermatology Lincolnshire, IL USA
Prelims Carniol-8028.qxd
8/23/2007
10:37 AM
Page x
Note on outcomes
Although every effort has been made to ensure that information about techniques and equipment is presented accurately in this publication, the ultimate responsibility rests with the practitioner physician. Use of these techniques or items of equipment does not guarantee outcomes or that they are the optimal procedures available. Procedure results and potential complications frequently vary between patients: physicians must evaluate their patients individually and make appropriate decisions about treatment based on each analysis. Although it is not always necessary, when a physician initiates any new therapy on a patient the use of ‘test spots’ or other tests of limited
areas should be considered for patient response before initiating the full treatment itself. Neither the publishers, nor the editors, nor the authors can be held responsible for errors or for any consequences arising from the use of information contained herein. For detailed instructions on the use of any product or procedure discussed herein, please consult the instructional material issued by the manufacturer. Some of the use of technology and procedures described in this text may be ‘off label’ as regards the FDA in the USA and may also not have EC approval in Europe, and are described as such, to be used at the discretion of the physician.
01 Carniol-8028.qxd
8/23/2007
3:30 PM
Page 1
1. Laser safety William Beeson
INTRODUCTION Surgical lasers have opened a new vista for aesthetic surgery. Laser skin resurfacing is commonplace, as is laser treatment for vascular lesions, varicosities, and laser hair removal. Laser blepharoplasty and facelifts, as well as the employment of the laser in endoscopic facial surgery, are becoming commonplace. With the increasing varieties of lasers and the numerous wavelengths available, laser safety has become a more complex issue.1 It is incumbent upon the surgeon to consider the safety of not only his or her patient, but also the entire operating room staff. With the increasing trend for more and more procedures to be performed in an ambulatory surgical setting, we find that medical lasers are commonly being employed in small clinics or office surgical settings. Not only physicians, but podiatrists, dentists, and others use lasers on a daily basis in their office clinical practices.The requirements and principles for the safe use of lasers are no less stringent in this setting than when the lasers are employed in a large metropolitan hospital. Laser safety standards apply equally in all of these settings. When a physician utilizes a medical laser, they have a medical, legal, and ethical responsibility to be aware of the requirements for the safe use of lasers in healthcare facilities.This means that the physician should be trained in laser safety and be knowledgeable as to local and federal regulations, as well as the advisory standards and professional recommendations for the use of lasers in their applicable speciality.
CLASSIFICATION OF LASERS Medical lasers are classified in the USA in accordance with the Federal Laser Product Performance Standard,
which essentially classifies lasers based on the ability of the laser beam to cause damage to ocular and cutaneous structures. The Food and Drug Administration (FDA) Center For Devices and Radiologic Health (CDRH) has the responsibility for implementing and enforcing the Federal Laser Product Performance Standard and Medical Device Amendment to the Food, Drug, and Cosmetic Act. In general, medical lasers are of class III-B or class IV. Medical lasers can be divided into two broad categories: those in the visible and mid-infrared range (roughly 400–1400 nm), in which the focal image on the retina presents the primary ocular hazard; and those in the ultraviolet and infrared regions, in which the main ocular hazard is to the cornea and skin. In general, class IV laser systems present a fire hazard in addition to the ocular and cutaneous hazards associated with class III-B lasers. A class I laser is considered to be incapable of producing damaging levels of laser emission. Class II applies only to visible laser emissions, which may be viewed directly for time periods ≤ 0.25 s: the aversion response time (aversion response is defined as movement of the eyelid or head to avoid exposure to a noxious stimulant or bright light). This is essentially the blink reflex time. Only if one purposely overcomes one’s natural aversion response to bright light can a class II laser pose a substantial ocular hazard. Class III lasers may be hazardous by direct exposure or exposure to specific reflection. A subcategory of class III (class III-A) consist primarily of lasers of 1–5 nW power. These pose a moderate ocular problem under specific conditions where most of the beam enters the eye. The aiming beam or alignment beam for a laser usually falls within this range, and can be hazardous when viewed momentarily if the beam enters the eye. For this reason, one must take particular caution when
01 Carniol-8028.qxd
2
8/23/2007
3:30 PM
Page 2
Clinical procedures in laser skin rejuvenation
using the alignment beam and be aware that ocular damage can occur with misuse. Class III-B lasers comprise those in the 5–500 mW output range. Even momentary viewing of class III-B lasers is potentially hazardous. Class IV lasers are those emitting > 500 mW (0.5 W) radiant power. Most surgical lasers fall within this class, and pose a potential hazard for skin injury, ocular injury, and fire hazards.
REGULATIONS In addition to FDA enforcement, other rules and regulations apply to the use of lasers in the medical setting. In recent years, the Occupational Safety and Health Administration (OSHA) has stressed the need for employers to inform and educate workers on workplace risks. This has been of particular importance with regard to the use of lasers in the workplace. The Department of Labor has developed guidelines for Laser Safety Hazard Assessment, which pertain to the use of medical lasers.2 Compliance with OSHA rules is an important component of a laser safety program.
HAZARD CLASSIFICATION There are no specific OSHA guidelines for assessing the level of compliance of a facility providing laser facelifts and laser blepharoplasty. However, the American National Standards Institute (ANSI) standard ‘Safe Use of Lasers in Health Care Facilities’ (Z136.3) is used as a benchmark. All assessments by the OSHA are made under the ‘general duty clause’, which states that there is a shared duty between the employer and employee for establishing and maintaining a safe working environment. The employer has a duty to provide the proper safety equipment, appropriate education and training, and a work environment free of known potential risks and hazards. The employee has a duty to attend the training, use of personal protective equipment, and follow safe work practices at all times. OSHA compliance officers respond to requests, complaints, and accidents reported. Facilities must demonstrate that they have established policies and procedures, identified proper personal protective equipment, implemented a
program for education of all employees who might be at risk for exposure to laser hazards, performed and documented periodic safety audits, and assured ongoing administrative control in program surveillance.3 In addition to governmental agencies such as the FDA, OSHA, and state departments of health, nongovernmental accrediting and review organizations also have guidelines and recommendations for the laser safety in healthcare facilities. The ANSI is a nonregulatory body that promulgates thousands of safety standards in the USA.Working committees have representation from industry, the military, regulatory bodies, user groups, research and educational facilities, and professional organizations. The ANSI also participates in international standard work through groups such as the International Organization for Standardization (ISO).The main objective of the ANSI is to establish and maintain benchmarks for national safety through consensus documents. ANSI Z-136.3 has become the expected laser safety standard in healthcare. Although it is not regulatory, it has taken on the impact of regulations through its wide acceptance. It is used by the OSHA and many accrediting organizations such as the Joint Commission (previously the Joint Commission on Accreditation of Healthcare Organizations, JCAHO) and the Accreditation Association of Ambulatory Healthcare (AAAHC), and it is exhibited as reference during litigations. The standard provides a comprehensive guide for the development of administrative and procedural control measures that are necessary for maintaining a safe laser environment and should be used as the cornerstone for all clinical laser programs. It is important to develop a risk management process regarding the safe use of lasers, consisting of written policies and procedures, as well as ongoing evaluations of compliance, and demonstrating timely and appropriate responses to incidents or accidents that could occur. Typically, the person responsible for the management of the laser safety–risk management program will be the laser safety officer. The ANSI Z136.3 standard defines the laser safety officer as ‘an individual with the training, self-study, and experience to administer a laser safety program. This individual (who is appointed by the administration) is authorized and is responsible for monitoring and overseeing the control of laser hazards. The laser safety officer shall effect the knowledgeable evaluation and control of
01 Carniol-8028.qxd
8/23/2007
3:30 PM
Page 3
Laser safety laser hazards by utilizing, when necessary, the appropriate clinical and technical support staff and other resources.’4 The laser safety officer should be responsible for verifying the classifications of the laser systems, hazard analysis, ensuring appropriate control measures are in effect, approving all policies and procedures, ensuring that protective equipment is available, overseeing instillation of equipment, ensuring that all staff are properly trained, and maintaining medical surveillance records. In private practice in small clinical settings, the physician who owns and runs the practice or clinic is very likely to serve as the laser safety officer. All laser users must adhere to the following principles: • Laser safety requirements are no less stringent in private practice than in a hospital setting. • The individual laser user must know all professional standards and regulations and be thoroughly trained in laser safety. • The user must ensure that the entire staff are properly trained in the safe use of lasers. • There must be an appointed laser safety officer. • The user must establish and follow standard-based policies and procedures. It is important that safety audits be utilized in a routine manner to be sure that laser safety programs are being adhered to. ANSI standards require an audit at least annually. A laser safety audit is an assessment of all equipment, supplies, and documents involved in performing laser treatments in a facility. It is supervised by the laser safety officer and consists of four basic components: 1. 2. 3. 4.
Inventory all equipment and develop a checklist. Inspect every item on the checklist. Document results. Identify action items based on audit results.
In addition to the ANSI, voluntary healthcare accrediting organizations such as the Joint Commission and the AAAHC all have standards that apply to the use of lasers in the medical environment, including the office surgical setting. Laser regulation at state and local government levels has increased significantly in recent years. Regulations vary from state to state. The current trend is for state
3
regulatory bodies, such as medical licensing boards and departments of health, to address laser safety issues by setting standards for credentialing and training. Regulations will usually dictate the type of individual or individuals who are qualified to perform laser treatments and prescribe levels of training to document current competency with each type of laser being used. Almost all require personnel using lasers in healthcare arenas to be cognizant of basic laser safety issues. Some states allow only physicians to perform laser surgery, while others allow physician assistants and advanced practice nurses to perform laser treatments. Some will allow nurses and other allied health personnel to perform laser treatments, but only with the direct supervision of a trained physician. Still other states permit the use of lasers by paramedical personnel and ‘others’ in less supervised situations. However, the current trend is for increased supervision and training. While some states may not directly address laser surgery, they do so indirectly by requiring accreditation of ambulatory surgical or office surgical units. In these cases, the medical licensing board has subrogated authority to a national accrediting organization such as the Joint Commission, the AAAHC, or the American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF). Each of these organizations has developed specific standards that can be applied to laser use in the medical setting. In 2005, the Joint Commission, currently in its sentinel event program, adopted measures for its accredited organizations to utilize in an attempt to reduce the likelihood of patient injury from fire resulting from the use of lasers in the operating room. Since the Joint Commission accredits the vast majority of hospitals in the USA and since all Joint Commission-accredited organizations using medical lasers must adhere to these recommended standards, one could argue from a legal standpoint that these are de facto ‘community standards’. The legal implications of not meeting the accepted ‘community standards’ if a patient has an injury when being treated with a medical laser are significant. It is imperative that any person in a medical practice who treats with a laser adhere to strict regulations regarding scope of practice, licensing requirements, and standardized procedures. It is also extremely important for the physician’s malpractice insurance carrier to determine who is covered under the physician’s policy. It is essential to know if the person doing the laser
01 Carniol-8028.qxd
4
8/23/2007
3:30 PM
Page 4
Clinical procedures in laser skin rejuvenation
treatments is outside his or her scope of practice, as an insurance company will not insure someone who is illegally practicing outside the scope of his or her license, etc. Health practitioners cannot ignore the importance of this issue for overall success and safety. At present, there are no national, state, or local certifications or licensing agencies to qualify the competency of surgeons, nurses, or technicians in the safe use of lasers. There is no standardized or universally accepted certification or training organization. It is, therefore, important to consider the ANSI guidelines as well as the recommendations of various professional medical societies in this regard (Boxes 1.1 and 1.2). Box 1.1 Recommendations for establishing laser program and clinical setting 1. Check with medical licensing board in your state regarding laser regulations 2. Develop laser safety protocols for your facility. Document training for yourself and your staff 3. Consider formal laser safety officer training and appoint a laser safety officer 4. Monitor changes in accreditation standards and ANSI Z-136.3 guidelines 5. Check with your medical liability carrier. Obtain delineation of coverage for yourself and your staff regarding the use of lasers in your practice
Box 1.2 Information resources for laser safety guidelines • American National Standards Institute (ANSI), 11 West 42nd Street, New York, NY 10 036 • Laser Institute of America, 12424 Research Parkway, Suite 125, Orlando, FL 32826 • US Food and Drug Administration (FDA), Center for Devices and Radiologic Health (CDRH), 9200 Corporate Boulevard, Rockville, MD 20850 • US Department of Labor, Occupational Safety and Health Administration (OSHA), 200 Constitution Avenue, NW,Washington, DC 20210 • Joint Commission (formerly JCAHO), 1 Renaissance Boulevard, Oak Brook Terrace, IL 60181 • Accreditation Association of Ambulatory Healthcare (AAAHC), 5250 Old Orchard Road, Suite 200, Skokie, IL 60077
BIOLOGICAL HAZARDS OF LASERS Laser hazards can essentially be divided into nonbeam-related hazards and beam-related hazards. The latter are unique to lasers, and pose the need for special attention and safety requirements when using lasers in the medical setting.This relates to the optical radiation hazard, which can result in damage to both eyes and skin. Because the eye is considered to be most vulnerable to laser light, the ocular hazards are considered of paramount importance. In most cases, the eye has a natural protective mechanism that limits retinal exposure to irritants. The blink reflex occurs at about every 0.25 s and accounts for the aversion response previously described. However, the intensity of some laser beams can be so great that injury can occur before the protective lid reflex. This usually happens with lasers operating at 400–1400 nm. It is commonly referred to as the ‘retinal hazard region’. Because of acoustic effects and heat flow, significant tissue damage can occur, leading to severe retinal impairment. For this reason, it is not uncommon to lose all visual function when exposed to even minimal amounts of laser energy when that energy is focused on critical areas of the retina such as the fovea. Such visual loss is generally permanent, since the neural tissue of the retina has minimal ability to replicate. Injury to the cornea and the anterior segment of the eye is possible from wavelengths in the ultraviolet and in the infrared beyond 1400 nm. When injury occurs to the cornea, it is usually superficial and involves the corneal epithelium. Re-epithelization usually occurs within 1–2 days, and total recovery of vision usually results. However, deeper penetration can result in corneal scaring and permanent loss of vision. Carbon dioxide (CO2) laser wavelengths pose such a potential risk. Excimer lasers operate in the ultraviolet range and pose a potential hazard to the cornea. Ocular injury can occur from direct penetration of a focused beam. However, it is more likely that injury will occur due to accidental ocular exposure to a reflected beam. Protection from reflected laser beams can be difficult. The most commonly employed surgical laser today is the CO2 laser. Since the CO2 laser wavelength of 10.6 µm is in the far-infrared region, it is invisible, and so this potential hazard can go unnoticed. For this
01 Carniol-8028.qxd
8/23/2007
3:30 PM
Page 5
Laser safety reason it is imperative that precautions be taken at all times when using CO2 lasers.This is also true of Ho:YAG and Nd:YAG lasers.This is in contrast to KTP and argon lasers, whose emissions are in the visible region. Reflections most commonly occur from flat metallic mirror-like surfaces such as nasal speculums or surgical instruments. Black anodized or abraded–roughened surfaces can reduce (but not totally eliminate) the potential for beam reflection. Roughening a surface is generally thought to be more effective than ebonizing it, since the beam is diffused to a greater degree.5 Because of the potential for ocular injury secondary to beam reflection, it is imperative that proper protection be afforded to the patient and all operating room personnel at all times when lasers are in use. Ordinary optic glass protects against all wavelengths shorter than 300 nm and longer than 2700 nm. Polycarbonate safety glasses with sideshields are suitable for use with the CO2 lasers if the power is < 100 W.The glass should have an optical density of 4. While polycarbonate glasses may be adequate, there can be burn-through with higher-power lasers. Thus, even when wearing protective eyewear, one should not focus the laser beam directly on the shield for any length of time. Laser safety glasses should always have sideshields. The optical density rating should be listed on the sidebar of the eyeglasses. It is important to realize that many lasers radiate at more than one wavelength. For this reason, eyewear of appropriate optical density for a particular wavelength could be completely inadequate at another wavelength radiated by the same laser. This is particularly important for lasers that are tunable over broad wavelength bands. When a patient is within a nominal hazard zone (NHZ), patient eye protection is imperative.The NHZ is a space within which the level of the direct, reflected, or scattered radiation during normal operation exceeds the acceptable maximal permissible exposure (MPE). Proper eye protection may range from wet eye pads to laser-protective eyewear. In most cases, corneal protectors provide the best protection. Plastic corneal protectors have become popular. However, in some cases, plastic shields can transfer thermal energy to the cornea, with resultant injury. This is especially true with darker-colored shields.6
5
CUTANEOUS INJURY While ocular injury is the most devastating direct beam laser injury, cutaneous hazards do exist.The skin can be injured either through a photochemical mechanism or by a thermal mechanism. First-, second-, and third-degree burns can be induced by visible and infrared laser beam exposure. Such injuries have been noted to occur in < 1% of patients, with 10% of surgeons reporting unintentional burns to either patients or operating room personnel.7,8 In most cases, moist towels draped around the operative site and fireresistant surgical drapes will provide proper protection.
NON-BEAM-RELATED HAZARDS In addition to direct laser beam hazards to the eye and skin, there are non-beam laser hazards that need to be considered. These include electrical hazards, lasergenerated airborne contaminants (laser plume), waste disposal of contaminated laser-related materials such as filters, and laser-generated electromagnetic interference. All medical lasers must operate in compliance with the National Electric Code (NFPA-70) and with state and local regulations. Electrical hazards can be related to damaged electrical cords and cables, inadequate grounding, and the use of conductive liquids in the vicinity of the laser when it is in operation. These problems can usually be minimized with an appropriate laser maintenance program by qualified biomedical engineers and adherence to appropriate laser safety guidelines when operating electrical equipment in the surgical environment. Laser-generated airborne contaminants present a significant problem. Studies have shown the presence of gaseous compounds, bio-aerosols, dead and live cellular materials, and viruses in the laser plume. The laser plume can cause ocular and upper respiratory tract irritation. The unpleasant odors of the laser plume can cause discomfort to both the physician and the patient.The laser plume can cause ocular irritation, and may be even more of a problem for individuals who wear soft contact lenses, as the particles can permeate the lenses and cause prolonged irritation.
01 Carniol-8028.qxd
6
8/23/2007
3:30 PM
Page 6
Clinical procedures in laser skin rejuvenation
However, of greatest concern is the mutagenic and carcinogenic potential of the compounds contained in the plume.At a time when the threat from bloodborne pathogens has led to enhanced awareness of the risks of contact with blood and blood byproducts, the practice of universal precautions has taken on a new meaning. The use of a laser smoke evacuator is imperative. If the evacuator is held 2 cm from the source of the laser plume, aerosolization of the particles is minimal. The suction created in the evacuator tubing is important. This results in the creation of a vortex that removes mutagenic debris and prevents aerosolization of the carbonized particles. (The latter impregnate the tubing, which should therefore be treated as a biohazard when it comes to disposal.) In most cases, routine operating room suction and suction tubing do not provide adequate evacuation of the laser plume. While surgical masks may help reduce laser exposure, their use alone is not adequate. At present, there is no mask respirator on the market that excludes all laser-generated plume particles, such as viruses, bacteria, and other hazards. Surgical masks are not designed to protect from plume contents. Rather, they are intended to protect patients from the surgeon’s contaminated nasal or oral droplets. Specialized surgical masks that filter out particles down to 0.3 µm with high efficiency are available and can help to decrease the inhalation of laser plume particles. While some laser masks are of sufficiently increased density to remove a higher proportion of laser-generated particles, their use alone is not adequate.9 As with smoke evacuator tubing, filters will be impregnated with potentially dangerous materials, and should therefore be treated as hazardous waste. Lasers can create electromagnetic interference. Electromagnetic radiation generated by lasers can interfere with other sensitive electronic equipment present in the facility, such as cardiac telemetry equipment.This can also affect patients who have pacemakers. The electromagnetic interference potential of a laser system is normally described in the manufacturer’s labeling, or it can be determined by a biomedical engineer with laser safety officer experience.
FIRE HAZARD Operating room fires are rare – but when such blazes do occur, they can be lethal. Potentially flammable
materials such as gauze, cotton, paper surgical drapes, and plastic endotracheal tubes can be ignited in the operating room by the laser, and the oxygen-enriched environment can intensify fires. Accidental fires are a well-known hazard associated with laser treatment. It has been estimated that combustion occurs in 0.4–0.57% of CO2 laser airway procedures.10 Others have demonstrated that, in the presence of oxygen concentrations of 21–25%, polyvinyl chloride, red rubber, and silicone endotracheal tubes can rapidly ignite when struck with CO2 laser beam.The threshold for ignition is increased with the addition of helium to the oxygen concentration. This is due to the fact that helium has a higher thermal density and acts as a heat sink, delaying combustion for about 20 s. Laser fires have also resulted from the ignition of polyvinyl chloride endotracheal tubes wrapped in aluminum tape.11 In general, medical lasers are class III-B or IV lasers. Class IV laser systems (emitting > 500 mW radiant power) present a fire hazard in addition to the ocular and cutaneous hazards associated with class III-B lasers. Most surgical lasers fall within this class. The basic elements of a fire are always present during surgery.A misstep in procedure or a momentary lapse of caution can quickly result in a catastrophe. Slow reaction to the use of improper firefighting techniques and tools can lead to damage, destruction, or death. To reduce the threat of a laser fire, it is essential to understand and to employ the principles of the ‘fire triangle’. For a fire to start, three components must be present: heat, fuel, and an oxidizer. The key to laser safety in this regard is to control all three components. ‘Heat’ represents the flame or the spark. It is the ‘ignition’ for the fire.The nature of the heat source can be extremely varied – often something that one would not immediately think of, such as an overhead surgical light, an electrocautery unit, a drill, or a fiberoptic light left on a surgical drape. A ‘fuel’ has to be present for the heat source to ignite. Once again, the potential ‘fuel’ can be an item that one would not likely consider, such as a petroleum-based ophthalmologic ointment. Fuels commonly encountered in surgery can be divided into five categories: the patient, prepping agents, linens, ointments, and equipment. The key ‘oxidizer’ in the operating room is the oxygen-rich environment. An oxidizer can be thought
01 Carniol-8028.qxd
8/23/2007
3:30 PM
Page 7
Laser safety of in this context as something that facilitates ignition and combustion. Decades ago, anesthesiologists recognized the hazards of flammable anesthetic agents in the operating room and eliminated them.Today, oxygen is one of the key components to deal with in regards to operating room fires. In the great majority of such fires that have been reviewed, an oxygen-rich environment and ineffective management of this ‘oxidizer’ were the key factors in the mishap. Preventing fires in the operating room is dependent on disrupting the fire triangle, as all of its components must be present for a fire to develop. One needs to control the heat source, manage the fuels, and minimize the oxygen concentration. One of the most common errors is inadvertent activation of the laser. Not infrequently, the surgeon thinks that he or she is stepping on the cautery foot pedal when they are actually stepping on the laser pedal, which activates the dangling laser, whose beam is directed on a flammable surgical drape (the ‘fuel’). One of the most basic – but most effective – safety measures is to eliminate the clutter of multiple foot pedals for the laser, cautery, liposuction unit, etc. Removing all of the foot pedals and having only the foot pedal of the equipment one is using in access range is extremely important. ANSI standards dictate that there be a laser-designated operator trained in the safe use of any particular laser.The responsibility of the laser operator is to release the laser from standby setting mode when the surgeon requests its activation and to immediately place the laser back on standby mode when the surgeon is finished.This markedly reduces the likelihood of inadvertent laser activation. It is essential that the laser operator ensure that there is an appropriate ‘environment’ before activating the laser.They should scan the room to ensure that no flammable agents such as acetone or cleaning agents are present, that all personnel are wearing appropriate eye protection, that the patient’s eyes are protected, and that the oxygen has been reduced to room air levels before the laser, is activated. Managing the potential ‘fuel’ source is important, and requires delegation and advanced planning. Proper prepping techniques are critical. If possible, the use of alcohol-based prepping solutions should be avoided. It is important that flammable prep solutions be removed and not allowed to drip and ‘pool’ on the drapes under the patient, enabling fumes to accumulate and possibly be ignited. It is also important to be
7
alert for potential fire risks on the patient, such as eye mascara, perfume, and hairspray, of all which can be flammable. Minimizing the oxygen environment is extremely important and must be done in concert with the anesthesiologist.This requires presurgical discussion regarding how one plans to perform the procedure, the type of anesthetic to be used, etc. In many cases, monitored anesthesia care can be used. It may be possible to reduce the oxygen concentration being delivered to room air levels during the time the laser is being activated and to return immediately to supplemented levels when the laser is deactivated.This requires coordination between the surgeon and the anesthesiologist and the ability of the surgeon to immediately terminate the laser use if the anesthesiologist notes a precipitous drop in FiO2 on the pulse oximeter. If a nasal cannula or a face mask is used to deliver oxygen, one has to be sure that surgical drapes are not tented, such that oxygen can pool under them. In cases where higher levels of oxygen are required by the patient, and alternating from supplemented oxygen to room air is not possible, a helium and oxygen combination may serve to increase the safety margin when oxygen has to be utilized. Helium acts as a heat sink. It can delay combustion for up to 20 s. The oxygen concentration should be maintained below 40%. Recommendations regarding anesthesia are summarized in Box 1.3. Box 1.3 Recommendations regarding anesthesia • Oxygen should be used at the lowest possible concentration • Oxygen (or other gases) should never be directed toward the laser field • Any mixture of nitrous oxygen and oxygen should be treated as if it were pure oxygen • Helium can be used to increase the ignition threshold • Laryngeal airways (with spontaneous respiration) are preferred over face masks; if a mask is used, an oxygen analyzer can be utilized to ensure minimal leakage • If an endotracheal tube is used, the cuff should be filled with saline rather than air. The tube should be wrapped in aluminum or copper tape • Collared masks, nasal cannulas, or airway materials should be avoided. • Anesthetics that are administered either by inhalation or topically should be nonflammable.
01 Carniol-8028.qxd
8
8/23/2007
3:30 PM
Page 8
Clinical procedures in laser skin rejuvenation
PREPARING FOR FIRES It is imperative to develop a laser-fire protocol. Being prepared for fire is an inexpensive insurance and will minimize the cost in dollars, loss in time, emotional shock, injury, and possibly death. Preparation involves a number of steps. The most important is practicing fire drills to teach all staff about their responsibility during a laser fire. This should be done similarly to what is done for medical codes and other routine disaster drills. It is surprising how many individuals do not know how to select a proper fire extinguisher or how to use one. Most fire extinguishers operate according to the mnemonic ‘PASS’: Pull the activation pin, next Aim the nozzle at the base of the fire, next Squeeze the handle to release the extinguishing agent, and Sweep the stream over the base of the fire. There are three classes of fire extinguishers: A, B, and C. Class C is used for electrical equipment. With the demise of Halons as fire-extinguishing agents, CO2 is the best all around fire extinguisher for the use in the operating room. Halons (bromofluorohydrocarbons) are damaging to the environment and are no longer made or sold. However, if a Halon fire extinguisher is available, it is the optimal one to use. Small CO2 fire extinguishers have five-pound charges and weigh approximately 15 pounds. This is easily enough for most people to handle and small enough to mount unobtrusively on the wall in the operating room near the door. CO2 fire extinguishers are rated for use against class B and class C fires in the operating room setting, although they can be used effectively against the kinds of class A fires that are likely to occur. CO2 fire extinguishers emit a fog of CO2 gas with liquid and solid particles that rapidly vaporize to cool and smooth the fire, while leaving no residue to contaminate the patient. Dry powder fire extinguishers employ primarily of ammonium sulfate, which is emitted in a stream against the fire. The powder smothers, cools, and to some extent disrupts the chemical reaction of the fire. During use, the powder limits visibility and covers everything in the surrounding area, which can damage delicate equipment. The powder irritates the mucous membranes and its long-term toxicity has not clearly been determined. Using a powder fire
extinguisher in the operating room will make the room and much of the equipment unusable for a period of time. For these reasons, dry powder should not be used as the first line of defense against operating room fires. Pressurized-water fire extinguishers are available, but are heavy and chiefly effective against only class A fires. If a laser fire should inadvertently occur, quick action is imperative.Ventilation should be stopped and anesthetic gases discontinued.Then the tracheal tube, mask, and nasal cannula should be removed.The fire should be extinguished with normal saline.The patient should then be mask-ventilated with 100% oxygen.The anesthesia should be continued in order to facilitate injury assessment to allow the patient to be stabilized. Iced saline compresses should be applied to areas of burn.A flexible nasal pharyngoscope or bronchoscope should be used to survey the upper airway and laryngeal tissues to evaluate the extent of injury. Foreign bodies and carbonized debris should be removed. Copious irrigation with normal saline and Betadine soap can be used to remove carbonized debris from cutaneous burned areas. Xeroform gauze and bacitracin ointment can be applied to areas of minor cutaneous burns. If thermal injury has occurred in the nasal airway, a light nasal packing with Xeroform gauze can be used to stent the airway to treat thermal damaged tissues. Depending on the severity of injury, it may be important to consider the use of intravenous steroids. High-humidity environments should be provided and oxygenation monitored. Patients may require ventilatory support for laryngeal edema as a potential problem. A chest X-ray should be considered in order to obtain a baseline evaluation to monitor for ‘shock lung’. Evaluation by other consultants such as a pulmonologist or ophthalmologist should be considered when appropriate. Systemic antibiotics such as cephalosporins should be considered. In all but the most minor cases, the patient should be observed overnight.12
ENVIRONMENT OF CARE Medical lasers should be used in the appropriate environment.There should be proper electrical grounding
01 Carniol-8028.qxd
8/23/2007
3:30 PM
Page 9
Laser safety to minimize potential electrical shock. There should be proper ventilation and the room should be of sufficient size to enable the use of smoke evacuators, laser equipment, and additional personnel needed for proper laser instrumentation. Treatment should be performed in a controlled area, which should limit entry by unauthorized personnel. Proper warning signs should be displayed at the entry and within the controlled area. Only those properly trained in laser safety should be admitted to the controlled area. All open portals and windows should be covered or restricted in such a manner as to reduce the transmission of laser radiation to levels at or below the appropriate ocular MPE for any laser used in the treatment area. It should be noted that normal window glass has an optical density in excess of 5.0 and therefore should be appropriate for CO2 lasers at 10:600 µm. Other lasers require the facility windows to have additional coverings or filtering. While it is important that the entryway to the laser room or treatment area be secured, it is equally important that emergency entry be permitted at all times. For this reason, internal locks are not advisable. If a laser, fire, or explosion should occur, an internally locked door could prevent appropriate emergency response. It is important to have proper safety equipment within the treatment environment.This includes proper eye protection for all staff, as well as the patient, a fire blanket, and a fire extinguisher available. Of equal importance is an appropriate laser plume evacuation device. In most cases, standard surgical wall suction does not suffice.
TRAINING It is imperative that all personnel using medical lasers be properly trained and that appropriate laser safety protocol exist within each facility. Acceptable standards dictate that an individual designated as a laser safety officer be in charge of developing criteria and authorizing procedures involving the use of lasers within the facility, and ensuring that adequate protective measures for control of laser hazards exist and that there exist a mechanism for reporting accidents or incidents involving the laser.
9
It is also important that accurate records be maintained for lasers, as well as laser-related injuries.
SUMMARY Lasers can be employed in a variety of medical settings.When used properly, lasers can provide dramatic improvements in the quality of patient care. However, as with any medical procedure, complications can and do occur. Close adherence to standard accepted laser safety protocols can dramatically reduce that risk and improve the quality of patient care.
REFERENCES 1. Sliney DH,Trokel SL. Medical Lasers and Their Safe Use. New York: Springer-Verlag, 1992. 2. ANSI Z-136.3-2004: American National Standard for Safe Use of Lasers in Health Care Facilities –. New York: American National Standards Institute, 2004. 3. Smalley P. Laser safety management; hazards, risks, and control measures. In: Alster T, Apfelberg D, eds. Cutaneous Laser Surgery. New York:Wiley-Liss, 1999. 4. ANSI Z-136.3:The Standard For the Safe Use of Lasers in Health Care Facilities. New York: American National Standards Institute, 2004. 5. Sliney DH. Laser safety. Lasers Surg Med 1985;16:215–25. 6. US Department of Labor, Title 29: Codes of the Federal Regulations, Occupational Health and Safety. 7. ANSI Z-136.3-1996: American National Standard for Safe Use of Lasers in Healthcare Facilities. New York: American National Standards Institute. 8. Wood RL, Sliney DH, Basye RA. Laser reflections from surgical instruments. Lasers Surg Med 1992;12:675–8. 9. Ries WR, Clymer MA, Reinisch L. Laser safety features of eye shields. Lasers Surg Med 1996;18:309–15. 10. Olbricht SM, Stern RS, Tany SV, Noe JM, Arndt KA. Complications of cutaneus laser surgery. A survey. Arch Dermatol 1987;103:345–9. 11. Baggish MS. Complications associated with CO2 laser surgery in gynecology. Am J Obstet Gynecol 1981; 139:658. 12. Fretzin S, Beeson WH, Hanke CW. Ignition potential of the 585nm pulse dye laser; Review of the Literature and Safety Recommendations. Dermatol Surg 1996;22: 699–702.
01 Carniol-8028.qxd
8/23/2007
3:30 PM
Page 10
02 Carniol-8028.qxd
8/23/2007
10:24 AM
Page 11
2. Evaluation of the aging face Philip J Miller
INTRODUCTION In this chapter, we will explore the algorithm involved in analyzing the aging face. But before we even begin that journey, we must ask the question ‘What is an aged face?’ While the answer may seemingly be self-apparent, further contemplation reveals a complexity not first appreciated. For starters, when is the face considered ‘aged’? Secondly, are all ‘aged features’ that we would typically list a result of aging? And finally, do we have a comprehensive and detailed understanding of the pathophysiology of facial aging, which serves as the foundation for our analysis?
WHAT IS AN AGED FACE While the jury may still be out regarding when life actually begins, one could argue that death begins at the moment of conception! Life is nothing more than the balance between anabolic activities and catabolic activities. Throughout our life, the ratio of anabolic and catabolic states simply switches. Somewhere along that continuum, we begin to demonstrate findings on the outside of our body, particularly the face, where the catabolic process has increased its relative strength compared with the anabolic process. From that movement on, at different rates and in different ratios, mixed with different environmental exposures, these processes determine the resulting ‘aged appearance’ of any one person. What is considered an aged face in one society may not in fact be so in another society.We are quite aware of the tremendous respect and honor awarded to
seniors in the Asian community – and, sadly, not so present in the Western world.Typical features that we would readily find people wanting to correct in the West may in fact be worn as a badge of honor in the East. Nevertheless, those features are still a result of the aging process, and identifying them is the purpose of this chapter.
ARE ALL FEATURES OF AN AGED FACE DUE TO THE AGING PROCESS? As Fig. 2.1 demonstrates, a typical aged face will consist of a myriad of features. However, further inspection reveals that these features can be divided into two different categories. One category is chronological aging alone.These are the features that are never seen in youthful individuals, they occur as one ages, and almost everyone who is aged has them. The second
Aged features
Chronological features:
Morphological features:
Those features that appear in nearly all aged individuals, and are not present in the young
Those features that appear in nearly all aged individuals, but are also present in some youthful individuals
Fig. 2.1 The breakdown of aged features into chronological and morphological features.
02 Carniol-8028.qxd
12
8/23/2007
10:24 AM
Page 12
Clinical procedures in laser skin rejuvenation
Table 2.1 Example of age-specific and non-age-specific features Aged features
Youthful features
It depends!!!!
• • • • • • •
• • • • •
• • • • •
Wrinkles, fine and coarse Malar depressions Furrows Skin excess Actinic changes Mandibular teeth showing Submental fat accumulation
Overall facial fullness/volume Prominent cheeks Plump lips Smooth, unblemished skin Maxillary teeth visible
category, I would like to refer to as morphological features.These are features that, although possessed by all aged people, are present in some individuals even in their youth. Examples of these two categories are listed in Table 2.1. It is interesting to note that features such as a nasojugal groove or a low-hanging upper lid crease or even a deepened nasolabial groove are present in some 6-year-olds. These individuals are certainly not chronologically aged, nor do they appear to appear old. Nevertheless, they certainly possess some of the very features that we readily admit to appearing in the aged face.
PATHOPHYSIOLOGY OF AGING A thorough analysis of the aging face begs us to ask us how it got that way. My impression is that the current pathophysiological model of facial aging is in its infancy, and we will see a rapid, indeed exponential, rise in our understanding of the pathophysiology of facial aging over the next two decades. Prominent in this model will be an ever-increasing role of facial volume depletion as contributing to – if not primarily responsible for – the ultimate contour irregularities and transformations that occur in the aged face. The old model of loss of elasticity, and sagging due to gravity, will be replaced by a more detailed and comprehensive understanding of the individual role of and complex interaction among • skin aging • skeletal remodeling • fat pad atrophy
Low lid crease Low brows Thin lip Nasojugal groove Nasolabial folds
• subdermal fat loss • fat deposition Furthermore, we will find that these processes inevitably exerts their effects on two anatomical components that are fixed: the muscle attachments to the bone and the osseocutaneous ligaments.This complex reaction of changes and exertions is subject to gravitational forces, resulting in a more typical aged facial appearance. Adding to that an increase in muscle tone in order to maintain facial function, particularly in the periorbital region, so that decreased visual fields are eliminated by contracting the frontalis, gives the characteristic superficial skin findings associated with the aged face.
YOUTH VERSUS BEAUTY Where do we begin the aging facial analysis? Do we start from the surface and proceed sequentially with our assessment layer after layer? Do we begin at the scalp and then proceed inferiorly towards the neck? Do we start at the nasal tip and work posteriorly? Do we make a global assessment and then work to the specific areas? Does it matter? I believe that the analytical algorithm that one uses is not nearly as important as the ‘ideal’ with which the patient is being compared. Thus, the real question in ‘aging face analysis’ is not so much ‘Why do they look old?’ as ‘with what are we comparing the patient’s face?’Are we trying to restore the patient to their own youthful appearance or to an idealized youthful appearance? Do most patients wish to be ‘restored’ to a prior
02 Carniol-8028.qxd
8/23/2007
10:24 AM
Page 13
Evaluation of the aging face
Fig. 2.2 Twins with very different upper eyelid formations. The female’s upper lids are age-appropriate and beautiful, but could be considered ‘aged’ if these very same features presented themselves in a 40-year-old.
age, or to look more refreshed and rejuvenated, but still look their ‘age’. Is there not a component of their desire, in fact, that struggles with the desire to improve their appearance while maintaining their essential features? Here it is worthwhile to explore the concept of ‘ageless beauty’ – which is ultimately the goal of the aging face surgery that we perform. ‘Aging face surgery’ is really a poor term, because it is not really youthfulness alone that we are attempting to achieve. Age does not necessarily make one less or more attractive – although it does play a role. Therefore, beauty and youth are not necessarily one and the same.Youth, in my opinion, is not our goal as much as an ageless appearance, not a particular time period in the patient’s past. The best result is a face whereby you cannot tell the patient’s age. One looks at the postoperative face (not compared with the preoperative face) and cannot tell whether the patient is 25 or 40. They possesses volume and fullness. Their face is ageless. It should be kept in mind that youth is not necessarily attractive. If we were capable of magically restoring our patients to their most desirable youthful state, would they be completely satisfied? Some patients would be, but others would not. For these patients, ‘aging face procedures’ means not only correcting an
13
aging face or features, but also aesthetic facial features by which we are asked to alter their appearance to make them more attractive.Therefore, ‘aging face analysis’ may mean a collection of aged and not necessarily aged features that the patient possesses to make them more attractive and appear more youthful. It should be kept in mind that we want to do that without altering those characteristics that are essential to the person’s uniqueness – those essential features that make us look undeniably who we are.These features may consist of the slight slant of the palpebral aperture, the position of the malar fat pad, the dimple on the cheek, the cleft in the chin, or the fullness of the upper lid. Over the years, some of these features have been routinely and erroneously thrown in with the list of aging face features. Consequently, we are quick to identify them as ‘aged’ and to eradicate them or modify them in an effort to create an idealized youthful appearance by removing all that is considered aged. Obviously, those features that are essential to one’s uniqueness should not be tampered with. A wonderful example of this is seen in my twins (Figure 2.2). My son has a very prominent upper eyelid crease, whereas my daughter has a much fuller upper eyelid crease with a lower brow. While typically a lower brow and upper eyelid fullness is deemed to be a classic sign of an aging face, requiring intervention, I submit that this particular feature in my daughter is her ‘essence’ and should not be at all manipulated now or 40 years from now. We have seen this as well in two classical examples, one being Mr Robert Redford and the second Mr Burt Reynolds. Both of their periorbital procedures resulted in what would be considered a youthful appearance. But their results occurred at the expense of removing their essential upper eyelid features.Those essential features for decades had been their ‘brand’; a masculine hooded upperlid with a low brow. Therefore, it is important to recognize that in performing aging face analysis, one needs to separate the analysis performed on a patient’s features that most likely were a result of the aging process and those that were never present at all and would in fact make this individual appear perhaps more attractive. For the sake of this chapter, we will focus exclusively on those features that are a result of the chronological process.
02 Carniol-8028.qxd
14
8/23/2007
10:24 AM
Page 14
Clinical procedures in laser skin rejuvenation
Table 2.2 Fitzpatrick skin types Type
Color
Reaction to UVA
Reaction to sun
I
Very sensitive
III
Caucasian; blond or red hair, freckles, fair skin, blue eyes Caucasian; blond or red hair, freckles, fair skin, blue or green eyes Darker Caucasian, light Asian
Sensitive
IV
Mediterranean,Asian, Hispanic
Moderately sensitive
V
Middle Eastern, Latin, light-skinned black, Indian Dark-skinned black
Minimally sensitive
Always burns easily, never tans; very fair skin tone Usually burns easily, tans with difficulty; fair skin tone Burns moderately, tans gradually; fair to medium skin tone Rarely burns, always tans well; medium skin tone Very rarely burns, tans very easily; olive or dark skin tone Never burns, deeply pigmented; very dark skin tone
II
VI
Very sensitive
Least sensitive
Table 2.3 Glogau wrinkle scale Skin type
Age (years)
Findings
1. no wrinkles 2. wrinkles in motion
Early 20s or 30s 30s to 40s
3. wrinkles at rest
50 plus
4 only wrinkles
60 or 70s
Early photoaging: early pigmentary changes, no keratoses, fine wrinkles Early to moderate photoaging: early senile lentigines, no visible keratoses, smile wrinkles Advanced photoaging: dyschromia and telangiectasia, visible keratoses, wrinkles at rest Severe photoaging: yellowish skin color, previous skin malignancy, generalized wrinkling
SKIN Among the absolute hallmarks of an aging face are the changes associated with the skin. The most common changes associated with facial skin aging are those due to photoaging (skin damage related to chronic sun exposure). This results in dyspigmented, wrinkled, inelastic skin, with associated redness and dryness. Furthermore, mild to moderate facial wrinkling and laxity with benign and malignant lesions round out the skin changes that should be addressed through many of the techniques presented in this book. See Tables 2.2 and 2.3, which show the Fitzpatrick and Glogau classifications of skin types and wrinkles respectively.
VOLUME LOSS It is easy to overlook this particular component of facial aging. Since surgical procedures reposition and lift, it is
only natural, but incorrectly, assumed that the cause of that descent is skin laxity and gravity. However, on further examination, evaluation, and analysis, it is clear that descent and laxity can result from volume loss. As illustrated in Figure 2.3(a), a fully inflated balloon appears robust and lacks contour abnormalities. However, as seen in Figure 2.3(b), a deflated balloon has the potential to not only descend, but also become deformed.The difference between Figure 2.3(a) and 2.3(b) is nota general laxity of the balloon’s tarp, but rather the volume inside the balloon. Reinflating the balloon, as opposed to repositioning the tarp, is responsible for eliminating all of those identifiable features. Likewise, many of the features that we will discuss below are in part due to a loss of volume, and one should train one’s eyes to appreciate that volume loss in the following areas: the temporal fossa, the lateral brow, and the malar eminence. Furthermore, volume loss may be seen in the lips and perioral region. Finally, it should be appreciated that overall loss of volume in
02 Carniol-8028.qxd
8/23/2007
10:24 AM
Page 15
Evaluation of the aging face
a
15
b
Fig. 2.3 Two identical balloons.The one in (a) is inflated and is rigid and wrinkle-free.The one in (b) is partially deflated, its surface contains ripples, like wrinkles, and it is lax and subject to deformation from wind or gravity. Human skin is like the tarp on these balloons. Fully inflated skin appears youthful and robust. Deflated skin sags and reveals wrinkles and furrows.
the subcutaneous tissue can make certain bony features much more prominent along the infraorbital rim, as well as the submandibular triangle, wherein the submaxillary gland appears quite prominent.
CHIN POSITION The next step in the facial analysis process is to assess the location of the chin in relationship to the patient’s lower lip as well as the surrounding tissue. One should look for the appearance of jowling, chin ptosis, chin retrusion, submental fat accumulation and severe neck skin laxity. Following the path of the mandible
posteriorly, the next assessment is the general protuberance and width of the angle of the mandible. Atrophy and medial displacement of the angle of the mandible or atrophy of the masseter muscle can in fact contribute to a narrow and withdrawn facial contour. The nasolabial lines are now assessed for their presence and degree, as well as for the contribution made to these lines by ptotic skin and subcutaneous tissue superior to them. In my experience, the presence of a nasolabial fold is less due to ptosis of the malar fat pad than to atrophy of the malar fat pad with resulting ptosis (see the balloon concept illustrated in Figure 2.3) of the resulting subcutaneous tissue. Elevation of the malar tissue superiorly and slightly posteriorly assesses
02 Carniol-8028.qxd
16
8/23/2007
10:24 AM
Page 16
Clinical procedures in laser skin rejuvenation
the degree of laxity, as well as the overall effect of repositioning this tissue to efface the nasolabial line and to reinflate the malar mound.
PERIORAL REGION The lips are now evaluated for the prominence of the white roll, the philtral ridge, and robust red lips. The maxillary teeth should be visible and the mandibular teeth hidden.White lip wrinkles are also assessed.
PERIORBITAL REGION Finally, attention is then directed towards the periorbital region. Signs of upper lid ptosis are identified and documented. Lower lid laxity and position are identified and documented. Brow position is similarly considered. Unlike the current trend of repositioning the brow cephalically, I find that a lower placed brow in both women and men, in combination with a more robust lateral brow fullness, provides a sophisticated and ageless appearance. An overly elevated brow does not convey youth. It conveys surprise.The absence and presence of forehead, glabellar, and periorbital rhytids are evaluated and documented. Lower lid pseudoherniation of fat is noted, as is the presence of an infraorbital hollow. The degree of nasojugal depression is documented, and photographs taken at an earlier age are reviewed to ascertain which of the facial features were present in youth and which were subsequently acquired with aging.
SUMMARY Technical expertise, however important to obtaining excellent and consistent results, is only part of the equation. The wrong technique performed flawlessly will typically reveal a result that is below par, while the correctly chosen procedure performed just satisfactorily typically results in acceptable if not extraordinary results. We can only recommend the most suitable procedure if we perform a thorough and accurate analysis, and that analysis includes not only an assessment of the patient’s facial features, but also their desires, expectations and their notions on which procedures they feel most comfortable with to get there.Therefore, proper and thorough analysis is paramount for it will lead us to selecting the most appropriate treatment plan and consequent results for any individual patient and thus predictable and consistent outcomes. Nevertheless, analysis cannot be learned in a vacuum. Analysis inevitably requires that we compare it with an idealized version, and even then it requires us to understand the pathophysiology by which we got to that point, and then we must correlate those findings with a suitable treatment.
PLAN Knowledge in all of these domains and re-exploring all of these disciplines are essential parts of our growth as physicians.
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 17
3. Carbon Dioxide Laser Resurfacing, Fractionated Resurfacing and YSGG Resurfacing Dee Anna Glaser, Natalie L Semchyshyn and Paul J Carniol
INTRODUCTION Although skin resurfacing has been performed for centuries in the forms of chemical peels, sanding, and dermabrasion, it was not until the 1990s that lasers were safely and effectively used as a resurfacing tool. Initially, carbon dioxide (CO2) lasers with a wavelength of 10 600 nm (1006 µm) were used as a destructive tool. Technology advanced quickly in the 1990s from continuous-wave CO2 lasers to pulsed CO2 lasers to help minimize the thermal damage produced by the older CO2 lasers. Ultrashort pulse technology emerged, as did computerized pattern generator (CPG) scanning devices that allowed for a more standardized delivery of the laser pulses. Because of the prolonged healing required and the risks associated with CO2 lasers, the erbium :yttrium aluminum garnet lasers (Er:YAG) lasers with stronger water absorption (2940 nm) and less thermal damage were developed. Er:YAG lasers proved to be excellent ablative tools, with shorter healing times, but did not provide the same tightening that was achievable with CO2 resurfacing. The next advance came in the form of erbium lasers with longer pulse widths that could provide more heating and thermal damage in the skin. The short-pulsed erbium lasers were combined with CO2 lasers and long-pulsed Er:YAG lasers to try to blend the benefits of shorter healing times with more substantial skin tightening. Attempts to improve the laser resurfacing technique continue to be studied, with a concentrated effort now looking at nonablative options to induce
dermal remodeling and fractionated skin resurfacing to minimize the risks from skin ablation and to shorten the healing times for patients. This chapter will focus on ablative resurfacing, with an understanding that the principles behind good patient selection and care will remain paramount despite continued changes in the lasers that might be developed.
INDICATIONS The most common uses for laser skin resurfacing are to treat wrinkles and acne scars of the face. Any epidermal process should improve with laser resurfacing, including lentigines, photoaging, actinic keratosis, and seborrheic keratosis (Box 3.1). Some dermal lesions, such a syringomas, trichoepitheliomas, and angiofibromas, will improve with laser resurfacing, but results will vary with the histologic depth of the process. In our experience, there is a high recurrence rate with dermal lesions. Actinically induced disease, including actinic keratosis (AK) and actinic cheilitis, can respond very well to laser resurfacing. Superficial and nodular basal cell carcinomas have been successfully treated with the UltraPulse CO2 laser. The cure rates achieved by Fitzpatrick’s group was 97% in primary lesions (mean follow-up 41.7 months).1 In addition, the use of laser resurfacing may be used prophylactically to reduce the risk for the development of future AK and AK-related squamous cell carcinoma.2 Prevention of some basal cell carcinomas may be achieved, although this has not been definitively demonstrated.3
03 Carniol-8028.qxd
18
8/23/2007
10:25 AM
Page 18
Clinical procedures in laser skin rejuvenation
Box 3.1 Indications for laser skin resurfacing • • • • • • • • • •
Photodamage Rhytids Acne scars Benign adenexal tumors Benign epidermal growths Rhinophyma Actinic cheilitis Actinic keratosis Basal cell carcinoma Scar revision
Despite the multiple uses, by far the prime use in our office is for the improvement of facial photoaging, rhytids, and acne scars.To date, ablative laser resurfacing is the most efficacious technique we have to treat perioral rhytids (Fig. 3.1). a
b
Fig. 3.1 Significant reduction in perioral rhytids at 4 months.
PATIENT SELECTION The key to successful laser resurfacing is proper patient selection (Table 3.1). Potential candidates need to have a realistic expectation of the outcome, risks, and significant amount of time required to heal, as well as the time to see the final results. The ‘ideal’ patient has fair skin with light eyes, has no history of poor wound healing, and is comfortable with wearing make-up during the postoperative healing period.The history should specifically address issues that relate to wound healing, such as immunodeficiency, collagen vascular diseases, anemia, diet, scarring history, keloid formation, recent isotretinoin usage, and past radiation therapy to the area. The history should include the patient’s general health, current or past medications, and mental health issues. Diseases known to koebnerize are also a relative contraindication – these include psoriasis, vitiligo, and lichen planus. Diseases that reduce the number of adenexal glands or alter their function are relative contraindications and need to be reviewed – these include collagen vascular diseases such as systemic lupus erythematosus and scleroderma. A history of herpes, frequent bacterial infections, or frequent vaginal candidiasis is not a contraindication, but should be noted to better plan how to treat the patient during the perioperative period. Equally important is to ascertain the pigment response of the patient (in terms of hyperpigmentation or hypopigmentation) to sun exposure or injuries. In our experience, patients with Fitzpatrick skin type IV are some of the most challenging to treat due to their risks of postoperative dyschromias. Patients will need to avoid sun exposure for several months after the surgery, and the physician needs to document the patient’s ability to do so along with their ability to use broad-spectrum sunscreens daily. In the Midwest of the USA, with four distinct seasons, it is preferable to perform deep resurfacing procedures during the winter months to minimize sun exposure. However, a thorough review of a patient’s travel plans during the 3- to 4-month healing period then becomes important. Although most patients recognize the risks of a trip to a warm sunny destination, many may underestimate the risks with higher altitudes such as with snow skiing.
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 19
Carbon dioxide laser resurfacing, fractionated resurfacing and YSGG resurfacing
19
Table 3.1 Patient selection Absolute contraindications
Relative contraindications
Unrealistic expectations Unable/unwilling to perform wound care Isotretinoin therapy within prior 6–12 months
Tendency to keloid formation Tendency to poor wound healing/scar History of radiation therapy in area History of collagen vascular disease History of vitiligo Diseases that koebnerize (e.g., psoriasis) Pregnancy/breastfeeding Unable/unwilling to avoid sun exposure postoperatively
PROCEDURE Preoperative care The preoperative care should begin at the time that the patient decides to undergo laser skin resurfacing. Photoprotection and prevention of tanned skin should be maximized before surgery. Melanocyte stimulation before the laser resurfacing may increase the risk of postinflammatory hyperpigmentation after the procedure.A sunscreen with a sun protection factor (SPF) of 30 or higher should be used daily, along with an ultraviolet A (UVA) blocker such as zinc oxide, titanium dioxide, or avobenzone. We advise patients to supplement sunscreen use with physical measures such as large sunglasses and hats. The use of topical therapy before surgery is common – this might include topical tretinoin, hydroquinone and antioxidants. It is clear that the use of a topical retinoid is quite valuable before skin resurfacing with chemical peels through its action on the stratum corneum and epidermis. The use of topical tretinoin can increase the penetration of the peel, provide a more even peel and enhance healing.4,5 Due to the high affinity for water with the CO2 and Er:YAG lasers, these lasers are very capable of evaporating the epidermis without the use of tretinoin. There may be other effects that could theoretically improve the laser resurfacing process and healing. Retinoids regulate gene transcription and affect activities such as cellular differentiation and proliferation. They can induce vascular changes of the skin and a reduction and redistribution of epidermal melanin.6 Retinoids (at least theoretically) can speed healing and perhaps
reduce pigmentary changes. Thus, it is our practice to begin a topical retinoid at least 2 weeks prior to the procedure – even earlier if possible. Because of the relatively common development of postinflammatory hyperpigmentation after laser resurfacing, especially in the darker skin tones, many physicians will pretreat with a bleaching agent such as hydroquinone (HQ). HQ works by inhibiting the enzyme tyrosinase, which is necessary for melanin production within the epidermis. It can also inhibit the formation of melanosomes. There is a clear role for HQ products after laser resurfacing to treat hyperpigmentations; this will be discussed later in the chapter. HQ may not have any clinical effect when used prior to laser surgery, since the melanocytes that it is working on are all removed during the laser procedure. It is certainly not unreasonable to initiate HQ in a 3–5% cream for those patients at high risk for developing hyperpigmentation after their procedure. Like the topical retinoids, it can be irritating and should be discontinued if it is causing an irritant dermatitis. A rare side-effect of HQ is exogenous ochronosis, but this usually occurs only with prolonged use of higher concentrations and should not develop even in predisposed individuals within just a couple of weeks.7 There is no proven role for the use of topical antioxidants, alpha-hydroxy acids, or beta-hydroxy acids, but they are often in the skin care regimen of patients and we do not discontinue their use prior to laser resurfacing. Tobacco smoking can delay wound healing, and patients are strongly encouraged to stop tobacco use.As an alternative, if the patient is unable or unwilling to stop smoking at least 2 weeks prior to the
03 Carniol-8028.qxd
20
8/23/2007
10:25 AM
Page 20
Clinical procedures in laser skin rejuvenation
procedure, he or she is encouraged to switch to a tobaccoless product such as a patch or gum. The use of oral antiviral therapy is standard practice, even if the patient does not have a history of herpes simplex virus (HSV) infections. Typically, famciclovir or valacyclovir is used in prophylactic doses such as famciclovir 250 mg twice daily or valacyclovir 500 mg twice daily. Doses need to be adjusted for renal dysfunction.The patient begins therapy the day before the procedure and continues until re-epithelialization is complete. It can be helpful to keep antiviral therapy in the office to administer to the patient if he or she forgot to initiate therapy before the procedure. The use of prophylactic systemic antibiotics is of questionable value prior to surgery and remains controversial.8 A first-generation cephalosporin is typically used by one of us (NLS), while no antibiotics are routinely used by the other (DAG). Interestingly, recent animal studies have shown that CO2 laser resurfacing reduces microbial counts of most microorganisms on lasered skin compared with skin treated using mechanical abrasion.9 On the other hand, nasal mupricin is routinely prescribed (by DAG) for healthcare workers due to the current high rates of methicillin-resistant Staphylcoccus aureus (MRSA) in hospitals and nursing homes. Unfortunately, the incidence of MRSA in the community is also increasing, and MRSA may be encountered in non-healthcare workers.10,11 Surgeons should monitor their local communities for recommendations regarding community-acquired MRSA. There have been no published studies on the use of antifungal therapy prior to laser resurfacing, although Candida infections can develop during the postoperative period, especially when occlusive dressings are used. It has been our practice, and that of others, to treat women with a known history or frequent or recurrent vaginal candidiasis with oral fluconazole after the procedure, even when using open healing techniques.9 Botulinum toxin is routinely administered to our patients prior to laser resurfacing of the face. Placebocontrolled studies have demonstrated improved results when compared with laser resurfacing alone.12,13 Preoperative use of botulinum toxin type A can diminish rhytids as well as textural, pigmentational and other features of skin aging when used in conjunction with
laser resurfacing.13 Our preference is to treat at least 2 weeks prior to laser surgery and repeat at approximately 3 months postoperatively. Patients are given instruction sheets listing skincare items they will need after the procedure along with their prescriptions for postcare medications. These will be discussed later in the chapter.
Laser resurfacing Before coming into the office for their procedures, patients are instructed to wash their face well. After drying, they apply a topical anesthetic cream such as EMLA (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) under occlusion with a plastic wrap. This is left intact for 2–2.5 hours. One of us (NLS) will reapply the topical anesthetic 45 minutes prior to the procedure. The EMLA not only helps to provide cutaneous anesthesia, but also hydrates the skin, which decreases the procedure’s side-effect profile.14 Further anesthesia or analgesia can be obtained with nerve blocks, local infiltration of lidocaine, tumescent anesthesia or diazepam, and, in our office, intramuscular meperidine and midazolam, or ketorolac, is used.The topical agents are removed prior to beginning the laser procedure. When using the UltraPulse CO2 laser (Lumenis, Santa Clara, CA), the face is treated at 90 mJ/45 W, and the first pass is usually performed at a density of 7 for central facial areas (periorbital, glabellar, nose, and perioral): the upper and lower eyelids are treated at a density of 6 with the energy setting at 80 mJ.The density should be decreased to 6 and then 5 when feathering to the hairline and jawline. The first pass is intended to remove the epidermis, which is wiped free with a wet gauze in the central facial areas only, and a second pass is performed to central facial areas at a density of 4–5 (90 mJ), depending on the tightening needed. If required, the second pass on the eyelids is performed at a density of 4. Energies are decreased towards the periphery of the face. A third pass may be needed in areas of acne scarring or in the perioral area with deeper wrinkles. As with any laser procedure, careful monitoring of tissue response during treatment is performed to determine the necessity of any additional passes and energy level used.
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 21
Carbon dioxide laser resurfacing, fractionated resurfacing and YSGG resurfacing A similar approach is taken when using one of the combined Er:YAG lasers such as the Sciton laser (Palo Alto, CA).The first pass is used to remove the epidermis and frequently 25 J/cm2 (100 µm ablation, zero coagulation) with 50% overlap is used. A second or third pass is used to heat and hopefully to induce skin tightening. Ablative and coagulative settings are used with a typical second, pass and a commonly used setting would have 50% overlap with 10 µm ablation and 80 µm coagulation. Where there are very deep rhytids or scars, the erbium laser in just the ablative setting can be used in a single spot to help sculpt the edges. It is important to remember that when used in the ablative mode, there is very little (if any) hemostasis, and pinpoint bleeding can help identify the depth of resurfacing. Laser resurfacing is best done to the entire face to avoid lines of demarcation between treated and untreated skin.The procedure should be carried into the hairline and at the jaw and chin; a feathering technique should be used. This includes a zone of decreased energy, decreased density, or pulse overlap.When treating a patient with moderate to severe photodamage, it is important to blend into the neck as much as possible. One approach is to lightly resurface the neck with a chemical peel; in our office, a Jessners and/or glycolic acid peel is used. Another option is to laser the neck, which will be reviewed later in the chapter.
Postoperative care Wound care is critical, and regimens vary among physicians. Occlusive and nonocclusive dressings are available. Occlusive dressings cover the skin and are usually removed in 1–3 days. These can decrease patient discomfort, but may promote infection by harboring bacteria or yeast. When opaque, the dressings can mask visualization of the wound, thus delaying the detection of an infection. Clear dressings (e.g., Second Skin) allow the patient and medical team to look at the lasered skin. When used in our office, they are most commonly removed on the second day postoperatively and the patient is switched to open healing. Open dressings or nonocclusive dressings are usually petroleum-based ointments. Frequent soaking and
21
cleaning are necessary (at least 4 times daily), followed by frequent application of petroleum jelly, Aquaphor ointment or one of the many wound care ointments that are available. Additives, fragrances, or dyes will increase the chance of contact allergic or irritant dermatitis developing and should be limited as much as possible. In very sensitive individuals, pure vegetable shortening can be used. Dilute vinegar can be used to soak and debride the wound, promote healing, and inhibit bacterial growth. Wound care needs to be performed until reepithelialization is complete. Depending on the type of laser used and how aggressive the surgeon was with his or her settings, re-epithelialization should be complete within 5–10 days. Prolonged healing times can indicate an infection, contact dermatitis, or other problem, and increases the risks of complications.
COMPLICATIONS AND THEIR MANAGEMENT Complications following laser surgery are relatively infrequent, but when they do occur, they need to be treated quickly and efficiently to minimize patient anxiety and long-term morbidity.15 Obviously, good patient selection, surgical management, and postoperative care are necessary to help prevent complications, but, even in the best of cases, complications do occur (Box 3.2).
Box 3.2 Complications of ablative laser resurfacing • • • • • • • • • • • •
Activation of herpes simplex virus (HSV) Bacterial infection Candidal infection Delayed healing Prolonged erythema Hyperpigmentation Hypopigmentation Acne Milia formation Contact dermatitis Scarring Line of demarcation with untreated skin
03 Carniol-8028.qxd
22
8/23/2007
10:25 AM
Page 22
Clinical procedures in laser skin rejuvenation
Table 3.2 Causative agents encountered in CO2 laser infections16 Organism
Pseudomonas Staphylococcus aureus S. epidermidis Candida Enterobacter Escherichia coli Proteus Corynebacterium Serratia Herpes simplex virus (HSV)
a
Percent
41.2 35.3 35.3 23.5 11.8 5.9 5.9 5.9 5.9 5.9
b
The most common complications seen immediately postoperatively are swelling and exudative weeping related to the degree of wounding. If facial swelling is severe, oral or intramuscular steroids, and non steroidal anti-inflammatory agents (NSAIDs) can be administered. Milia formation is common, with the development of small white papules, usually < 1mm in size, which need to be distinguished from pustules. Papules are an occlusive phenomenon, and will resolve without treatment. Infections can occur, and may be bacterial, viral, or fungal in nature (Table 3.2).16 Signs and symptoms include pain, redness, pruritus, drainage (usually not clear), yellow crusting, and sometimes erosions, vesicles or pustules may develop (Fig. 3.2). Pruritus, especially, should alert the physician to a possible infection. Appropriate evaluation may include tzanck smear, potassium hydroxide (KOH) prep, gram stain, and cultures to accurately diagnose the causative agent. Treatment should begin early, pending culture results. Fitzpatrick’s group found that half of their patients who developed a post-laser infection had more than one microorganism. Thus, broad coverage should be initiated, and should generally include an agent that will cover Pseudomonas aeruginosa. Acne is another complications that can be seen relatively early in the course. Oral antibiotic therapy and discontinuation of petroleum-based ointments usually suffice. Topical acne therapies are not generally well
Fig. 3.2 A postoperative infection at day 3, with redness, edema, yellow drainage and crusting, and pustules.The patient noted increasing discomfort and pruritus. tolerated, due to skin sensitivity, and need to be used judiciously. Contact dermatitis can occur, and may be due to an allergic reaction or an irritant reaction. It may occur within the first few weeks or months after laser resurfacing. Redness, pruritus, and delayed healing may be noted, but vesiculation is rare. Topical antibiotics are a common cause of allergic contact dermatitis, and should be avoided. Patients may be using them without the knowledge of their physician. Topically applied agents should be reviewed and discontinued. Dyes and fragrances that are added to laundry detergents, fabric softeners, and skincare items are also potential causes. Discontinuation of the offending agent(s) and topical corticosteroids should be initiated early.17
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 23
Carbon dioxide laser resurfacing, fractionated resurfacing and YSGG resurfacing
23
PIGMENTARY ABNORMALITIES Hypopigmentation Lightening of the skin is desirable for most patients undergoing facial rejuvenation. Patients who undergo resurfacing of cosmetic units such as the perioral area or periocular area may exhibit a noticeable difference between the ‘new’ treated skin and the untreated skin that exhibits the various dyschromias associated with photoaging.This should be avoided as indicated previously, but when faced with such a patient, treating the remaining skin will lighten the hyperpigmentation and help to blend in the differences.Although topical agents such as retinoids and hydroquinones can be used, visible results take months and are not practical for most patients. Resurfacing is the fastest way to improve patients’ appearance in these cases. Depending on the severity, a chemical peel such as a Jessner’s/35% trichloroacetic acid (TCA) peel may be sufficient, or laser resurfacing can be performed. Superficial resurfacing is all that is required for most, and the Er:YAG laser is an excellent device.The goal is to remove the epidermis, and one or two passes maybe all that is required. This heals rapidly and with minimum risks. In the very sun-damaged patient, it may be difficult to find a good stopping point. In these instances, treating the full face may only accentuate the discoloration of the neck. Light rejuvenation of the neck can be done, but may accentuate the damage to the chest. Light resurfacing can be performed down the neck and chest area, extending onto the breast – but this may then accentuate the damage to the arms and forearms, etc. In these patients, a combination of modalities can be used: topical agents as described above for the entire area; laser resurfacing of the face; lighter resurfacing of the neck and chest (we generally use chemical agents such as 20–30% TCA or 70% glycolic acid, but Er:YAG laser resurfacing is used successfully by many physicians); and chemical resurfacing of the arms, forearms, and hands with 20–30% TCA or 70% glycolic acid. Another option is the use of nonablative laser technology such as the ‘Photofacial’ technique. Several intense pulsed light (IPL) systems are now available, which use a broad-spectrum intense pulsed light source with changeable crystals attached to the hand-
Fig. 3.3 Persistent depigmentation 2½ years following CO2 laser resurfacing that was performed in the perioral area only.
piece to filter out undesirable wavelengths. This modality has been applied to the face, neck, chest, and upper extremities. Numerous treatment sessions are required, but are generally well tolerated, with little to no ‘healing-time’ for the patient.The fluence varies with skin type and area, but the neck is generally treated more conservatively and using lower fluences. It is important that the operator carefully place the filters to avoid overlapping and also to prevent skipped areas or ‘footprinting’.
Depigmentation True depigmentation of the skin following laser resurfacing is more difficult to treat than the pseudohypopigmentation described above. The skin acquires a whitish coloration and does not flush or change color with normal sun exposure (Fig. 3.3). A slight textural change can even be noted at times such that make-up does not ‘stick’ to the skin well or does not last as long as make-up applied to other areas. The latter represents superficial scarring or fibrosis. It can occur after any form of resurfacing, but it is more commonly encountered with CO2 laser resurfacing and is much less common with Er : YAG resurfacing. Like pseudohypopigmentation, depigmentation seems to be more
03 Carniol-8028.qxd
24
8/23/2007
10:25 AM
Page 24
Clinical procedures in laser skin rejuvenation
evident when cosmetic units are treated individually or when a cosmetic unit such as the upper lip is treated more aggressively than the surrounding skin. Depigmentation has been considered a permanent complication of CO2 laser resurfacing.When evaluated histologically, there is a varying quantity of epidermal melanin present. Residual epidermal melanocytes are present, indicating that repigmentation should be possible. Mild perivascular inflammation has been noted in 50% of biopsies, and superficial dermal fibrosis was present in all biopsies.18 This suggests that the pathogenesis of the laser-induced hypopigmentation may be related to a suppression of melanogenesis and not complete destruction of the melanocytes. Grimes et al18 have reported successful treatment of hypopigmentation following CO2 laser resurfacing using topical photochemotherapy twice weekly.18 Seven patients were treated with topical 8-methoxpsoralen (0.001%) in conjunction with UVA therapy. Moderate to excellent repigmentation was demonstrated in 71% of the patients. Using the same reasoning, narrowband UVB and an eximer laser may both be effective. Narrowband UVB, which emits at 311–312 nm, has been reported to be efficacious for vitiligo, while excimer lasers emit at 308 nm and can be targeted to a given site.19 Alexiades-Armenakas et al 20 have reported two patients who were treated for laserinduced leukoderma using an excimer laser. They speculate that repigmentation is related to the stimulation of melanocyte proliferation and migration, along with the release of cytokines and inflammatory mediators in the skin. Potential disadvantages of any of these therapies, however, include the time necessary to see repigmentation, cost, erythema and pruritus during therapy, and hyperpigmentation of skin immediately surrounding the treated skin, which can take months to return to normal. Unfortunately, the results are mixed, and return to baseline can occur after therapy is discontinued. Repigmentation has been an unrealistic goal, and until more data are available on investigative tools such as phototherapy, an honest discussion must take place with the patient. Additional resurfacing of the unaffected skin may be helpful to reduce any hyper pigmentation or dyschromia if present, but will only help to reduce the differences with adjacent areas. Once again, care should be taken not to re-treat too aggressively.
Scarring The development of scarring following laser surgery is perhaps the most feared and distressing complication encountered. Deeper wounds are more likely to result in scarring, which is not usually encountered unless the wound extends into the reticular dermis. However, since this is the level that is generally targeted with the CO2 laser to eradicate wrinkles, acne scars, and varicella scars, cosmetic surgeons will be faced with scarring if they perform enough procedures. Hypertrophic scars can develop anywhere, but are most likely to occur around the mouth, chin, mandibular margin, and less often over other bony prominences such as the malar and forehead regions. Nonfacial skin is also more likely to develop scarring due to the relative paucity of pilosebaceous units and adenexal structures. It has been the experience of one of us (DAG) that patients with a history of acne scarring, regardless of prior isotretinoin use, are more likely to develop delayed wound healing and hypertrophic scarring when compared with the average patient. The surgeon should be alerted to possible scarring when there is delayed wound healing for any reason. Infections need to be treated early and aggressively. Candidal, bacterial, and herpetic infections can delay healing, prolong the inflammatory stage, and increase the chance that the wound will heal with scar development. Likewise, contact dermatitis that is not controlled early and poor wound care are potential precursors for postoperative scarring. Early on, the treated skin may appear redder than the surrounding skin. As the process continues, textural changes can be discerned with palpation of the area (Fig. 3.4), and, as time progresses, a mature scar will develop. In the early stages, topical steroids may have a role.A medium to potent steroid should be used twice daily, but should be applied only to the area of concern and not to the entire lasered area. If prolonged erythema alone is noted without any discernible textural changes, a class II or III steroid may suffice but if thickening or induration is present, a class I steroid should be considered.The patient needs to be monitored closely so that steroid-induced atrophy, stria, or telangectasia do not develop and so that progression of the scarring can be followed.
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 25
Carbon dioxide laser resurfacing, fractionated resurfacing and YSGG resurfacing
a
b
Fig. 3.4 (a) Persistent erythema with textural changes at 6 months post CO2 laser resurfacing. (b) Scar development present at the lip 6 months post CO2 laser resurfacing. Intralesional glucocorticosteroids are probably more effective than topical steroids if textural changes and induration have developed.We typically use triamcinolone acetonide diluted to a concentration of 2.5–5 mg/cm3 for facial scars, but will use 7.5–10 mg/cm3 for very thick or indurated scars. A 30-gauge needle is used to minimize further trauma to the area, and the injection is given into the superficial dermis of the scar. Injections can be repeated every 2–4 weeks, depending on the response or progression of the scar. Treatment should be continued until the skin returns to the same texture and consistency as the surrounding tissue. Overtreatment can result in atrophy, and telangectasia can develop. Some surgeons use occlusion therapy in the early stages of scarring. A very large number of silicone gel dressings have become available over the past few years. If utilized, they should be applied to the scar daily and worn for 12–24 hours per day as tolerated. A mild dishwashing detergent can be used to clean the
25
dressing. An onion skin extract, Menderma gel (Merz Pharmaceuticals, Greensboro, NC), is also marketed to improve and prevent scarring. Its efficacy in not known, and patients using any such product need to be monitored for irritant and allergic contact dermatitis. Another treatment used after laser surgery to treat scars is 5-fluorouracil (5-FU).21 This antimetabolite is a pyrimidine analog and works by inhibiting fibroblast proliferation. A concentration of 50 mg/cm3 is injected into the scar and a total dose of 2–100 mg is used each injection session. Although effective, the injections are quite painful. The addition of Kenalog should be considered and is mixed such that 0.1 cm3 of Kenalog 10 mg/cm3 is added to 0.9 cm3 of the 5-FU (45 mg 5-FU). Less pain and potentially greater efficacy are associated with the latter solution. Approximately 0.05cm3 is injected per site, separated by approximately 1 cm. Injections should be performed two or three times weekly initially, and only the indurated portions of the scar should be injected. Side-effects include pain with injection, purpura, and rarely superficial tissue slough. Flashlamp-pumped dye laser (FLPDL) therapy is effective, and was first described by Alster.22 The settings typically used with the 585 nm FLPDL are 5–7.5 J/cm2 with a 7 mm spot size or 4–5J/cm2 with a 10 mm spot size. Newer vascular lasers and intense pulsed light sources are also being used to treat surgical scars. The V Beam (Candela Corp., Wayland, MA) has a wavelength of 595 nm and a cryogen spray to help cool the epidermis is our preferred laser for scars. Broad-spectrum, intense pulsed light such as the VascuLight (Lumenis, Santa Clara, CA) has been effective with a 570 nm filter. Treatments are administered at 3- to 4-week intervals, and generally will require a minimum of 2–4 treatment sessions. Patients may develop anxiety about having ‘more laser surgery’ if they have already developed a scar from previous laser surgery, but these techniques are generally well tolerated and with minimal risks. Because of the low fluences used, purpura generally does not develop. Although well accepted as an effective treatment, not all studies have demonstrated good results using the pulsed dye laser for scars. In a study by Wittenber et al,23 the flashlamp pulsed dye laser and silicone gel sheeting showed improvement in scar
03 Carniol-8028.qxd
26
8/23/2007
10:25 AM
Page 26
Clinical procedures in laser skin rejuvenation
blood flow, volume, and pruritus, but the results were no different than the controls. Combining modalities will ensure the best results in reduction of scar volume and erythema and improvement of texture. Laser therapy can be added to the regimen after the scar has begun to show flattening with 5-FU or steroids. Thus, fibroblast activity is suppressed by 5-FU, inflammation is suppressed by corticosteroids, and pulsed dye laser suppresses angiogenesis and endothelial cell growth factors. Concomitant use of the CO2 laser and the pulsed dye laser has been described for nonerythematous scars.24 The CO2 laser is used to de-epithelialize the scar; total vaporization of the scar is not suggested. Then the 585nm pulsed dye laser is used with fluences of 6–6.5 J/cm2 with a 7 mm spot. Finally, resurfacing can be tried for scars that have not responded to the treatment modalities already described. This, however, can result in further scarring, and should be used judiciously.The patient needs to be counseled extensively regarding the potential risks. The scarred area and a small amount of normal appearing skin surrounding the scar should be anesthetized with local anesthesia. Either a CO2 Er:YAG laser can be used, but we prefer the Er:YAG system since it provides ablation with little thermal injury.The scarred area should be ablated superficially with an additional pass to blend with the surrounding skin. Wound care is performed in the standard fashion. Less commonly, hypertrophic scars are hyperpigmented. In these cases, either a pulsed dye laser or a pigment-specific pulsed dye 510 nm laser and a 532 nm frequency-doubled neodymium (Nd):YAG laser can be used to lighten the scar. The immediate endpoint is the production of an immediate ash-white color. ‘Significant’ or ‘average’ improvement can be achieved in approximately 75% of scars.25
SPECIAL CONSIDERATIONS Resurfacing cosmetic units For patients who are not willing to undergo entire face resurfacing and who have deep rhytids limited to the perioral area, CO2 laser resurfacing can be combined with more superficial resurfacing. The preoperative
care is the same, but the face is first resurfaced or peeled to the desired depth. When using chemical peeling, the face is first degreased with alcohol or acetone. Jessner’s peel is applied and then TCA is applied directly onto the skin in concentrations of 20–35%, depending on the desired results. Application of the TCA is performed one cosmetic unit at a time to decrease discomfort and to monitor for the desired level of frost. A hand-held fan or cooling device will enhance the patient’s comfort. Once the peel or superficial laser resurfacing has been performed, the perioral area can be treated with the more aggressive CO2 or Er:YAG lasers as described above. The peeled skin will be red and clearly identifiable to the laser surgeon.Wound care is the same as previously described. Due to the smaller surface area that is more deeply treated, there is less total swelling and exudative drainage. This approach is especially popular in our patients who are ready to undergo a second resurfacing procedure for the mouth area but have retained satisfactory results to the rest of their face.
Neck resurfacing Due to the relative paucity of adenexal structures in the neck, rejuvenation procedures need to be performed judiciously. The use of the Er:YAG laser to improve photoaging was established in the late 1990s, but only modest improvements were seen.26 The desire to improve results led to the use of the CO2 laser, but with mixed results. In 2001, Fitzpatrick and Goldman27 published a study on 10 subjects using the UltraPulse CO2 laser. Despite no complications being seen at the initial neck test areas, 40% of the patients had complications observed at 3–6 months, including patchy hypopigmented scarring (with and without textural changes) in the lower portions of the neck. Despite some obvious improvements noted in the color and texture of the skin (although no improvement in wrinkling was observed), it was concluded that the risks outweighed the potential benefits, at least at the three different parameters studied. In 2006, Kilmer et al28 reported their experience in performing CO2 neck resurfacing in over 1500 patients. Only 2 patients developed hypopigmentation. Over 99% of the neck cases in this study were treated concomitantly with facial resurfacing. Any patient who had undergone
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 27
Carbon dioxide laser resurfacing, fractionated resurfacing and YSGG resurfacing prior neck radiation was excluded from neck CO2 resurfacing. Topical EMLA was used as previously described in this chapter with a second application 45 minutes before the procedure. Lower energy densities were used as the treatment proceeded down the neck. Epidermal debris was not wiped off the neck, in order to minimize additional trauma.
Fractional CO2 resurfacing Carbon dioxide laser resurfacing can give the most dramatic improvements, in terms of smoothing skin, decreasing rhytids, removing lentigines and tightening facial skin. However, due to the typical associated length of recovery it remains unpopular with patients. Other lasers have been developed to try to achieve a more carbon dioxide laser resurfacing type of improvement with a relatively brief recovery period. One of these is fractional CO2 laser resurfacing and the other is the new YSGG resurfacing laser. Although fractional lasers are now available in several different wavelengths, the fractional 10 600 nm carbon dioxide laser can offer some of the beneficial ablative and tightening effects associated with traditional Carbon dioxide laser resurfacing. In fractional photothermolysis, a fraction of the skin surface is treated with the laser, resulting in small zones of thermal injury bridged by surrounding areas of untreated skin.29 Since, only a fraction of the skin is treated, reepithelialization occurs relatively quickly by migration of epithelial elements from the adjacent untreated skin, into the lasered areas. The fractional CO2 laser (Active Fx, Lumenis, Inc., Santa Clara, CA, USA), produces small spots (approximately 1.3 mm) that are scanned using the computerized pattern generator. Between the spots there are areas of untreated skin. This laser is designed to decrease the possible lateral thermal effects of the laser, while allowing the deeper thermal heating effects in each of the treated areas for stimulation of neocollagen production and inducing skin contraction. Since the laser treatment is fractionated the lateral heating effects are decreased by leaving adjacent untreated areas which allow for heat dissipation. Furthermore the device’s CoolScanTM setting allows
27
the spots to be placed in a “random” pattern, which skips from one region to the next rather than treating sequential adjacent areas. This allows for additional thermal relaxation between pulses resulting in less overall thermal injury, and quicker recovery. Posttreatment erythema resolves more rapidly. The treated areas are smaller and placed in a less dense manner than in traditional CO2 laser resurfacing. Settings are variable and are based on patient need in terms of acceptable downtime and degree of photodamage or acne scarring. Initially, post treatment patients develop area of punctate crusting surrounded by areas of unlasered skin. As could be anticipated this also becomes pink and develops mild swelling. Typically, the third author has the patients keep the area moist until it completely reepithelializing. This can be achieved by application of Aquaphor (Beiersdorf,) every 8 hours or other dressings with a moisturizing effect. The third author also routinely gives antivirals starting twenty four hours prior to the laser treatment. Each physician, must decide in their own prophylaxis and after care regimens. Typically patients can resume their regular activities 4–7 days post treatment. Although the results are not as dramatic as with traditional carbon dioxide laser resurfacing the third author’s patients have been pleased with the results of these treatments.They have noted improvement in their skin texture, wrinkles, and lentigines as well as some mild skin tightening. More aggressive settings can also be used for more dramatic results dramatic results with a consequent increase in patient downtime. Patients with deep rhytids and significant skin laxity who are willing to deal with the healing process associated with CO2 resurfacing can have a non-fractionated resurfacing. A different type of fractional CO2 laser is currently under development (Reliant Technologies, Mountain View, CA USA). This laser penetrates the skin more deeply than the traditional CO2 laser and may allow a greater tightening effect. (presented at American Society of Dermatologic Surgery Annual meeting, palm Desert, CA, October 2006) Another alternative to fractional CO2 resurfacing is the 2790 nm laser. (the Pearl, Cutera, Brisbane, California.) This laser is designed to resurface similar to an erbium laser but to provide deeper associated thermal effects to create greater collagen stimulation
03 Carniol-8028.qxd
28
8/23/2007
10:25 AM
Page 28
Clinical procedures in laser skin rejuvenation
and skin tightening.The effect is between the effect of the typical erbium laser and the carbon dioxide laser. It is used to improve skin smoothness, reduce mild wrinkles and decrease hyperpigmentation.
THE FUTURE Fractional laser, contiguous laser and plasmakinetic resurfacing will undoubtedly continue to advance and improve. Further improvements in patient outcomes may be obtainable with combination therapy including using nonablative lasers, fillers, neurotoxins, and cosmeceuticals.The push continues for less invasive, more efficacious tools with added predictability and safety. The key is to a successful resurfacing practice hower, still involves proper patient selection, good technique and wound care, and the early identification and management of complications.
REFERENCES 1. Iyer S, Bowes L, Kricorian G, Friedli A, Fitzpatrick RE. Treatment of basal cell carcinoma with the pulsed carbon dioxide laser: a retrospective analysis. Dermatol Surg 2004;30:1214–18. 2. Iyer S, Friedli A, Bowes L, Kricorian G, Fitzpatrick RE. Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med 2004;34:114–19. 3. Kilmer SL, Semchyshyn N. Ablative and nonablative facial resurfacing. In: Goldberg DJ, ed. Laser Dermatology. Berlin: Springer-Verlag 2005:83–98. 4. Hevia O, Nemeth AJ, Taylor JR. Tretinoin accelerates healing after trichloroacetic acid chemical peel. Arch Dermatol 1991;127:678–82. 5. Vagotis FL, Brundage SR. Histologic study of dermabrasion and chemical peel in an animal model after pretreatment with Retin-A. Aesth Plast Surg 1995;19:243–6. 6. Kang S, Leyden JJ, Lowe NJ, et al Tazarotene cream for the treatment of facial photodamage. Arch Dermatol 2001;137:1597–604. 7. Penneys NS. Ochronosis-like pigmentation from hydroquinone bleaching creams. Arch Dermatol 1985; 121:1239–49. 8. Nester MS. Prophylaxis for and treatment of uncomplicated skin and skin structure infections in laser and cosmetic surgery. J Drugs Dermatol 2005;4:20–5.
9. Manolis E, Tsakris A, Kaklamanos I, Siomos K. In vivo effect of carbon dioxide laser skin resurfacing and mechanical abrasion on the skin’s microbial flora in an animal model. Dermatol Surg 2006;32:359–64. 10. Crum NF, Lee RU,Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006;119:943–51. 11. Fritsche TR, Jones RN. Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus. J Drugs Dermatol 2005;4:4–8. 12. Zimbler M, Holds J, Kokoska M, et al. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Arch Facial Plast Surg 2001;3:165–9. 13. West T, Alster T. Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing. Dermatol Surg 1999;25:259–61. 14. Kilmer SL, Chotzen VA, Zelickson BD, et al. Full-face laser resurfacing using supplemented topical anesthesia protocol. Arch Dermatol 2003;139:1279–83. 15. Fitzpatrick RE, Geronemus RG, Grevelink JM, Kilmer SL, McDaniel DH. The incidence of adverse healing reactions occurring with UltraPulse CO2 resurfacing during a multicenter study. Lasers Surg Med 1996; Suppl 8:S34. 16. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, Smith SR. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997;23:527–35. 17. Railan D, Kilmer SL. Ablative treatment of photoaging. Dermatol Ther 2005;18:227–41. 18. Grimes P, Bhawan J, Kim J, Chiu M, Lask G. Laser resurfacing-induced hypopigmentation: histologic alterations and repigmentation with topical photochemotherapy. Dermatol Surg 2001; 27:515–20. 19. Hong S, Park H, Lee M. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. J Kor Med Sci 2005;20:273–8. 20. Alexiades-Armenakas MR, Bernstein LJ, Friedman PM, Geronemus RG. The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba. Arch Dermatol 2004;140:955–60. 21. Fitzpatrick R. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25:736–7. 22. Alster T. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg 1994;32:186–90. 23. Wittenberg G, Fabian B, Bogomilsky J, et al. Prospective, single-blind, randomized, controlled study to assess the efficacy of the 585-nm flashlamp-pumped pulsed-dye
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 29
Carbon dioxide laser resurfacing, fractionated resurfacing and YSGG resurfacing
24.
25.
26.
27.
laser and silicone gel sheeting in hypertrophic scar treatment. Arch Dermatol 1999;135:1049–55. Alster T, Lewis AB, Rosenbach A. Laser scar revision: comparison of CO2 laser vaporization with and without simultaneous pulsed dye laser treatment. Dermatol Surg 1998;24:1299–302. Bowes LE, Nouri K, Berman B, et al. Treatment of pigmented hypertrophic scars with the 585 nm pulsed dye laser and the 532 nm frequency-doubled Nd : YAG laser in the Q-switched and variable pulse modes: a comparative study. Dermatol Surg 2002;28:714–19. Goldman MP, Fitzpatrick RE, Manuskiatti W. Laser resurfacing of the neck with the erbium : YAG laser. Dermatol Surg 1999;25:736–7. Fitzpatrick RE, Goldman MP, Sriprachya-Anunt S. Resurfacing of photodamaged skin on the neck with
29
an UltraPulse carbon dioxide laser. Lasers Surg Med 2001;28:145–9. 28. Kilmer SL, Chotzen VA, Silva SK, McClaren ML. Safe and effective carbon dioxide laser skin resurfacing of the neck. Lasers Surg Med 2006;38:653–7. 29. Manstein D, Herron GS, Sink RK,Tanner H,Anderson R. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34:426–38. 30. American Society of Dermatologic Surgery Annual Meeting, Palor Desert, CA, October 2006.
03 Carniol-8028.qxd
8/23/2007
10:25 AM
Page 30
04 Carniol-8028.qxd
8/23/2007
3:34 PM
Page 31
4. Erbium laser aesthetic skin rejuvenation Richard Gentile
MODALITIES OF SKIN REJUVENATION Aesthetic skin rejuvenation (ASR) is certainly not a new process, and historical accounts date back as many as four millennia (2000 BC). For thousands of years, humans (both male and female) have been utilizing treatments to improve the appearance of a poor complexion or to enhance the beauty of a natural complexion. Throughout the ages, humans have sought out simple, elective cosmetic methods to improve highly visible and undesirable permanent cutaneous signs: facial wrinkles and residual facial scars that may follow ailments such as acne, smallpox, and chickenpox.1 The first examples of such ‘treatments’ were apparently noted in ancient Egypt and recorded in the famous Edwin Smith Surgical Papyrus, the oldest medical document in existence.2 The description of the wrinkleremoval recipe prepared from hemayet fruit included the composition and the technique for application. Ancient Greece and the Roman Empire are both well represented in the quest for more beautiful skin, and Cleopatra (whose name has been synonymous with beauty through the ages) wrote a book on beautification that was quoted by Galen and other medical writers. Her recipes were quoted well into the Middle Ages. Due to the lack of sophisticated medical technology, many of these treatments relied on what we would now call homeopathic ‘spa’ products and abrasives. The transition to utilizing chemicals for ASR occurred in the early to mid 1800s. Phenol was first prepared in 1842 by the French chemist August Laurent and presented at the 1867 Paris Exhibition.The mid to late 1800s also found Hebra3 utilizing various acids, alkalis, and other corrosives to treat freckles and melasma. It is not clear whether Hebra treated wrinkles with these chemical agents. Chemical agents facilitating ASR (particularly phenol) became more widely utilized in the early 1900s,
and George Miller MacKee4 became a proponent of chemical ASR after first experimenting on himself. In 1953, Abner Kurtin5 published ‘Corrective surgical planing of the skin’, capturing the imagination of plastic surgeons and dermatologists. He proposed dermabrasion as a better method to improve acne pits and scars. Kurtin’s description of dermabrasion actually reintroduced Ernst Kronomayer’s dermabrasion procedure, which Kronomayer had introduced in Germany in 1905. Dermabrasion, chemical peeling (trichloroacetic acid (TCA) and phenol) were considered standards for ASR until the 1990s. The last decade has seen unprecedented technological development of lasers, other light sources, and radiofrequency (RF) approaches for ASR. They have dominated the ASR arena, although a reverse trend towards a return to chemical exfoliation exists in some practices. Currently lasers, other light sources, and RF devices are generally classified as ablative and nonablative. Goldberg6 has reviewed the four different tissue interactions of laser, light, and RF with regard to the biological effects of ASR devices on skin and adjacent structures. The description traces the evolutionary development of these devices: 1. The initial devices ablated the epidermis, caused dermal injury, and provided a significant thermal effect (carbon dioxide (CO2) lasers). 2. Subsequent devices caused highly selective epidermal ablation, with minimal thermal effects (erbium : yttrium aluminum garnet (Er:YAG) short pulsed lasers). 3. Later devices ablated the epidermis, caused dermal injury, and provided variable thermal effects (dualmode and long- or variable-pulsed Er:YAG lasers). 4. The more recent evolution of devices do not ablate the epidermis, wound the dermis and provide
04 Carniol-8028.qxd
32
8/23/2007
3:34 PM
Page 32
Clinical procedures in laser skin rejuvenation minimal thermal effects (nonablative lasers and light sources).
The fifth generation of devices (not mentioned by Goldberg) are nonablative or subablative devices that produce a more substantial thermal effect for skin tightening and rejuvenation, and include mono- and bipolar RF devices, with or without optical energy, and infrared and fractionated devices.Variable-pulsed Er:YAG lasers are also included in this category, as these devices have been developed to provide higher degrees of thermal effects at the level of the dermis and perhaps below as one function of their clinical application.
EVOLUTION OF USE OF ERBIUM LASERS IN AESTHETIC AND MEDICAL DERMATOLOGY As reviewed by Ronel,7 laser technology applied to skin resurfacing was discovered to yield more predictable depths of injury when compared with chemical peels or dermabrasion.The first laser used for laser-assisted skin rejuvenation (LASR) was a pulsed CO2 laser that Fitzpatrick and colleagues modified from a device that had been developed for otolaryngological and gynecological use. It was initially utilized for periorbital and perioral LASR, but initial appraisals of substantial aesthetic improvement led to its use for full facial rejuvenation.The CO2 laser quickly became the workhorse for LASR, and its advantages and limitations became well recognized. Although the long-term skin rejuvenation and tightening provided by this device are unparalleled, marked erythema persisting for weeks or months and permanent (sometimes delayed) hypopigmentation occur at a rate that is not acceptable for many patients. In some patients, as with a deep phenol peel, the recovery ‘downtime’ can approach 2 weeks, which may be unacceptable for those with active lifestyles or work obligations. Subsequent to the laser boom of the early to mid 1990s, further research led to the development of other lasers for LASR.The aim was to employ a more precise laser beam, resulting in less intense adverse sideeffects and a shorter recovery period. In 1990, Kaufman and Hibst8 reported on the cutaneous laser ablative effects of the mid-infrared Er:YAG laser utilized in short pulses.They employed the laser on pig skin and on
experimental patients, treating superficial lesions such as epidermal nevi. Precise control of epidermal ablation was achieved, with small ablation depths and also thermal necrosis rates that did not exceed 50 µm. Kaufman and Hibst8 concluded that the laser should have potential for LASR, but also noted that, due to the limited dermal thermal depths of action, bleeding could be a problem. The Er:YAG laser was first introduced as a bonecutting tool in the USA in 1996, but commercial availability for LASR followed the completion of Food and Drug Administration (FDA) studies of photodamage. Initial enthusiasm for the Er:YAG laser was high due to its ability to operate at a more superficial level and with greater precision. Collagen contraction was noted to be 1–2% during lasing, reaching 14% in the long term. Concurrent with its introduction, some short comings of the Er:YAG laser became apparent. A major disadvantage of the superficial and fleeting energy absorption of the Er:YAG laser is its poor ability to maintain hemostasis.There is not much ‘heat sink’ in the wound, so thermal necrosis does not significantly impair the laser’s subsequent ablation, but blood in the wound bed does make controlling wound depth difficult.The blood spatter also creates more of a biological hazard to the surgeon and assistants.The other limitation of the Er:YAG laser is that there is less collagen contraction, although this may be due to the fact that comparable depths of resurfacing are not being accomplished due to the lack of hemostasis.The shortcomings of the short-pulsed Er:YAG laser led to some technological modifications, which included a longer variable pulse duration as well as the development of lasers with ‘dual-mode’ capabilities.These dual-mode capabilities allow the operator to dial in the depths of ablation as well as the thermal effects (coagulation) desired.
ERBIUM LASER PHYSICAL PROPERTIES AND LIGHT–TISSUE INTERACTION Erbium laser physical properties Solid state lasers have lasing material distributed in a solid matrix.Yttrium aluminum garnet (YAG,Y3Al2(ALO4)3) is a synthetic crystalline material of the garnet group
04 Carniol-8028.qxd
8/23/2007
3:34 PM
Page 33
Erbium laser aesthetic skin rejuvenation
Fig. 4.1 Yttrium aluminum garnet (YAG,Y3 Al2 (AlO4 )3 ) is used for synthetic gemstones.When doped with neodymium (Nd3) or erbium (Er),YAGs are used as the lasing medium in lasers.
(Fig. 4.1) used as the active laser medium in various solid state lasers.YAG is commonly ‘doped’ with other elements to obtain a specific laser wavelength. In the Nd:YAG laser, the dopant is the rare earth element neodymium. In the Er:YAG laser, it is another rare earth element, erbium (Fig. 4.2). Er:YAG lases at a wavelength of 2940 nm. Its absorption bands suitable for pumping are wide and are located between 600 and 800 nm, allowing for efficient flashlamp pumping (Fig. 4.3).The dopant concentration used is high: about 50% of yttrium atoms are replaced. The Er:YAG laser emission couples well with water and bodily fluids, making these lasers especially useful in medicine and dentistry: Er:YAG lasers are used for treatment of tooth enamel as well as aesthetic dermatological applications. Er:YAG lasers are also used for noninvasive monitoring of blood sugar.The mechanical properties of Er:YAG are essentially the same as those of Nd:YAG. Er:YAG lasers operate at relatively eye-safe wavelengths (radiated incident through the lens is absorbed in the eye and does not damage the retina), work well at room temperature, and have high slope efficiency. Er:YAG laser light is pale green.
Erbium laser light–tissue interaction (biophotonics) There are four primary interactions of laser light with tissue (Fig. 4.4). The first interaction is surface reflection. There may also be scattering. This is then
33
Fig. 4.2 Elemental erbium is a rare silvery rare earth metal. Erbium is associated with several other rare earth elements in the mineral gadolinite fromYtterby in Sweden (from which both the names yttrium and erbium are derived).
followed by absorption by the target, and some of the light may be transmitted through the tissues on the other side of the target.The absorption of laser light in tissue is a remarkably strong function of wavelength.The result is that lasers of different wavelengths have qualitatively and quantitatively different interactions with tissue (Fig. 4.5). The thermal relaxation time depends very strongly on the absorption length.The absorption length is the distance the laser light travels in tissue before it is 63% absorbed.Taken together, these two parameters determine a critical power density. This is the minimum power density that must be used to limit thermal damage to a depth equal to one absorption length (Table 4.1). For the Er:YAG laser, the absorption length is 0.001 mm, the thermal diffusion time is 4 µ, the critical power density is 600 W/mm2, and the critical pulse energy is 0.0025 J/mm2. In addition to the initial interactions of light with the target, subsequent interactions can be summarized as having photothermal, photochemical, or photoacoustic effects on the target. As is widely recognized, the Er:YAG wavelength of 2940 nm is absorbed 12–18 times more efficiently by superficial (water-containing) cutaneous tissue than is the CO2 laser emission at 10 600 nm. Considering the typical short-pulse erbium pulse duration of 250 µs, a cutaneous ablation depth of 10–20 µm is accomplished at a fluence of 5. The vaporization threshold of the Er:YAG laser is 0.5–1.7 J/cm2. The fluence and depth of tissue ablation are directly related.
04 Carniol-8028.qxd
34
8/23/2007
3:34 PM
Page 34
Clinical procedures in laser skin rejuvenation
Flashlamp (pump source)
Partially reflective mirror
Laser output
Highly reflective mirror Er:YAG crystal
(Laser medium)
Optical resonator
Fig. 4.3 Laser pumping is the act of energy transfer from an external source (flashlamp) into the laser gain medium (the Er:YAG crystal). Stimulated emission occurs when a population inversion occurs, with more members in an excited state than in lower-energy states.
Backward scattering
Forward scattering
Transmission Laser beam Absorption Direct reflection
For every 1 J/cm2, 2–4 mm of tissue depth is ablated. This allows for precise control of tissue ablation. It occurs with minimal residual thermal damage and can be compared with the 20–60 µm of tissue damage per standard pass of the CO2 laser with 150 µm of residual thermal damage per standard pass. Pulsed laser energy causes controlled vaporization of the skin according to the principles of selective photothermolysis. Target tissues contain chromophores with absorption peaks that selectively absorb the particular wavelength of the laser pulse. Tissue adjacent to the chromophore absorbs the energy to a much lesser degree. The interaction of target tissue with the CO2 laser is predominantly a thermomechanical reaction that leads to target destruction of dermal vessels and proteins. The Er:YAG laser interacts with tissue via a photomechanical reaction.
Fig. 4.4 Biophotonics examines the interface of laser and human tissue and is characterized by reflection, absorption, scatter, and transmission.
Absorption of the optical laser energy causes immediate ejection of the dessicated tissue from its location at supersonic speeds. This popping sound (like a cap gun) is audible and represents the microexplosion taking place at the tissue level.The translation of Er:YAG laser energy into mechanical work is an important factor that protects the surrounding tissue: minimal thermal energy remains to dissipate and cause collateral damage.
COMMERCIALLY AVAILABLE ERBIUM LASERS While it is beyond the scope of this chapter to detail every Er:YAG laser manufactured, we do want to review some models that are or have been commercially
04 Carniol-8028.qxd
8/23/2007
3:34 PM
Page 35
35
Erbium laser aesthetic skin rejuvenation a
105
104
Absorption coefficient (cm−1)
103
Melanin
102
Water Hemoglobin
101
100 Protein 10−1 10−2 Scatter
10−3
10−4 0.1
1
10
Wavelength (µm)
Penetration depth (mm)
Nd:YAG
0
Diode
CO2
Alexandrite
Ho: Er: YAG YAG
Pulse dye
Nd: YAG
KTP
KTP
CO2
Excimer
Er:YAG
Type of laser
b
Pigmented tissue
1 2
3
Unpigmented tissue
4 0 −1
Depth of Penetration 1
10
Wavelength (µm) Ultraviolet
Visible
Infrared
Fig. 4.5 Biophotonics also examines laser absorption (a) and tissue penetration (b) as functions of wavelength, pulse duration, and thermal relaxation time. Selective photothermolysis describes the process of wavelength-specific target destruction.
available so that the laser’s unique specifications and design can be understood.These will be listed as shortpulsed systems, dual-mode systems, and variablepulsed systems.
Short-pulsed Er:YAG systems The prototype of the Er:YAG short-pulsed systems, and one of the first to market in 1996, was the
04 Carniol-8028.qxd
36
8/23/2007
3:34 PM
Page 36
Clinical procedures in laser skin rejuvenation
Table 4.1 Critical power densities and minimum coagulation depths a
Laser
Absorption length (minimum damage zone) (mm)
Thermal diffusion time (s)
Critical power density (W/mm2)
Critical pulse energy (J/mm2)
0.1 pigmented ∞ unpigmented 0.1 pigmented ∞ unpigmented 5 0.4 0.001 0.02 2
0.4 — 0.4 — 100 1 4 × 10−6 0.002 16
0.6 — 0.6 — 0.1 1 600 50
0.25 — 0.25 — 13 1.0 0.0025 0.040
Argon ion Doubled Nd:YAG (KTP) Nd:YAG Hol:YAG Er:YAG CO2 Electrocautery
a Wavelength and thermal relaxation time determine the critical power density. This is the minimum power density that must be used to limit thermal damage to a depth equal to one absorption length. Short-absorption-length lasers such as Er:YAG are capable of producing less thermal damage than lasers with long absorption lengths. In order to achieve this desirable effect, these strongly absorbed lasers must be operated at high power density. When laser energy is delivered in a pulsed mode, it is possible to limit the tissue damage to one absorption length while working at an average power density less than the critical value. This result is only possible if the pulsed energy exceeds the critical value shown in the last column.
Coherent Ultrafine Erbium (Fig. 4.6). At the time of its release in 1996, the UltraFine Erbium was advocated for incision, excision, ablation, vaporization, and coagulation of soft tissue, including superficial skin resurfacing, precision microplaning, etching, and tissue sculpting. The laser vaporizes 20–50 µm of tissue with very little thermal effect. It is equipped with a computerized pattern generator as well as a variablewidth handpiece. The laser has a maximum output of 3000 mJ and pulse variability from 200 to 600 µs. We have used this laser for 10 years, and it has been very reliable. Others like it include the ConBio CB Erbium/2.94 and the recently introduced Friendlylight portable laser, which is highly transportable. The Nexgen Pixel is a short-pulsed Er: YAG laser that utilizes a pixel grid pattern of 49 or 81 ablations, sparing intervening epidermis.The planned ablation is 20–50 µm per pass for epidermal ablation.
Dual-mode Er:YAG systems Dual-mode, different laser type Recent developments in Er:YAG lasers have led to the combination of ablative and coagulative pulses (hence
Fig. 4.6 The Coherent UltraFine Er:YAG laser was one of the first to be available commercially, in 1996.
04 Carniol-8028.qxd
8/23/2007
3:34 PM
Page 37
Erbium laser aesthetic skin rejuvenation the term dual-mode), which allow much deeper vaporization with significant control of hemostasis. One of the earliest dual-mode systems was the Sharplan DermaK. (Both Coherent and Sharplan brands are now owned by Lumenis.) Both the CO2 laser and Er:YAG laser are clinically proven to be effective technologies for ablative skin rejuvenation.Yet, alone, each laser has its limitations. In order to provide physicians access to the best characteristics of each laser wavelength, Sharplan combined a high-power Er:YAG laser and a subablative CO2 laser in the blended DermaK system. DermaK has the unique capability to deliver both Er:YAG and CO2 beams simultaneously (K blend mode) to the same tissue area for skin rejuvenation. The Er:YAG laser carries out accurate ablation of superficial layers, opening the way for the CO2 laser to affect the deeper tissue layers. DermaK combines the best of both the Er:YAG and CO2 lasers for improved clinical efficacy. It replicates the precise tissue ablation and minimal necrosis found in Er:YAG systems and significantly controls the heating of deeper tissue layers, typical of CO2 systems.The concurrent delivery of both wavelengths provides the physician with enhanced control over hemostasis (dry erbium technique), thereby increasing the range of applications of the Er:YAG laser. The CO2 mode of the DermaK delivers sufficient thermal energy to seal small blood vessels throughout the surgical procedure, creating the benefit of a clean, dry surgical field. Simultaneous operation of both the Er:YAG and CO2 lasers minimizes the number of passes required for a given procedure, thereby minimizing erythema and decreasing the recovery time. At the same time, the dual wavelengths allow more overall energy to be transferred to the tissue, increasing the ablation depth and controlling thermal impact. DermaK can also perform many standard CO2 laser surgical and aesthetic incisional procedures, such as blepharoplasty. There is generally no need for deep sedation when treating most body areas in LASR. Same laser type, variable pulse duration Another dual-mode system is the Sciton Contour (Fig. 4.7) The Contour Er:YAG contains not one but two Er:YAG lasers providing 45 W of power.The engineers use a technology called optical multiplexing to
37
Fig. 4.7 The Sciton Profile is an example of a second-generation Er:YAG laser. Such lasers are known as dual-mode devices.
generate multiple variable-length ‘macropulses’ to generate high tissue fluence.At 50% overlap, fluences of up to 100 J/cm2 can be generated for aggressive vaporization. Sufficient energy can be delivered to remove the epidermis in one pass. The optical multiplexing also allows the laser to be used in an ablative mode, a combined ablative/coagulative dual mode, or a pure coagulative mode. The ablative mode is characterized by a short (200 µs) suprathreshold pulse. The dual-mode ablation/coagulation is achieved by an ablative pulse immediately followed by a relatively long subablative pulse.The coagulative mode consists simply of a series of subablative pulses.The Sciton Contour is the model for many current lasers featured below.
04 Carniol-8028.qxd
38
8/23/2007
3:34 PM
Page 38
Clinical procedures in laser skin rejuvenation
Table 4.2 Dermatological conditions treatable with the Er:YAG laser Becker nevi Compound nevi Naevi spili Verrucae Epidermal nevi Xanthelasma Syringomas Milia palpebrarum Seborrhoic keratoses Darier’s disease
• • • • • • • • •
• • • • • • • • •
Trichoepitheliomas Sebaceous hyperplasia Eruptive hair cysts Xanthelasma Adenoma sebaceum Angiofibroma Hidradenoma Morbus Favre–Racouchot Lentigines
Introduced in 2002, the Fontona laser systems feature a proprietary VSP (Variable Square Pulse) technology. This allows the practitioner to accommodate the laser pulse duration and its fluence according to the needs of the specific application (Fig. 4.8). By means of digital online energy regulation, the energy of each pulse is actively controlled to match the required value while the laser is in operation.This enables the practitioner to treat selected tissues without heating the surrounding tissue unnecessarily.With a short pulse width, the VSPshaped Er:YAG laser induces minimal thermal effects to underlying tissue while rejuvenating the superficial skin layers through ablation of the epidermis.This allows the practitioner to offer effective skin rejuvenation treatments with higher comfort levels and shorter recovery. By increasing the pulse duration, more heat is diffused in the skin and a resulting collateral thermal effect is achieved. Long-pulsed lasers characteristically have pulse durations of the order of milliseconds, in contrast to short-pulse durations of the order of microseconds. These thermal effects produce pronounced collagen contraction and new collagen stimulation in the dermis. Clinical trials have proven a light ablative effect on the epidermis, relatively noninvasive stimulation of new collagen formation, and no post-treatment downtime. Fotona’s stacked pulse technology provides a purely nonablative Er:YAG laser SMOOTH mode for skin rejuvenation treatments.The thermal SMOOTH mode allows dermal remodeling and rejuvenation without affecting the epidermis. The Cynosure CO3 laser has a similar variable-pulse technology, featuring pulse durations of 0.5, 4, 7, and 10 ms.
Ablation speed
Variable-pulse Er:YAG systems
0
Miliary osteomas Papillomas Café-au-lait spots Syringomas Basal cell carcinoma Squamous cell carcinoma Telangiectasia Rhinophyma Hailey–Hailey disease (familial benign pemphigus)
High power
Low power
Short pulse
Long pulse
0.5
1.0
Thermal effect
• • • • • • • • • •
1.5
Pulse duration (ms)
Fig. 4.8 Biophotonics has also resulted in understanding dosimetry of pulse duration and fluence in an attempt to achieve more collateral thermal damage with the Er:YAG laser in order to achieve better hemostasis as well as collagen contraction. The FDA has recently given approval for use in the USA of the BURANE XL Er:YAG laser, which also features variable triple-pulse technology.The BURANE XL features a specially designed and patented pulse sequence for each application (coagulation, scars, and wrinkles) that heats the deeper skin layers to a specific temperature while protecting the epidermis by allowing it to cool down during the pauses of the pulse sequences.All these dosimetry models are based on longer pulse duration and subablative laser energies for subablative dermal heating.
CLINICAL DERMATOLOGICAL APPLICATIONS OF ERBIUM LASERS Due to its superficial action and tendency to not promote dermal scarring, the Er:YAG laser is well adapted to ablating and etching superficial cutaneous neoplasms and cutaneous blemishes (Fig 4.9). The high ablative
04 Carniol-8028.qxd
8/23/2007
3:34 PM
Page 39
Erbium laser aesthetic skin rejuvenation
a
b
c
d
39
Fig. 4.9 This patient presented for removal of an irritated seborrheic keratosis, as shown in the preoperative photograph (a).The lesion is excised by sharp intradermal excision (b).The underlying dermal components are ablated and the edges are ‘feathered’ (c).The final result is shown in (d). potential results in microexplosive destruction of the skin lesions without the associated scarring that would result from epidermal or dermal excisions. Numerous clinical applications are listed in Table 2.
CLINICAL AESTHETIC APPLICATIONS OF ERBIUM LASERS LASR with a short-pulsed Er:YAG laser is most commonly used for the improvement of fine rhytides. In patients with moderate photodamage and rhytides, modulated Er:YAG laser skin resurfacing results in greater collagen contraction and improved clinical
results compared with short-pulsed Er:YAG systems. The clinical improvement of severe rhytides treated with a modulated Er:YAG laser can be impressive (Fig. 4.10).There are conflicting reports as to whether or not the endpoints of CO2 LASR can be reached even when ablating to similar depths. Newman and colleagues compared a variable-pulse Er:YAG laser with traditional pulsed or scanned CO2 laser resurfacing for the treatment of perioral rhytides.9 Although a reduced duration of re-epithelialization was noted with the modulated Er:YAG laser (3.4 days vs 7.7 days with a CO2 laser), the clinical results observed were less impressive than those following CO2 laser resurfacing. Er:YAG laser systems may greatly improve atrophic scars caused by acne,
04 Carniol-8028.qxd
40
a
8/23/2007
3:34 PM
Page 40
Clinical procedures in laser skin rejuvenation
b
c
d
Fig. 4.10 This treatment took place over two sessions. (a) Preoperative photograph. (b) Following excision/ablation of seborrheic keratosis with basal cell carcinoma.The patient then elected to have aesthetic full-face LASR 1 year postoperatively and is shown 4 days (c) and 12 days (d) post LASR, with multiple excision ablations.
04 Carniol-8028.qxd
8/23/2007
3:34 PM
Page 41
Erbium laser aesthetic skin rejuvenation trauma, or surgery. In a series of 78 patients,Weinstein reported 70–90% improvement of acne scarring in the majority of patients treated with a modulated Er:YAG laser10. Pitted acne scars may require ancillary procedures, such as subcision or punch excision, for optimal results.These procedures can be performed either prior to or concomitant with Er:YAG laser resurfacing.
ERBIUM LASER TECHNIQUES Cutaneous ablative surgery In treating superficial epidermal lesions such as irritated seborrheic keratoses, the primary lesion can be ablated or an epidermal shaving of the lesion followed by ablative pulses can be performed. On most treatments with the short-pulsed laser system, the fluence is set to 5, which corresponds to about 20 µm of ablation. The lesion ablation is continued until the entire lesion is vaporized. The adjacent dermis is ‘feathered’ to taper the cutaneous margins of the lesion.
‘Dry erbium’ This is a fairly new term, with the ‘dry erbium’ representing an epidermal ablation that does not extend into the papillary dermis, where bleeding is encountered. Often, this treatment is done with subablative levels of laser energy and is associated with rapid recovery and a result that is intermediate to microdermabrasion or photorejuvenation but not as significant as superficial laser resurfacing.
Superficial LASR The technique used for superficial LASR is to set the fluence to 5 and use three passes.This equates to about 40–60 µm of ablation. After the inititial ablation, the same settings are maintained until punctuate bleeding is encountered.
Medium-depth LASR The techniques utilized for medium-depth LASR will be influenced by the Er:YAG laser technology available
41
and by other techniques that the laser surgeon can call upon. With longer-pulsed or dual-mode systems and progression beyond 60–80 µm, there may be bleeding from the dermal plexus, which will slow the procedure down. It is our preference to change our technique if we wish to accomplish a deep LASR for moderate to deep rhytides.When employing a combination technique for the full face, we generally perform the CO2 laser resurfacing in the first pass, followed by Er:YAG laser ablation of the char. When using ablative bipolar RF (BPRF) (Visage, Arthrocare Corp.), we ablate the epidermis and then heat the dermis (Fig. 4.11) with several passes of ablative BPRF.This technique serves to contract dermal collagen without excessive thermal damage to the deeper dermal layers.When treating acne scarring, we sometimes convert to dermal sanding in the deeper dermal layers.
Deep LASR Essentially the same techniques are utilized as in medium-depth treatment, but the deeper dermal treatment is performed with more passes. This is frequently necessary for deeply creased upper lip rhytids. It is important to always use a graduated approach for deeper techniques and to treat the facial skin with an appreciation of the skin thickness in each facial area as well as the depth or degree of the rhytids. We occasionally utilize a fractionated CO2 laser pass after completing the medium-depth LASR. This involves spatially separated pulses of the CO2 laser over the treatment area. The smallest possible spot size is utilized, with no overlapping of pulses.
PATIENT SELECTION AND PERIOPERATIVE MANAGEMENT As with most aesthetic facial procedures, appropriate patient selection and reasonable patient expectations are the cornerstones of any successful intervention. A complete medical and surgical history should be obtained prior to any recommendations. The contraindications to laser resurfacing are unrealistic patient expectations, a tendency toward keloid or hypertrophic scar formation, isotretinoin use
04 Carniol-8028.qxd
42
8/23/2007
3:34 PM
Page 42
Clinical procedures in laser skin rejuvenation
Fig. 4.11 Combination resurfacing techniques utilize other modalities to achieve the same endpoint that multiplexing pulse duration achieves. Ablative bipolar radiofrequency or fractional CO2 laser treatment to the upper dermis enhances hemostasis and collagen contraction.
within 6 months prior to surgery, and a lack of patient compliance with postoperative instructions. Other medical considerations include identifying patients with reduced numbers of adnexal skin structures, such as those with scleroderma, burn scars, or a history of prior ionizing radiation to the skin. These patients should be approached with caution. Long-term use of skin pharmaceuticals such as glycolic acid products or retinoids may thin the dermis and alter the depth of penetration of the LASR. A history of previous skin rejuvenation procedures is noteworthy, because these procedures could potentially slow the wound healing process due to the presence of fibrosis. Patients who have undergone prior transcutaneous lower lid blepharoplasty or have limited infraorbital elasticity may be at increased risk for postoperative ectropion.When applicable, patients who smoke should be discouraged from doing so before and after surgery to reduce the risk of delayed or impaired wound healing. Physical examination of the treatment area includes careful attention to Fitzpatrick skin type and specific areas of scarring, dyschromia, and rhytid formation. For patients desiring periorbital laser treatment, the eyes must be examined for scleral show, lid lag, and ectropion. Other epidermal pathology should also be noted, including seborrheic keratoses, solar lentigines, actinic keratoses, and cutaneous carcinomas.The author prefers to address this during the LASR, but some lesions may need to be addressed prior to the LASR.
LASR can lead to reactivation of latent herpes simplex virus (HSV) infection or predispose the patient to a primary infection during the re-epithelialization phase of healing. Prophylactic antiviral medication should be prescribed during the postoperative period, regardless of a patient’s HSV history.11 Currently used regimens include famciclovir 250 mg twice daily, acyclovir 400 mg three times daily, or valacyclovir 500 mg twice daily. The medication may be administered the day before or on the morning of laser resurfacing, and should be continued for 7–10 days or until re-epithelialization is complete. Antibiotics for bacterial prophylaxis may be prescribed; however, little data exist to support their use, because of the relatively low incidence of postoperative bacterial infections reported. The routine use of antibiotic prophylaxis may increase the incidence of antibiotic resistance and predispose patients to organisms of increased pathogenicity. When used, cephalosporin (cephalexin), semisynthetic penicillin (dicloxacillin), macrolide (azithromycin), or quinolone (ciprofloxacin) is administered 1 day before or on the morning of surgery, and is continued until re-epithelialization is complete.The use of topical antibiotics on the laser-induced wound may be recommended, but neomycin-based products should be avoided due to a 10% incidence of sensitivity to this compound. Postoperative wound care can follow an open or closed method.With the closed method, a semiocclusive
04 Carniol-8028.qxd
8/23/2007
3:34 PM
Page 43
Erbium laser aesthetic skin rejuvenation dressing (Flexan) is placed on the denuded skin.These wound dressings have been shown to accelerate the rate of re-epithelialization by maintaining a moist environment. In addition, decreased postoperative pain has been reported with their use.The closed method may create a low-oxygen environment that may promote the growth of anaerobic bacteria and subsequent infection. As such, many proponents of the closed technique currently endorse removal of the dressing with wound inspection 24–48 hours after the procedure, followed by topical emollients.The open wound technique consists of frequent soaks with cool saline or Domeboro solution.These soaks are followed by the application of ointment to promote re-epithelialization while allowing adequate visualization of the resurfaced wound. Er:YAG laser resurfacing ablates superficial cutaneous tissue and causes a thermal injury to denuded skin.Therefore, some adverse effects are to be expected and should be considered complications. These ‘sideeffects’ of cutaneous laser resurfacing include transient erythema, edema, burning sensation, and pruritus. Short-pulsed Er:YAG laser resurfacing procedures are associated with a significantly shortened period of reepithelialization and erythema when compared with the CO2 laser. However, when equivalent depths of ablation and coagulation are achieved with the aforementioned modulated systems, postoperative healing times are comparable.
LASER RADIATION SAFETY AND ERBIUM LASERS All laser devices distributed for both human and animal treatment in the USA are subject to Mandatory Performance Standards. They must meet the Federal laser product performance standard, and an ‘initial report’ must be submitted to the Center for Devices and Radiological Health (CDRH) Office of Compliance prior to the product being distributed. This performance standard specifies the safety features and labeling that all laser products must have in order to provide adequate safety to users and patients. A laser product manufacturer must certify that each model complies with the standard before introducing the laser into US commerce.This includes distribution
43
for use during clinical investigations prior to device approval. Certification of a laser product means that each unit has passed a quality assurance test and that it complies with the performance standard.The firm that certifies a laser product assumes responsibility for product reporting, for record-keeping, and for notification of defects, non-compliance, and accidental radiation occurrences. A certifier of a laser product is required to report the product via a Laser Product Report submitted to the CDRH. Er:YAG lasers belong to safety class IV; i.e., these lasers are high-power lasers (500 mW for continuous-wave and 10 J/cm2 or the diffuse reflection limit for pulsed), which are hazardous to view under any condition (directly or diffusely scattered), and are a potential fire hazard and a skin hazard. Significant controls are required of class IV laser facilities.
AVOIDANCE AND TREATMENT OF COMPLICATIONS Complications of Er:YAG laser resurfacing should be differentiated from temporary ‘side-effects’ of the procedure. Temporary side-effects of Er:YAG laser resurfacing include transient erythema, edema, burning sensation, and pruritus. Healing times are short for the short-pulsed systems, but second- and third-generation models are designed to function more on a par with CO2 laser systems and so the complication profile may be similar, but appears to be intermediate in terms of the most frequent complications of prolonged erythema, hyper- or hypopigmentation, and dermal fibrosis or scarring. In addition to the complications mentioned above, mild complications of Er:YAG laser resurfacing include milia, acne exacerbation, contact dermatitis, and perioral dermatitis. Moderate complications include localized viral, bacterial, and candidal infection. The most severe complications include disseminated infection and the development of ectropion. Diligent evaluation of the patient is necessary during the re-epithelialization phase of healing. This is important, because a delay in recognition and treatment of complications can have severe deleterious consequences, such as permanent dyspigmentation and scarring.As always, patient selection and avoidance of these
04 Carniol-8028.qxd
44
8/23/2007
3:34 PM
Page 44
Clinical procedures in laser skin rejuvenation
procedures in any patient predisposed to delayed or abnormal cutaneous wound healing will reduce the frequency of severe postoperative sequellae. Although short-pulsed Er:YAG laser resurfacing has a significantly better adverse-effect profile and complication rate when compared with pulsed or scanned CO2 laser resurfacing, long-term data for the modulated Er:YAG laser systems are not yet available. Because the modulated Er:YAG laser systems may be used to create zones of collateral thermal damage similar to those created by the CO2 laser, further studies are necessary to determine the incidence of delayed hypopigmentation.
REFERENCES 1. Goldman MP, Fitzpatrick RE. Cutaneous Laser Surgery: The Art and Science of Selective Photothermolysis, 2nd edn. St Louis, MO: Mosby-Year Book, 1999:339–436. 2. Kotler R. Chemical Rejuvenation of the Face. St Louis, MO: Mosby-Year Book, 1992:1–35.
3. Hebra F, Kaposi M. On Diseases of the Skin, Including Exanthemata. London: New Sydenham Society, 1874: Vol 3:22–23. 4. MacKee GM, Karp FL. The treatment of post acne scars with phenol. Br J Dermatol 1952;64:456–9. 5. Kurtin A. Corrective surgical planing of skin. Arch Dermatol Syph 1953;68:389. 6. Goldberg DJ. Lasers for facial rejuvenation. Am J Clin Dermatol 2003;4:225–34. 7. Ronel DN. Skin resurfacing, laser: erbium YAG. eMedicine. http://www.emedicine.com/plastic/topic 108.htm (accessed November 2006). 8. Kaufmann R, Hibst R. Pulsed 2.94-microns erbium–YAG laser skin ablation – experimental results and first clinical application. Clin Exp Dermatol 1990;15:389–93. 9. Newman JB, Lord JL, Ask K, McDaniel DH. Variable pulse erbium: YAG laser skin resurfacing of perioral rhytides and side-by-side comparison with carbon dioxide laser. Lasers Surg Med 2000;26:208–14. 10. Weinstein C. Modulated dual mode erbium CO2 lasers for the treatment of acne scars. J Cutan Laser Ther 1999; 1:204–8. 11. Tanzi EL: Cutaneous laser resurfacing: erbium:YAG. eMedicine. http://www.emedicine.com/derm/topic 554.htm (accessed November 2006).
05 Carniol-8028.qxd
8/23/2007
10:26 AM
Page 45
5. Complications secondary to lasers and light sources Robert M Adrian
INTRODUCTION The name laser is an acronym for Light Amplification by Stimulated Emission of Radiation. In 1917, Albert Einstein was the first to theorize about the mechanism that makes lasers possible, called ‘stimulated emission’. In 1958, Charles Townes and Aurthur Schawlow theorized about a visible laser system that would use infrared or visible electromagnetic energy. Although some controversy exists regarding the individual who invented the first laser, Gordon Gould, who first used the term ‘laser’, has been credited with inventing the first light laser. In 1965, the carbon dioxide (CO2) laser was invented by Kumar Patel. Since that time, there has been a tremendous increase in theoretical and practical laser knowledge, resulting in an explosion of laser technology used in thousands of everyday applications. One of the first individuals to report on the effects of lasers on the skin was Leon Goldman, whom many consider to be the father of laser medicine. Goldman’s pioneering work using pulsed (ruby) and continuouswave argon lasers serves as the foundation for our present understanding of laser medicine and surgery. The first lasers used to treat skin conditions were continuous-wave CO2 dioxide, argon, and argonpumped tunable dye lasers.The major disadvantage of continuous-wave lasers is that the side-effects are related to how long the beam is in contact with the target (dwell time), and are thus operator-dependent. This resulted in high rates of complications, primarily in the form of scarring. In the late 1980s, the first pulsed lasers became available with the introduction of the flashlamp-pumped pulse dye laser by the Candala Corporation. Pulsed lasers were a major advance in laser medicine, since
energy delivery was now selectable and dwell time on tissue became an independent factor in treatment.The introduction of pulsed lasers greatly reduced the incidence of scarring secondary to laser treatment.The subsequent addition of cutaneous cooling during laser delivery was another significant advance in cutaneous laser surgery. Epidermal protection and increased patient comfort secondary to cooling served to advance the art and science of laser medicine. In the early 1980s, there were few major companies providing lasers for cutaneous application.Today, there are dozens worldwide, and hundreds of laser devices are available for use in the treatment of numerous congenital and acquired skin conditions. Along with the explosion of interest in cosmetic laser surgery came a tremendous number of ‘new’ users of this technology.As a result, we have seen a significant increase in side-effects and complications associated with the use of lasers. Since most laser and light sources ultimately are designed to heat targets, complications secondary to treatment using lasers and light sources is most often related to excessive thermal energy delivered during the procedure. It is this excess thermal energy that most often contributes to unfavorable clinical results. In this chapter, we will not address side-effects of lasers that are common or anticipated and often unique to the laser or light source used, but will rather confine our discussion to complications that are events not generally expected as a result of treatment. Complications secondary to lasers and light sources may be minor or serious, but all need prompt and accurate diagnosis and treatment to prevent further patient morbidity. As shown in Box 5.1, there are numerous potential complications seen as a result of the use of lasers and light sources. Box 5.2 lists some
05 Carniol-8028.qxd
46
8/23/2007
10:26 AM
Page 46
Clinical procedures in laser skin rejuvenation
of most common causes of complications resulting from the use of lasers and light sources (Figs 5.1–5.3). Box 5.1 Complications of lasers and light sources • Ocular complications: − Corneal − Retinal • Infection of personnel • Hyperpigmentation • Hypopigmentation • Blistering • Crusting • Delayed wound healing • Infection • Cutaneous infarction • Scarring
Box 5.2 Causes of complications from lasers and light sources • Lack of basic knowledge and training on a specific treatment modality • Incorrect choice of laser or light source to treat a clinical condition • Failure to adequately recognize the clinical condition confronting the operator • Failure to anticipate, recognize, and treat common or uncommon postoperative complications • Failure to refer patients with evolving or nonresponding complications to more experienced colleagues − ‘When you’re in a hole, stop digging.’ • Failure to adequately screen and counsel patients prior to the procedure, thus avoiding postoperative disappointment and frustration for both patient and treating individual
LACK OF OPERATOR KNOWLEDGE AND EXPERIENCE The single most important cause of postoperative complications is lack of proper training and experience of the treating individual. The explosion of interest in cosmetic laser treatments has served as a magnet for those who wish to provide such services primarily for the purpose of financial gain. Unfortunately, most of these individuals are not willing to spend the time or
Fig. 5.1 Severe herpes simplex infection post carbon dioxide laser resurfacing (by permission of Jean Rosenbloom)
monetary investment learning the basic science of laser surgery, treatment protocols, and techniques necessary to provide safe and effective laser and light source-based procedures. So-called ‘weekend warriors’ abound.This is a term used to describe ‘laser experts’ who are constantly unleashed on an unsuspecting public after a few hours at an evening or weekend training session. The use of a given laser or light source by any individual should be complemented by a complete understanding of cutaneous structure and function, basic dermatology, laser safety and physics, infectious diseases of the skin, cutaneous wound care, and management of common side-effects and complications. It is inconceivable how any individual without prior knowledge or training in dermatology could reasonably fulfill all of the
05 Carniol-8028.qxd
8/23/2007
10:26 AM
Page 47
Complications secondary to lasers and light sources
47
Fig. 5.3 Hypertrophic scarring after long-pulse YAG laser treatment of a tattoo.
Fig. 5.2 Severe hypertrophic scarring secondary to CO2 laser burn
above prerequisites during a single evening or weekend ‘laser seminar’. My views are not meant to suggest that only dermatologists or plastic surgeons are suitable to perform laser- or light-based procedures, but rather that non-dermatologist physician specialists or allied health professionals should spend the necessary time and effort to become properly trained prior to turning themselves loose on their patients or clients.
INCORRECT CHOICE OF LASER OR LIGHT SOURCE FOR A GIVEN CONDITION Despite the fact that there are hundreds of lasers and light sources available to treat cutaneous conditions,
there are relatively few tissue targets or chromophones available within the skin (Box 5.3). Although it may seem intuitive, many individuals will often use a given laser or light source to treat a condition that is not within the technological scope of the device (Figs 5.4–5.6). Although one might conclude that this was related to lack of knowledge and experience, I have found that it is more often related to monetary consideration on the part of the operator. Common sense would suggest that one would choose a laser or light source that would reasonably address the target chromosphere – however, many examples of laser clinical condition mismatches are seen in clinical practice.
Box 5.3 Cutaneous chromophones • • • • • • • •
Melanin Oxygenated hemoglobin Reduced hemoglobin Water Tattoo ink Iron Medication-induced pigment Foreign-body pigments
05 Carniol-8028.qxd
48
8/23/2007
10:26 AM
Page 48
Clinical procedures in laser skin rejuvenation
a
b
Fig. 5.4 Scarring and pigmentation from improper use of an IPL Device
FAILURE TO RECOGNIZE THE PRESENTING CLINICAL CONDITION Most physicians and allied health professionals with training in cutaneous medicine can properly recognize the clinical condition confronting them. Unfortunately, inexperienced or untrained individuals often fail to recognize the presenting condition, resulting in worsening of the condition or complications from treatment. What excuse could one offer for treating a nodular melanoma as a hemangioma or a linear verrucous nevus, or tuberous sclerosis as warts, other than lack of knowledge on the part of the physician? In addition, many serious medical conditions, such as collagen
Fig. 5.5 Perioral scarring secondary to CO2 laser resurfacing.
Fig. 5.6 Scarring of the chest after CO2 laser resurfacing.
vascular disease, congenital neurocutaneous syndromes, and vascular anomalies, present for cosmetic treatment while actually needing proper diagnosis and treatment rather than simply ‘cosmetic’ improvement.
FAILURE TO ANTICIPATE, RECOGNIZE AND TREAT COMMON POSTOPERATIVE COMPLICATIONS Most laser and light source treatments are accompanied by various postoperative side-effects, which are defined as conditions that are expected and directly related to
05 Carniol-8028.qxd
8/23/2007
10:26 AM
Page 49
Complications secondary to lasers and light sources
Fig. 5.7 Scarring from smooth laser treatment of a tatoo
the procedure itself. Examples include purpura secondary to pulsed dye laser treatment, pinpoint bleeding and crusting from Q-switch laser treatment, and swelling and weeping of the skin after CO2 or Er:YAG laser resurfacing. Complications, on the other hand, are conditions that may or may not be expected, but are caused by the procedure and are of significant nature to require proper diagnosis and treatment. Such complications can be relatively minor, such as mild hypo- or hyperpigmentation, edema, or minor crusting. Serious complications include bacterial, fungal, or viral infections; severe pigment disturbances; and hypertropic and keloidal scarring. Sepsis and systemic allergic reactions, although less common, may be life-threatening, and need prompt proper diagnosis and treatment by skilled, welltrained individuals. Failure to recognize and skillfully address these complications is a major cause of postlaser morbidity.
FAILURE TO TIMELY REFER PATIENTS WITH EVOLVING OR NONRESPONSIVE COMPLICATIONS TO MORE EXPERIENCED COLLEAGUES IN A TIMELY MANNER All practitioners of laser- and light-based techniques, regardless of experience, have encountered
49
postoperative complications. Morbidity secondary to postoperative complications can often be greatly reduced in most cases by arriving at the correct diagnosis and providing prompt treatment. Physicians who fail to refer in a timely manner most often do so because they actually fail to accurately diagnose the presenting condition itself. Most often, I have encountered failure to recognize and treat postoperative viral (herpes) and fungal (Candida) infection. Many patients are treated for weeks with the wrong diagnosis, only to rapidly heal when proper diagnosis and treatment is intiated. Unfortunately, lack of training and lack of experience lead to a failure of proper diagnosis and treatment, causing significant morbidity for patients. Again, proper training and experience are the primary causes of late referral of complications.
FAILURE TO ADEQUATELY SCREEN AND INFORM PATIENTS PRIOR TO THE PROCEDURE The cornerstone of a successful cosmetic and laser practice is informed consent. Why? Because an adequately informed patient will understand the risks, benefits, and possible outcomes prior to the procedure. Preoperative counseling with blunt and honest answers prior to the procedure all but eliminate the likelihood of postoperative patient dissatisfaction and complaints. I have found that patients are much more relaxed post-treatment when they had undergone a detailed discussion covering risks, benefits, and realistic outcomes prior to the procedure. In my opinion, informed consent is the single most important factor leading to a smooth postoperative experience.
SUMMARY There is no doubt that the use of lasers and light sources has been one of the most significant advances in cosmetic medicine and surgery in the last century. Millions of people have benefited from new technologies to treat a wide variety of congenital and acquired medical and cosmetic conditions. Unfortunately, many
05 Carniol-8028.qxd
50
8/23/2007
10:26 AM
Page 50
Clinical procedures in laser skin rejuvenation
practitioners fail to undergo adequate training, resulting in an unacceptable number of complications secondary to the use of these new technologies. Blame can be placed on all those involved: laser companies who will sell or rent a laser or light source to ‘any willing provider’ regardless of their level of training or experience; practitioners who themselves fail to undergo the necessary training in order to provide safe and effective laser procedures; and finally the patients themselves, who fail to adequately evaluate the training and experience of their provider prior to
the procedure and then complain that they had an unfavorable result or complication. The internet age has given patients powerful tools to ‘interview’ physicians online, narrowing down the list of local experts who will most likely provide more successful and safer outcomes than their inadequately trained colleagues. The explosion of laser day-spas, med-spas and nonphysician-supervised ‘laser centers’ presents a growing challenge to patients to seek out experts in their community and avoid those who may ultimately do more harm than good.
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 51
6. Nonablative technology for treatment of aging skin Amy Forman Taub
ABLATIVE VERSUS NONABLATIVE
Nonablative
To understand nonablative technology, it is important to understand ablative technology, which came earlier. Understanding the difference between the two technologies puts their respective advantages and weaknesses into perspective.
Nonablative lasers attempt to spare the epidermis and to influence the dermis directly with light and/or radiofrequency (RF) energy.With no epidermal wound, there is no recovery period and thus no interruption of life’s daily routines. Although efficacy is less than that of ablative laser procedures, the dermal wound response from nonablative laser treatments stimulates new collagen production and repairs tissue defects.3 Energy is deposited 100–500 µm below the skin surface, where most histological changes (solar elastosis) associated with photoaging occur. Nonablative laser procedures target the dermis and avoid epidermal damage by cooling during treatment,4–10 as well as targeting chromophores other than water: hemoglobin, melanin, and collagen. In addition, the wavelengths utilized for nonablative lasers are in the visible and near-infrared region of the electromagnetic spectrum and penetrate to the upper and mid-dermis – the target zone. A variety of studies5,7,11–19 indicate that skin tightening and wrinkle reduction months after nonablative laser or light therapy are associated with collagen remodeling. This relationship was established by comparing clinical improvement with changes in histological characteristics, ultrastructure, and biochemical constituents known to play a role in wound healing and the production of dermal collagen.
Ablative In ablative skin resurfacing, the outer layers of skin are vaporized and replaced by new collagen and epidermis as wound healing occurs over days to weeks. Ablation is possible because water has a high absorption coefficient in the infrared region. The most widely used lasers for ablative resurfacing are the pulsed 10 600 nm carbon dioxide (CO2) and 2940 nm erbium : yttrium aluminum garnet (Er:YAG) lasers. The Er:YAG wavelength is more efficiently absorbed by water, and thus leaves little residual heat deposition to collateral tissue, whereas the CO2 laser deposits more heat in the surrounding area. This may be an important stimulus to collagen renewal and hence skin tightening and rhytid effacement,1 but leads to more complications. In either case, the mechanism of renewal is epidermal and dermal injury, which denatures collagen and activates fibroblasts, causing the synthesis of new collagen and extracellular matrix material.2 Nonablative lasers were developed in response to the two fundamental problems with ablative lasers: long periods of downtime and the risk of long-term hypopigmentation and scarring.
Microablative Fractional photothermolysis (FP) has recently been introduced for ‘microablative’ resurfacing.20,21
06 Carniol-8028.qxd
52
8/23/2007
3:32 PM
Page 52
Clinical procedures in laser skin rejuvenation
a
b
c
100 µm
100 µm 0 days
d
100 µm 1 days
3 days
100 µm 7 days
Fig. 6.1 Photomicrograph of skin treated with fractional device, 15 mJ. At 0 days, one can see thermal denaturation of the epidermis and dermis, with no effect to the structural integrity of the stratum corneum (remains intact).At 1 day post treatment, a vacuole is overlying the re-epithelized epidermis and the zone of thermal denaturation in the dermis.The vacuole is known to contain epidermal necrotic debris and dermal contents.At 3 days post treatment, one can see a compacted MEND (‘microscopic epidermal necrotic debris’ – this is actually a misnomer, as there is epidermal and dermal content) overlying the epidermis (which appears almost completely healed) and the thermally denatured dermis.At 7 days post treatment, one can see that the MEND is starting to exfoliate, while the epidermis has regained full thickness.The dermal aspect of the lesion also appears to have started healing, with an influx of cellular activity in and around the vicinity of the lesion. (Photomicrograph courtesy of Reliant Technologies, Inc.) Although FP is associated with limited downtime and usually requires multiple sessions, its main mechanism is via tissue ablation; thus, it has features of both ablative and nonablative techniques. In the novel FP technique, a 1550 nm laser creates a pattern of microscopic thermal wounds rather than uniform thermal damage in the skin.These microthermal zones (MTZs) are typically 100 µm wide and 300 µm deep and are surrounded by undamaged tissue, thus promoting a rapid healing response. The density and space between MTZs can be adjusted for a given energy level, and adverse effects, pain, and discomfort are manageable.20,22 This results in more rapid epithelialization than with ablative therapy, as well as deeper penetration into the dermis, with the possibility of eliminating abnormal dermal deposits and/or breaking up scars mechanically (Fig. 6.1). Clinical examples are shown in Figs 6.2 and 6.3.
NONABLATIVE TECHNOLOGIES FOR PHOTOREJUVENATION Many nonablative devices have been developed over the past 10 years.There are infrared devices targeting superficial collagen with nonspecific heating, pulsed dye lasers (PDLs), which heat the vessels and radiate heat into the other parts of the dermis, long-pulsed neodymium (Nd):YAG lasers, intense pulsed light (IPL) devices, lightemitting diode (LED) devices, photodynamic therapy (PDT), and the new tissue tightening devices designed to cause three-dimensional changes in the skin through nonablative methods. Each of these modalities will be discussed in the following sections.
Laser or visible light technology In photorejuvenation, technologies with wavelengths in the visible spectrum target the upper dermis. Many
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 53
Nonablative technology for treatment of aging skin
a
53
b
Fig. 6.2 Before (a) and after (b) three treatments of a woman with melasma and textural irregularities treated with a fractional device, 6–8 mJ, density level 6, with eight passes. (Photographs courtesy of Amy Forman Taub MD.) lasers and light sources have been developed with the principal use in mind of removing excessive epidermal pigmentation, reducing upper dermal telengiectasia, and improving the texture and tone of the skin. It has been noted by a number of investigators that these modalities also seem to improve superficial wrinkles and cause some skin smoothing and tightening.
Pulsed dye laser As the first laser developed to apply the principle of selective photothermolysis, the 585 nm PDL remains the gold standard for the treatment of vascular lesions.23 Zelickson et al13 reported the first investigation of the PDL for the treatment of sun-induced facial rhytids. Histological examination revealed dermal changes consistent with collagen remodeling. These results were confirmed in 2000 by Bjerring et al24 who, by altering the pulse duration, obtained cosmetic improvement without purpura. Tanghetti et al25 reported similar clinical improvements in facial dyspigmentation and wrinkling after single-pass and double-pass treatment with either 585 nm or 595 nm PDL devices. In a controlled, split-face study, Hsu et al26 reported improvements in surface topography of 9.8% (one treatment) and 15% (two treatments), supported by histological evidence of collagen remodeling. Key studies are summarized in Table 6.1.
Intense pulsed light Generally considered the gold standard for the nonablative treatment of superficial photodamage, IPL therapy achieves selective photothermolysis with noncoherent polychromatic light (about 500–1200 nm). Due to the broad spectrum of visible light, the two main chromophores, hemoglobin and melanin, can be effectively targeted with only one piece of technology.The minimal risk and downtime associated with this procedure have contributed to its success.8 Two key studies were reported in 2000. Bitter11 showed that serial full-face treatments with IPL visibly improved wrinkling, irregular pigmentation, skin coarseness, pore size, and telangiectasias in more than 90% of patients with little downtime.The patient satisfaction rate exceeded 88%. A clinical example and photomicrographs of biopsy specimens are shown in Figs 6.4 and 6.5, respectively. Goldberg and Cutler27 showed that IPL therapy nonablatively improved facial rhytids and skin quality with minimal adverse effects. Other studies are summarized in Table 6.2. Using treatment parameters similar to those used by Bitter, Negishi and colleagues28,29 showed that IPL improved pigmentation, telangiectasias, and skin texture of Asian skin. Goldberg and Samady30 revisited perioral rhytids, using different IPL parameters and comparing results with those of a 1064 nm Nd:YAG laser. Patient
06 Carniol-8028.qxd
54
8/23/2007
3:32 PM
Page 54
Clinical procedures in laser skin rejuvenation
a
b
c
d
Fig. 6.3 (a,b) A 27-yearold man whose acne scars had been treated three times unsuccessfully with trichloroacetic acid (15%) peels. (c,d).After a single fractional photothermolysis session, the acne scars are markedly improved 4 weeks later. Skin texture was also improved. (Reproduced with permission from Hasegawa T, Matsukura T, MizunoY, Suga Y, Ogawa H, Ikeda S. Clinical trial of a laser device called fractional photothermolysis system for acne scars. J Dermatol 2006;33:623–7.)
satisfaction rates were similar, although blistering and erythema were more common with IPL. In a 93-patient study, Sadick et al31 showed that up to five full-face IPL treatments resulted in significant
improvement in a variety of clinical indications of photoaging. A newer technology combining IPL with RF (electro-optical synergy, or ELOS) was evaluated by Sadick et al31 and found to be at least as efficacious
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 55
Nonablative technology for treatment of aging skin
55
Table 6.1 Studies of the use of the pulsed dye laser (PDL) for photorejuvenation Areas/ conditions treated (No. of treatments)
Wavelength (nm)/Fluence 2 (J/cm )/Pulse duration (ms)
Ref
No. of patients
13
20
Mild to severe perioral and periorbital wrinkles (1)
585/3.5–6.5/ 0.45
24
40
Facial wrinkles (1)
25
17
26
58
Adverse effects
Follow-up (months)
9/10 with mild to moderate wrinkling showed 50% or greater improvement at 6 months, 3/10 with moderate to severe wrinkling showed clinical improvement at 3 months
Transient purpura, swelling
Up to 14
585/2.4/ 0.350
Statistically significant decreases in Fitzpatrick class I, II, III wrinkles
None
Up to 6
Facial dyspigmentation and wrinkling (4)
585 or 595/ 3–4/0.5
Clinically observable improvement in dyspigmentation and wrinkling for all subjects
None
6
Periorbital wrinkling (1 or 2)
585/2.4–2.9/ 0.35
Improvements in surface topography of 9.8% (one treatment) and 15% (two treatments)
Minor pain 1, 3 during initial treatment, minimal temporary reddening
a
Efficacy
b
Fig. 6.4 A 54-year-old woman: (a) before and (b) 4 weeks after five full-face intense pulsed light (IPL) treatments. Note the improvement in fine wrinkles and skin texture. (Reproduced with permission from Bitter PH Jr. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835–42. for pigmentation and vascularity but potentially more advantageous for pore size, superficial rhytides, laxity and texture due to the addition of the RF modality which can penetrate more deeply into the dermis to stimulate collagen remodeling.
Potassium titanyl phosphate The 532 nm wavelength of the potassium titanyl phosphate (KTP) laser device is readily absorbed by oxyhemoglobin and melanin,34 making it especially
06 Carniol-8028.qxd
56
8/23/2007
3:32 PM
Page 56
Clinical procedures in laser skin rejuvenation
a
The efficacy of the KTP laser is comparable to that of IPL.36 The smaller spot size and ergonomic flexibility of the KTP handpiece, however, promote ease of use and allow practitioners to focus on resistant lesions.34 Although fewer treatments are required, the risk of erythema and edema is higher with the KTP laser21 and the treatment is less tolerable.36 The results of key studies are presented in Table 6.3.
Photomodulation
b
Fig. 6.5 Photomicrographs of biopsies of forehead skin from (a) the untreated forehead and (b) the treated forehead 4 weeks after the fifth IPL treatment. (Reproduced with permission from Bitter PH Jr. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835–42).
effective for treating red and brown discolorations due to photodamage35 and inducing growth of collagen and elastin fibers when endothelial damage causes the release of cytokines.34 Combining the KTP laser with the 1064 nm Nd:YAG laser device15,35 makes use of the greater penetration depth of the longer wavelength to create a synergistic effect that further improves skin quality and wrinkle reduction beyond what is achievable by KTP alone (Figure 6.6).15
In photomodulation, a light-emitting diode (LED) is used to manipulate cellular activities without thermal effect.37 McDaniel and colleagues showed37,38 that they could upregulate procollagen synthesis and downregulate matrix metalloproteinase (collagenase) in fibroblast culture with specific pulse sequences and durations of low-energy, narrowband, or coherent light. The effects were strongest when 590 nm LED devices were used. These findings led to a multicenter trial in which 90 patients with photodamaged skin received eight LED photomodulation treatments using a full-panel 590 nm nonthermal full face LED array delivering 0.1 J/cm2 with a specific sequence of pulsing treatments over 4 weeks.12 More than 90% showed improvement in at least one Fitzpatrick photoaging category and 65% showed improvement in facial texture, background erythema, fine lines, and pigmentation, all without pain or adverse effects. Improvements peaked in 4–6 months after the final treatment. The clinical results were supported by post-treatment histological studies that showed increased collagen in the papillary dermis. The use of combination 633 nm and 830 nm LED light therapy for the treatment of photodamaged skin has been reported by two groups.19,39 In a 31-patient study, Russell et al39 treated facial rhytids nine times and noted (1) 25% to 50% improvement in photoaging scores of 52% of patients and (2) significant patient-reported improvement in periorbital wrinkles in 81% of patients 12 weeks after the final treatment. In a similar 36-patient study, Goldberg et al19 reported very similar results. Electron microscopic data of posttreatment tissue showed collagen fibers of increased thickness. Adverse effects were limited to mild erythema in one patient.
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 57
Nonablative technology for treatment of aging skin
57
Table 6.2 Studies of the use of intense pulsed light (IPL) for photorejuvenation Areas/ conditions No. of treated (No. Ref patients of treatments)
Cut-off filter (nm)/Fluence (J/cm2)/Pulse duration (ms)
27
30
Perioral rhytids (1–4)
11
49
28
Efficacy
Adverse effects
Follow-up (months)
645/40–50/7
16/30 patients had some improvement, 9/30 substantial improvement
Transient erythema, blistering
6
Full face/overall photorejuvenation (mean 4.94)
550 or 570/ 30–50/ 2.4–4.7
75% of patients reported ≥ 50% overall improvement
Mild, temporary erythema, blisters, darkening of lentigines and freckles
1
97 (Asian skin)
Facial photorejuvenation (3–6)
550 or 570/ 28–32/2.5–5
88.4% of patients reported ≥ 51% improvement in pigmented lesions, 77.7% reported ≥ 51% improvement in telangiectasias, 77.3% reported ≥ 51% improvement in skin texture
30
15
Perioral rhytids (3–5)
590/755/ 40–70, 3–7
On 1–10 scale, mean patient satisfaction scores 6.4 (at 590 nm), 6.2 (at 755 nm) at 6 months
Blistering, erythema with IPL
Up to 6
39
36 (Asian skin)
Facial freckles (1–3)
550–590/ 25–35/4
91.7% of patients reported very or extremely satisfied
Transient erythema, pain, hyperpigmentation, crusting
6
32
47
Facial rhytids, vascularity, dyschromia, pore size
550/570/ 28–34/2.4–4
Long-term improvement in rhytids, vascularity, dyschromia, pore size
Temporary swelling, erythema, crusting, purpura
6
33
23
Midfacial photoaging (3)
500–690, 890–1200/ 24–30/pulse duration not reported
Improvement in surface texture, mottled hyperpigmentation/ solar lentigines, erythema/ telangiectasias
Discomfort during treatment, transient focal vesiculation, crusting, erythema
1
31
93
Wrinkles, elastosis, vascular and pigmented lesions of face (up to 5)
560 or 640/ 20–44/2–7
Significant reduction in wrinkles, elastosis, vascular and pigmented lesions; improvement in 90% of patients at 6 months; patient satisfaction high
Temporary erythema, edema, purpura, hyperpigmentation
6
a
Results were evaluated at the end of the third treatment.
0a
06 Carniol-8028.qxd
58
8/23/2007
3:32 PM
Page 58
Clinical procedures in laser skin rejuvenation
a
b
Fig. 6.6 A 51-year-old woman: before (a) and (b) 6 months after six treatments with combined potassium titanyl phosphate (KTP) and neodymium : yttrium aluminum garnet (Nd:YAG) lasers. Note the overall improvement in erythema, pigmentation, skin tone and texture, pore tightening, and rhytid reduction. (Reproduced with permission from Lee MW. Combination 532 nm and 1064 nm lasers for noninvasive skin rejuvenation and toning.Arch Dermatol 2003;139:1265–76.)
Table 6.3 Studies of the use of the 532 nm potassium titanyl phosphate (KTP) laser for photorejuvenation
No. of Ref patients
Areas/ conditions treated (No. of treatments)
Fluence (J/cm2)/ Pulse duration (ms)
15
50
Face (3–6)
34
7
36
17
Efficacy
Adverse effects
Follow-up (months)
7–15/7–20
All patients had mild to moderate improvement in appearance of rhytids, moderate improvement in skin toning and texture, great improvement in reduction of pigmentation and redness; KTP results superior to 1064 nm laser results
Mild, temporary erythema, edema; sensitivity to heat and recurrence of flushing and telangiectasias in patients with rosacea; mild to moderate pain during and after treatment
Up to 18
Periorbital and midfacial (4)
10–14/ 13–17
Noticeable overall improvement in all patients, all patients pleased with results
Temporary mild erythema
2
Facial dyschromias and telangiectasias (1)
7–9/30
Average improvement 42%/30% for vascular/ pigmented lesions
Pain during treatment; temporary edema and erythema, crusting of dyschromias
1
LEDs are promising, as they are less expensive to manufacture, they take only seconds of irradiation, and they are painless. They have also been used to reduce
inflammation in sunburn and provide palliation for breast cancer metastatic to the chest wall, and more novel indications for this modality may be discovered in the future.
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 59
Nonablative technology for treatment of aging skin
a
59
b
Fig. 6.7 Before (a) and after (b) four monthly treatments with blue light and δ-aminolevulinic acid photodynamic therapy. (Photographs courtesy of Michael Gold MD.)
Photodynamic therapy PDT uses a light-activated photosensitizing agent to create cytotoxic singlet oxygen within abnormal tissue. Because the photosensitizer accumulates preferentially in abnormal cells, PDT selectively destroys these target cells without damaging surrounding tissue.Although PDT with δ-aminolevulinic acid (ALA) is approved by the US Food and Drug Administration (FDA) only for the treatment of actinic keratosis (AK) in the face and scalp, the technique is being used to treat a wide variety of skin conditions (including photorejuvenation) because of its efficacy, safety profile, and minimal downtime.40 Photodynamic rejuvenation denotes the use of PDT to improve the clinical manifestations of photodamage.41 Touma et al42 showed that 1-hour ALA incubation provided approximately the same improvement in photodamage as 14- to 18-hour ALA incubation and that ALA–PDT could be used to treat broad areas of photodamage. A variety of studies have led to the recommendation40 that either IPL (preferred), blue light (alternate), or PDL (other) be used to activate the photosensitizer when ALA–PDT is used for photorejuvenation. One of the advantages of PDT is its ability to be performed with many different technologies. Protoporphyrin IX is the photoabsorbing molecule, and although absorption is greatest at 417 nm (blue light), there are multiple Q-bands of absorption up to about
650 nm. This means that IPL, PDLs, KTP lasers, red light, and LED diodes all will activate the photosensitizer and be able to produce a photodynamic treatment. Another huge advantage of PDT is that it can eradicate precancerous cells while improving photodamage (Fig. 6.7). Blue light, red light, LEDs,43 ELOS,44 PDLs, and IPL have been used in PDT for photorejuvenation.Two topical photosensitizers are currently in use: ALA and methyl aminolevulinate. Studies of the use of IPL or blue light are shown in Table 6.4. Split-face studies45–47 have shown the superiority of PDT with IPL versus IPL alone.
Long-wavelength lasers and light sources for collagen stimulation Collagen remodeling with the use of infrared lasers has been extensively studied. Early studies7,16,17 using the 1320 nm Nd:YAG laser showed minimal to visible clinical improvement in facial rhytids, with histological evidence of dermal collagen 1–6 months after the final of a series of treatments. Results with the 1540 nm Er:glass laser were less encouraging, possibly because collagen denaturation and dermal fibroplasia had occurred too deeply in the dermis to improve wrinkles.5 A 24-patient study52 showed gradual clinical improvement in mild to moderate facial rhytids during and 6 months after a series of three once-monthly treatments with a 1540 nm Er:glass laser device. An
06 Carniol-8028.qxd
60
8/23/2007
3:32 PM
Page 60
Clinical procedures in laser skin rejuvenation
Table 6.4 Results of photodynamic therapy with δ-aminolevulinic acid (ALA–PDT), using intense pulsed light (IPL) or blue light, for photorejuvenation. Ref
No. of patients
ALA contact time (hours)
Light source
No. of treatments
Improvement, clearance, or response rate (%)
Adverse effects
Follow-up (months)
48
10
1
IPL
3
90 (crow's feet); 100 (tactile skin roughness); 90 (mottled hyperpigmentation); 70 (facial erythema); 83 (actinic keratosis)
—
3
49
32
Short contact
Blue
1
90 (actinic keratosis); 72 (skin texture); 59 (skin pigmentation)
—
—
50
17
1
IPL
1
68 (actinic keratosis); 55 (telangiectasias); 48 (pigment irregularities); 25 (skin texture)
Mild transient erythema, edema
1, 3
45
Not available
—
IPL
3a, 2b
80 (ALA–PDT–IPL) vs 50 (IPL) photoaging; 95 vs 65 (mottled hyperpigmentation); 55 vs 20 (fine lines)
46
13
—
IPL
3a
55 (ALA–PDT-IPL) vs 29.5 (IPL) crow’s feet; 55 vs 29.5 (tactile skin roughness); 60.3 vs 37.2 (mottled hyperpigmentation); 84.6 vs 53.8 (facial erythema); 78 vs 53.6 (actinic keratosis)
Erythema, edema
3
51
10
1
IPL
2a
1.65a (ALA–PDT–IPL) vs 1.28c (IPL)
Temporary erythema, mild edema, desquamation
6
47
20
0.5–1
IPL
3a, 2b
80 (ALA–PDT–IPL) vs 45 (IPL) global score; 95 vs 60 (mottled hyperpigmentation); 80 vs 80 (fine lines); 95 vs 90 (tactile roughness); 75 vs 75 (sallowness)
Mild stinging during treatment; temporary erythema, scaling, edema, oozing, crusting, vesiculation
1
a
—
1
Split face, ALA–PDT–IPL vs. IPL. Full face, IPL alone. c Mean clinical grade (1= 25% improvement, 2= 25–50%; 3 = 51–75%; 4 = 76–100%). Adapted with permission from Nestor M, Gold M, Kauvar A, et al.The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 2006; 5:140–54. b
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 61
Nonablative technology for treatment of aging skin
a
61
b
Fig. 6.8 Before (a) and after (b) two treatments with electro-optical synergy (ELOS) with pulsed light and ELOS with a diode laser. (Photographs courtesy of Macrene Alexiades-Armenakas MD,PhD.)
increase in dermal collagen was not observed until several months after the final treatment. A recent review of clinical trials with the 1540 nm Er:glass laser53 confirmed that collagen remodeling and improvement were gradual, and emphasized the importance of explaining this to patients. With regard to the 1064 nm Nd:YAG laser, the studies of Lee15,54 revealed subtle and gradual improvements in wrinkles, skin laxity, and overall appearance, supported by histological evidence of collagen remodeling. In another study,55 a series of four treatments with a 1450 nm diode laser (SmoothBeam, Candela Corp.,Wayland, MA) resulted in mild to moderate improvement in facial rhytids in all 25 patients treated and increases in dermal collagen 6 months after the final treatment.The treatment was well tolerated, and adverse effects were transient and limited to erythema, edema, and postinflammatory hyperpigmentation. Two other groups56,57 have reported clinical evaluations of the 1064 nm Nd:YAG laser. Dayan et al56 found an approximately 12% reduction in Fitzpatrick scale scores for coarse wrinkles, a 17% reduction for skin laxity, and a 20% overall improvement. Taylor and Prokopenko57 reported a 30% improvement in wrinkles and skin laxity and an approximately 16% improvement in texture, pores, and pigmentation. Dang et al58,59 focused on head-to-head comparisons on mouse skin. In one study,58 they compared the histological, biochemical, and mechanical responses associated with the Q-switched 1064 nm Nd:YAG laser
and the 1320 nm Nd:YAG laser.The 1064 nm laser produced a 25% greater improvement in skin elasticity, a 6% greater increase in skin thickness, and an 11% greater hydroxyproline synthesis (a measure of collagen content59) by the second month after treatment. Type III collagen increased markedly after 1064 nm laser treatment, while type I collagen increases were greater after treatment with the 1320 nm laser. In another study59 comparing a 595 nm PDL (Vbeam, Candela Corp.,Wayland, MA) with a 1320 nm Nd:YAG laser (Cooltouch II, ICN Pharmaceuticals Inc., Roseville, CA), PDL treatment produced a greater increase in dermal thickness, hydroxyproline levels, and type I and type III collagen, while improvement in skin hydration was greater with the 1320 nm laser. However, none of these differences was statistically significant. Orringer et al60 assessed collagen remodeling after a single treatment of photodamaged skin with either a 585 nm PDL (NLite, ICN Pharmaceuticals Inc.) or 1320 nm Nd:YAG laser (Cooltouch II, ICN Pharmaceuticals Inc.).At 1 week post treatment, histological examination revealed statistically significant increases in type I procollagen messenger RNA expression (47% and 84% above pretreatment levels for the 585 and 1320 nm lasers, respectively), as well as induction of primary cytokines, matrix metalloproteinases, and type III procollagen. Doshi and Alster61 evaluated the combination RF and diode laser (ELOS: Polaris WR, Syneron Medical Ltd, Israel) for the treatment of facial rhytids and skin laxity. This device delivers RF and 910 nm diode laser energy
06 Carniol-8028.qxd
62
8/23/2007
3:32 PM
Page 62
Clinical procedures in laser skin rejuvenation
Fig. 6.9 Partially denatured collagen after Thermage treatment as 160 microns by electron microscopy. (Reproduced courtesy of Dr. Brian Zelickson and Thermage Corp.) sequentially through a bipolar electrode tip with epidermal cooling. Three treatments were given at 3-week intervals to 20 patients with mild to moderate rhytids and skin laxity. Optical and RF fluences ranged from 30 to 40 J/cm2 and from 50 to 85 J/cm3, respectively. The prospective study showed a mean clinical improvement of superficial rhytids at 6 months of 1.63/4. For skin laxity of the jowl and cheek, improvement scores reached 2.00/4 at 6 months. Patient assessments were similar. Side-effects were mild. In a combined study62 of ELOS with both IPL and a diode laser (Fig. 6.8), overall effectiveness scores in multiple measures of photodamage was approximately 26%.
NONABLATIVE TECHNOLOGIES FOR SKIN TIGHTENING From the evidence that collateral heating of the dermis while targeting vascular and pigmented lesions created new collagen and decreased wrinkles sprang the idea of bulk dermal heating. Bulk dermal heating requires relatively deep energy deposition over a period of seconds as opposed to microseconds, with cooling to protect the epidermis.The intent of tissue tightening is to actually lift or firm tissue in a three-dimensional manner. This is not the same as stimulating collagen to fill in superficial scars or wrinkles, but a deeper shift in tissue
volumes, leading to a remodeling of the entire soft tissue envelope, a completely new aesthetic capability. Collagen fibers consist of protein chains held in a triple helix. When collagen is heated, non-colavent bonds linking the protein strands together are ruptured, producing an amorphous arrangement of randomly coiled chains.63 As the chains rearrange, fibers of the denatured collagen become shorter and thicker. Heat-induced contraction of collagen and long-term fibroblastic stimulation are is the basis for the treatment of skin laxity.64 For exposures lasting several seconds, the denaturation temperature of collagen has been estimated at 65°C.65,66 In practice, however, collagen denaturation has a complex dependence on temperature described by the Arrhenius reaction-rate equation.This relationship may not hold for very short time exposures to heat, because the kinetics of collagen denaturation are not known.66 There are two technologies supported by peerreviewed literature at present for evaluation: RF and broadband infrared (IR) light.
Radiofrequency-based tissue tightening RF energy interacts with tissue to generate a current of ions that, when passed through tissues, encounters resistance. This resistance, or impedance, generates
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 63
Nonablative technology for treatment of aging skin
63
Table 6.5 Studies of the use of radiofrequency (RF) for skin tightening Ref
No. of patients
Fluence (J/cm2)
Areas treated
Efficacy
Adverse effects
Follow-up (months)
Face, anterior neck
70% of patients noticed significant improvement in skin laxity and texture at 3 months
Moderate pain during treatment; 3/40 patients experienced superficial blistering
1, 2, 3
73
40
—
74
15
52 (only for 2 patients treated with 1 cm2 tip)
Face
14/15 patients responded; nasolabial folds: 50% of patients had at least 50% improvement; cheek contour: 60% had 50% improvement; mandibular line: 27% had at least 50% improvement; marionette lines: 65% had at least 50% improvement.
Minimal discomfort during treatment in all patients; superficial burn (1 patient)
6–14
69
86
58–140
Periorbital wrinkles, brow position)
Fitzpatrick wrinkle scores improved by 1 point or more in 83.2% of patients; 50% of patients satisfied to very satisfied; 61.5% of eyebrows lifted by 0.5 mm
Minimal erythema, edema, 2nd-degree burn; small residual scar at 6 months in 3 patients
6
70
16
—
Cheeks, jaw line, upper neck
5 of 15 patients contacted were satisfied with results
Mild, transient erythema and edema
6
78
17
125–144
Brow, jowls, nasolabial folds, puppet lines
Gradual tightening
Mild, temporary erythema
4
75
50
97–144 (cheeks) 74–110 (neck)
Mild to moderate skin laxity in neck and cheek
Significant improvement in most patients; patient satisfaction was similar to observed clinical improvement
Mild and temporary edema, erythema, rare dysesthesia
6
68
24
Upper third of face; brow elevation; forehead, temporal regions
Objective data showed non-uniform (asymmetric) improvement; patient satisfaction low; 72.7% said they would not have the procedure again; results not predictable
Pain during treatment; redness
4–14 weeks
57
7
Face; laxity, wrinkles, pores, pigmentation, texture
About 16% median improvement in wrinkles and skin laxity; about 16% improvement in texture, pores, and pigmentation; patients satisfied; improvement maintained 2–6 months
None
2–6
—
73.5
06 Carniol-8028.qxd
64
8/23/2007
3:32 PM
Page 64
Clinical procedures in laser skin rejuvenation
heat in proportion to the amount of impedance. Tissues with high impedance will be heated more than tissues of low impedance.67 Traditional RF devices used in skin surgery deliver therapeutic energy through the tip of an electrode in contact with skin. The concentrated thermal energy produces heat at the surface of the skin, which injures both the dermis and epidermis.68 To reduce heat-induced epidermal injury while heating the dermis, developed the ThermaCool, a device that delivers RF energy to the skin via a thin capacitive coupling membrane that distributes RF energy over the tissue volume beneath the membrane’s surface (rather than concentrating the RF energy at the skin surface) while cooling the epidermis by cryogen spray.69,70 Although the deep dermal layer can theoretically reach temperatures exceeding 65°C, permitting the heat-sensitive
a
collagen bonds to go beyond their 60° denaturation threshold, the temperature of the epidermis is maintained between 35°C and 45°C.68 A study of the histological and ultrastructural effects of RF energy suggested that collagen fibrils contract immediately after treatment and that production of new collagen is induced by tissue contraction and heat-mediated wounding (Fig. 6.9).71 The first clinical study of the ThermaCool assessed skin contraction, gross pathology, and histological changes for a range of RF doses.70,72 Iyer et al73 reported that 70% of patients noticed skin laxity improvement 3 months after a single RF treatment and that improvement increased with additional treatments. A subsequent report described a prototype device designed to produce heat in the dermal layer of tissue while protecting the epidermis by cryogen spray
b
Fig. 6.10 Before (a) and 8 months after (b) tissue tightening treatments: one radiofrequency treatment on the left side of the face and two broadband infrared light device treatments on the right. Note the decreased depth of the nasolabial folds and marionette lines, the firming of the skin over the mid cheek and the restoration of the shape of the face toward an oval, instead of a rectangle. (Photographs courtesy of Amy Forman Taub MD.)
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 65
Nonablative technology for treatment of aging skin
65
Table 6.6 Studies of the use of broadband infrared (IR) light for skin tightening
Ref
No. of patients
79
25
80
42
Device (No. of treatments)
Fluence (J/cm2)
Local anesthesia
Treatment target
1100– 1800 nm (1–3)
20–40
For first 5 patients
Forehead; lower face and neck
1100– 1800 nm (2)
30–38
Sometimes
Face, neck, abdomen
cooling.74 Of the 15 patients,14 responded to a single treatment without wounding or scarring. Pain was used to indicate the tolerability of treatment. Patients resumed normal activities immediately after treatment. Other RF studies that followed are summarized in Table 6.5. In each study, patients had a single treatment, local anesthesia was used during treatment, and results were evaluated by comparing pre- and posttreatment photographs. Improvements with a single treatment were gradual and subtle and lasted for several months. Higher fluences were required with thick skin.69 When low fluences were used, improvements were less pronounced.70,75 Initially, it was believed that the highest fluences would yield the best results. However, this was accompanied by significant patient discomfort and a relatively high rate of significant side-effects,76 such as scars and changes in skin surface textures (e.g., indentation or waffling). A different model based on a lower-fluence, multiple-pass protocol was shown via ultrastructural analysis of collagen fibril architecture to provide much more collagen deposition deeper in the dermis than the high-fluence protocol.77 This is believed to yield more consistent results, higher patient tolerability, and fewer complications. Recent advances include specialized tips for more superficial areas (eyelids) and body areas (arms and abdomen).
Adverse effects
Follow-up (months)
Immediate improvement in 22 patients, persisted for follow-up period; all patients satisfied
Small burns
Up to 12
Improvement moderate or higher in 52.4% of patients
Transient minor swelling and erythema, rare blister
4
Efficacy
Infrared light-based tissue tightening A broadband infrared light tightening device has recently been developed as an alternative technology for tissue tightening (Titan, Cutera, Brisbane, CA). This generates energy of up to 50 J/cm2 energy at 1100–1800 nm wavelengths, with pre- and postcooling being built into the multisecond pulse. The long wavelengths of near- and mid-IR radiation offer three major advantages over shorter wavelengths: (1) deeper penetration into the dermal layer (2) less absorption by melanin, and (3) reduced risk in dark-skinned patients.56 This device targets the dermis at a depth of 1–2 mm, which is more superficial than the RF device. The author has found this to be an advantage for thinner skin, whereas the RF technology may be better for thicker skin with more subcutaneous tissue attached – but these observations are anecdotal. However, in many skin types, the results may be similar (Fig. 6.10). Studies of the use of infrared light in tissue tightening are summarized in Table 6.6.
THE FUTURE AND CONCLUSIONS A major advantage of nonablative techniques is that treatment requires little or no downtime for patients. The importance of this feature is evident from the
06 Carniol-8028.qxd
66
8/23/2007
3:32 PM
Page 66
Clinical procedures in laser skin rejuvenation
growth and proliferation of nonablative devices since they were introduced in the late 1990s. Disadvantages are that efficacy is modest and multiple treatments are required to achieve results. Future efforts will be focused on increasing efficacy and reducing the number of treatments, making treatment more affordable for more patients.
REFERENCES 1. Fitzpatrick R, Rostan E, Marchell N. Collagen tightening induced by carbon dioxide laser versus erbium:YAG laser. Lasers Surg Med 2000;27:395–403. 2. Nelson J, Majaron B, Kelly K. What is nonablative photorejuvenation of human skin? Semin Cutan Med Surg 2002;21:238–50. 3. Grema H, Greve B, Raulin C. Facial rhytids – subsurfacing or resurfacing? A review, Lasers Surg Med 2003;32: 405–12. 4. Herne K, Zachary C. New facial rejuvenation techniques. Semin Cutan Med Surg 2000;19:221–31. 5. Ross E, Sajben F, Hsia J,et al. Nonablative skin remodeling: selective dermal heating with a mid-infrared laser and contact cooling combination. Lasers Surg Med 2000; 26:186–95. 6. Kelly K, Nelson J, Lask G, Geronemus R, Bernstein L. Cryogen spray cooling in combination with nonablative laser treatment of facial rhytids. Arch Dermatol 1999; 135:691–4. 7. Goldberg D. Full-face nonablative dermal remodeling with a 1320 nm Nd:YAG laser. Dermatol Surg 2000; 26:915–18. 8. Goldberg D. New collagen formation after dermal remodeling with an intense pulsed light source. J Cutan Laser Ther 2000;2:59–61. 9. Trelles M, Allones I, Luna R. Facial rejuvenation with a nonablative 1320 nm Nd:YAG laser: a preliminary clinical and histologic evaluation. Dermatol Surg 2001; 27:111–16. 10. Fournier N, Dahan S, Barneon G, et al. Nonablative remodeling: a 14-month clinical ultrasound imaging and profilometric evaluation of a 1540 nm Er:Glass laser. Dermatol Surg 2002;28:926–31. 11. Bitter P. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835–42. 12. Weiss R, McDaniel D, Geronemus R, Weiss M. Clinical trial of a novel non-thermal LED array for reversal of photoaging: clinical, histologic, and surface profilometric results. Lasers Surg Med 2005;36:85–91.
13. Zelickson B, Kilmer SL, Bernstein E, et al. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med 1999;25:229–36. 14. Rostan E, Bowes L, Iyer S, Fitzpatrick R. A double-blind, side-by-side comparison study of low fluence long pulse dye laser to coolant treatment for wrinkling of the cheeks. J Cosmet Laser Ther 2001;3:129–36. 15. Lee M. Combination 532-nm and 1064-nm lasers for noninvasive skin rejuvenation and toning. Arch Dermatol 2003;139:1265–76 [Erratum: 2004;140:625]. 16. Menaker G, Wrone D, Williams R, Moy R. Treatment of facial rhytids with a nonablative laser: a clinical and histologic study. Dermatol Surg 1999;25:440–4. 17. Goldberg D. Non-ablative subsurface remodeling: clinical and histologic evaluation of a 1320-nm Nd:YAG laser. J Cutan Laser Ther 1999;1:153–7. 18. Sadick N, Alexiades-Armenakis M, Bitter P Jr, Hruza G, Mulholland R. Enhanced full-face skin rejuvenation using synchronous intense pulsed optical and conducted bipolar radiofrequency energy (ELOS): introducing selective radiophotothermolysis. J Drugs Dermatol 2005; 4:181–6. 19. Goldberg D, Amin S. Russell B,et al. Combined 633-nm and 830-nm LED treatment of photoaging skin. J Drugs Dermatol 2006;5:748–53. 20. Manstein D, Herron G, Sink R, Tanner H, Anderson R. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004;34:426–38. 21. Weiss R,Weiss M, Beasley K, Munavalli G. Our approach to non-ablative treatment of photoaging. Lasers Surg Med 2005;37:2–8. 22. Geronemus R. Fractional photothermolysis: current and future applications. Lasers Surg Med 2006;38:169–76. 23. Kauvar A, Rosen N, Khrom T. A newly modified 595-nm pulsed dye laser with compression handpiece for the treatment of photodamaged skin. Lasers Surg Med 2006;38:808–13. 24. Bjerring P, Clement M, Heickendorff L, Egevist H, Kiernan M. Selective non-ablative wrinkle reduction by laser. J Cutan Laser Ther 2000;2:9–15. 25. Tanghetti E, Sherr E, Alvarado S. Multipass treatment of photodamage using the pulse dye laser. Dermatol Surg 2003;29:686–90. 26. Hsu T, Zelickson B, Dover J, et al. Multicenter study of the safety and efficacy of a 585 nm pulsed-dye laser for the nonablative treatment of facial rhytids. Dermatol Surg 2005;31:1–9. 27. Goldberg D, Cutler K. Nonablative treatment of rhytids with intense pulsed light. Lasers Surg Med 2000;26: 196–200. 28. Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg 2001;27:627–631; discussion 632.
06 Carniol-8028.qxd
8/23/2007
3:32 PM
Page 67
Nonablative technology for treatment of aging skin 29. Huang Y, Liao Y, Lee S, Hong H. Intense pulsed light for the treatment of facial freckles in Asian skin. Dermatol Surg 2002;28:1007–12. 30. Goldberg D, Samady J. Intense pulsed light and Nd:YAG laser non-ablative treatment of facial rhytids. Lasers Surg Med 2001;28:141–4. 31. Sadick N,Weiss R, Kilmer S, Bitter P. Photorejuvenation with intense pulsed light: results of a multi-center study. J Drugs Dermatol 2004;3:41–9. 32. Brazil J, Owens P. Long-term clinical results of IPL photorejuvenation. J Cosmet Laser Ther 2003;5:168–74. 33. Kligman D, Zhen Y. Intense pulsed light treatment of photoaged facial skin. Dermatol Surg 2004;30:1085–90. 34. Carniol P, Farley S, Friedman A. Long-pulse 532-nm diode laser for nonablative facial skin rejuvenation. Arch Facial Plast Surg 2003;5:511–13. 35. Tan M, Dover J, Hsu T, Arndt K, Steward B. Clinical evaluation of enhanced nonablative skin rejuvenation using a combination of a 532 and a 1,064 nm laser. Lasers Surg Med 2004;34:439–45. 36. Butler E, McClellan S, Ross E. Split treatment of photodamaged skin with KTP 532 nm laser with 10 mm handpiece versus IPL: a cheek-to-cheek comparison. Lasers Surg Med 2006;38:124–8. 37. McDaniel D,Weiss R, Geronemus R, Ginn L, Newman J. Light-tissue interactions I: Photothermolysis vs photomodulation laboratory findings. Lasers Surg Med 2002;14:25. 38. Weiss R, Weiss M, Geronemus R, McDaniel D. A novel non-thermal non-ablative full panel LED photomodulation device for reversal of photoaging: digital microscopic and clinical results in various skin types. J Drugs Dermatol 2004;3:605–10. 39. Russell B, Kellet N, Reilly L. Study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation. J Cosmet Laser Ther 2005;7:196–200. 40. Nestor M, Gold M, Kauvar A, et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 2006;5:140–154. 41. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic rejuvenation, Dermatol Surg 2002;28:742–4. 42. Touma D,Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004;140:33–40. 43. Lowe N, Lowe P. A pilot study to determine the efficacy of ALA–PDT photorejuvenation for the treatment of facial ageing. J Cosmet Laser Ther 2005;7:159–62. 44. Hall J, Keller P, Keller G. Dose response of combination photorejuvenation using intense pulsed light-activated photodynamic therapy and radiofrequency energy. Arch Facial Plast Surg 2004;6:374–8.
67
45. Bhatia A, Dover J, et al. Adjunctive use of topical aminolevulinic acid with intense pulsed light in the treatment of photoaging. Paper presented at: Controversies and Conversations in Cutaneous Laser Surgery, Mt Tremblant, Canada, August 2004. 46. Gold M, Bradshaw V, Boring M, Bridges T, Biron J. Splitface comparison of photodynamic therapy with 5aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006;32:795–801. 47. Dover J, Bhatia A, Stewart B, Arndt K.Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging.Arch Dermatol 2005;141:1247–52. 48. Gold M. Intense pulsed light therapy for photorejuvenation enhanced with 20% aminolevulinic acid photodynamic therapy. J Lasers Med Surg 2003; 15(Suppl):47. 49. Goldman M, Atkin D, Kincad S. PDT/ALA in the treatment of actinic damage: real world experience. J Lasers Med Surg 2002;14(Suppl):24. 50. Avram D, Goldman M, Effectiveness and safety of ALA– IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004;3(1 Suppl):S36-S39. 51. Alster T,Tanzi E,Welsh E. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 2005;4:35–8. 52. Lupton JR,Williams CN,Alster TS. Nonablative laser skin resurfacing using a 1540 nm erbium glass laser: a clinical and histologic analysis. Dermatol Surg 2002;28:833–5. 53. Fournier N, Mordon S. Nonablative remodeling with a 1,540 nm erbium:glass laser. Dermatol Surg 2005;31: 1227–35. 54. Lee M. Combination visible and infrared lasers for skin rejuvenation. Semin Cutan Med Surg 2002;21:288–300. 55. Tanzi E, Williams C, Alster T. Treatment of facial rhytids with a nonablative 1,450-nm diode laser: a controlled clinical and histologic study. Dermatol Surg 2003;29:124–8. 56. Dayan SH, Vartanian AJ, Menaker G, Mobley SR, Dayan AN. Nonablative laser resurfacing using the long-pulse (1064-nm) Nd:YAG laser. Arch Facial Plast Surg 2003; 5:310–15. 57. Taylor M, Prokopenko I. Split-face comparison of radiofrequency versus long-pulse Nd-YAG treatment of facial laxity. J Cosmet Laser Ther 2006;8:17–22. 58. Dang YY, Ren QS, Liu HX, Ma JB, Zhang JS. Comparison of histologic, biochemical, and mechanical properties of murine skin treated with the 1064-nm and 1320-nm Nd:YAG lasers. Exp Dermatol 2005;14:876–82. 59. Dang Y, Ren Q, Hoecker S, et al. Biophysical, histological and biochemical changes after non-ablative treatments with the 595 and 1320 nm lasers: a comparative study.
06 Carniol-8028.qxd
68
60.
61.
62.
63.
64.
65.
66.
67. 68.
69.
70.
8/23/2007
3:32 PM
Page 68
Clinical procedures in laser skin rejuvenation Photodermatol Photoimmunol Photomed 2005;21: 204–9. Orringer JS, Voorhees JJ, Hamilton T, et al. Dermal matrix remodeling after nonablative laser therapy. J Am Acad Dermatol 2005;53:775–82. Doshi S, Alster T. 1,450 nm long-pulsed diode laser for nonablative skin rejuvenation. Dermatol Surg 2005;31: 1223–6. Alexiades-Armenakas M. Rhytides, laxity, and photoaging treated with a combination of radiofrequency, diode laser, and pulsed light and assessed with a comprehensive grading scale. J Drugs Dermatol 2006; 5:731–8. Lennox MA. Febrile convulsions in childhood; a clinical and electroencephalographic study. Am J Dis Child 1949;78:868–82. Ruiz-Esparza J. Near painless, nonablative, immediate skin contraction induced by low-fluence irradiation with new infrared device: a report of 25 patients. Dermatol Surg 2006;32:601–10. Koch D. Histological changes and wound healing response following noncontact holmium:YAG laser thermal keratoplasty. Trans Am Ophthalmol Soc 1996; 94:745–802. Ross E, McKinlay J, Anderson R.Why does carbon dioxide resurfacing work? A review. Arch Dermatol 1999; 135:444–54. Taub A. Harnessing radiofrequency energy. Skin Aging 2003;11:52–8. Bassichis BA, Dayan S, Thomas JR. Use of a nonablative radiofrequency device to rejuvenate the upper one-third of the face. Otolaryngol Head Neck Surg 2004;130:397–406. Fitzpatrick R, Geronemus R, Goldberg D, et al.Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med 2003;33:232–42. Hsu T, Kaminer M.The use of nonablative radiofrequency technology to tighten the lower face and neck. Semin Cutan Med Surg 2003;22:115–23.
71. Zelickson B, Kist D, Bernstein E, et al. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device: a pilot study. Arch Dermatol 2004;140:204–9. 72. Kilmer S. A new, nonablative radiofrequency device: preliminary results. In: Controversies and Conversations in Cutaneous Laser Surgery. Chicago: American Medical Association Press, 2002:95–100. 73. Iyer S, Suthamjariya K, Fitzpatrick R. Using a radiofrequency energy device to treat the lower face: a treatment paradigm for a nonsurgical facelift. Cosmet Dermatol 2003;16:37–40. 74. Ruiz-Esparza J, Gomez J.The medical face lift: a noninvasive, nonsurgical approach to tissue tightening in facial skin using nonablative radiofrequency. Dermatol Surg 2003;29:325–32. 75. Alster T, Tanzi E. Improvement of neck and cheek laxity with a nonablative radiofrequency device: a lifting experience. Dermatol Surg 2004;30:503–7. 76. Narins RS,Tope WD, Pope K, Ross E. Overtreatment effects associated with a radiofrequency tissue-tightening device: rare, preventable, and correctable with subcision and autologous fat transfer. Dermatol Surg 2006;32:115–24. 77. Kist D, Burns AJ, Sanner R, Counters J, Zelickson B. Ultrastructural evaluation of multiple pass low energy versus single pass high energy radio-frequency treatment. Lasers Surg Med 2006;38:150–4. 78. Narins D, Narins R. Non-surgical radiofrequency facelift. J Drugs Dermatol 2003;2:495–500. 79. Ruiz-Esparza J. Near painless, nonablative, immediate skin contraction induced by low-fluence irradiation with new infrared device: a report of 25 patients. Dermatol Surg 2006;32:601–10. 80. Taub A, Battle E Jr, Nikolaidis G. Multicenter clinical perspectives on a broadband infrared light device for skin tightening, J Drugs Dermatol 2006;5:771–8.
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 69
7. Lasers, light, and acne Kavita Mariwalla and Thomas E Rohrer
INTRODUCTION Acne vulgaris is an exceedingly common multifactorial disease of the pilosebaceous unit, believed to affect approximately 40 million adolescents and 25 million adults in the USA alone.1 It is thought to be physiologic in adolescence due to its affect on nearly 85% of young people between the ages of 12 and 24 years.2 However, 12% of adult women and 3% of adult men will have clinical acne until the age of 44.3 Many authors have described that, in addition to long-term scarring, which can be disfiguring, patients with acne often carry significant psychosocial morbidity, including anxiety, sleep disturbances, clinical depression, and suicide.4–8 In many cases, acne can be successfully treated using conventional topical or oral medications such as antibacterials, antimicrobials, and retinoids. However, this approach often has drawbacks involving side-effect profiles, length of treatment, and patient compliance.9–13 With oral retinoids, practitioners are faced with federally mandated paperwork that takes not only time, but also several patient visits in order to deliver treatment.14,15 For the subset of patients who have failed these treatment modalities, laser and light-based systems have emerged as standalone and adjunct therapies. These devices work by targeting the components of the pilosebaceous unit that lead to acne lesions, namely either the resident bacterium Propionibacterium acnes, inflammation, or the pilosebaceous unit itself.
THE BUILDING BLOCKS OF ACNE VULGARIS In order to select the appropriate device for treating acne, it is essential to understand the pathogenesis of
the acne lesion itself (Fig. 7.1). Acne vulgaris can be broken down into lesion types based on pathogenesis and severity: comedones, inflamed papules, nodules, and cysts. The majority of data involving laser and light-based therapies are based on the treatment of the non-cystic form of acne vulgaris. Simply put, acne has four main pathophysiological features: hyperkeratinization, sebum production, bacterial proliferation, and inflammation. The early comedone is produced when there is abnormal proliferation and differentiation of keratinocytes in the infundibulum, forming a keratinous plug. This leads to impaction and distention of the lower infundibulum, creating a bottleneck affect.As the shed keratinocytes form concretions, the sebum in the follicle thus becomes entrapped. This stage represents the noninflammatory closed comedone. As accumulation increases, so too does the force inside the follicle itself, eventually leading to rupture of the comedo wall, with extrusion of the immunogenic contents and subsequent inflammation. Depending on the nature of the inflammatory response, pustules, nodules, and cysts can form. One factor in the pathogenesis of acne vulgaris is the role of the resident P. acnes found deep within the sebaceous follicle.16–18 P. acnes is a slow-growing, gram-positive anaerobic bacillus. It contributes to the milieu of acne production in the lipid-rich hair follicle by producing proinflammatory cytokines (e.g., interleukin-1 (IL-1) and tumor necrosis factor α (TNF-α)), as well as many lipases, neuraminidases, phosphatases, and proteases. True colonization with P. acnes occurs 1–3 years prior to sexual maturity, when numbers can reach approximately 106/cm2, predominantly on the face and upper thorax.19 Although some suggest that the absolute number of P. acnes does not correlate with clinical severity,16 it is common belief that the
07 Carniol-8028.qxd
70
8/23/2007
10:28 AM
Page 70
Clinical procedures in laser skin rejuvenation Hair shaft
Pore
Resident P. acnes
Sebaceous lobule
Sebum
The pilosebaceous unit
Hair shaft
Pore
Retained keratin and lamellar concretions
P. acnes proliferation
Inflammation
Sebaceous lobule regression
Inflammatory papule/pustule
Fig. 7.1 The pathogenesis of acne. Lasers & light based devices target either the pilosebaceous unit, to decrease sebum production or improve sebum flow out of the gland, or the resident Propionibacterium acnes to combat acne vulgaris. Comedones result from hyperkeravatosis at the level of the infundibulum along with increased sebum secretion.As the accumulated keratin and sebum form a plug, inflammation and proliferation of P. acnes produces the clinically inflammatory acne papule.
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 71
Lasers, light, and acne proinflammatory mediators released by these bacteria are at least partially responsible for the clinical acne lesion. In practice, acne is predominantly found on the face and to a lesser degree on the back, chest, and shoulders.The majority of studies using laser and light-based systems target acne on the face, although we present data from a limited number of studies performed elsewhere on the body.
71
CLINICAL EXPERIENCE AND CONSIDERATIONS
therapy, some see little to no improvement. Compared with conventional therapy, laser and light devices require no daily routine, are not altered by antibiotic resistance, have few systemic side-effects, and are easy to administer, and some (infrared and radiofrequency devices) offer significant textural improvement of acne scars. On the other hand, these modalities are much more expensive, involve some degree of patient discomfort during treatment, have post-treatment recovery/downtime due to erythema, and require multiple trips to the dermatologist’s office. As with any laser procedure, patients’ skin phototype and underlying psychosocial disturbances should be considered.
Patient screening
Choosing the appropriate laser
As new laser- and light-based systems emerge for the treatment of acne vulgaris, the selection of patients and the type of device to use for each one can seem daunting. In our clinical practice, we use a series of simple guidelines before initiating laser or light-based therapies.
In most practices, the choice of device depends on what is available to the practitioner. When multiple devices are available, it is crucial to keep in mind the area of involvement and the presence of scarring. For example, in large areas such as the chest and back, treatment with infrared lasers with a 4–6 mm spot size is generally too time-consuming and painful for the patient. Instead, for wide treatment areas, light-based therapy with or without δ-aminolevulinic acid can be used. In cases of significant acne scarring, infrared lasers are often used, since these devices are also frequently employed to improve the texture of the skin, including scars. The ultimate decision, however, is up to the individual practitioner and the patient, and should be evaluated in terms of what the treatment is targeting: the sebaceous gland or P. acnes itself.
1. Is the patient a topical or oral medication failure? 2. Has the patient tried isotretinoin or are there circumstances that make isotretinoin a less-thanideal medication for the patient? 3. Is the patient’s acne mainly comedonal or are there inflammatory acne papules as well? To what extent is the patient’s acne nodulocystic? 4. Does the patient have acne and acne scarring? It is important to keep in mind that most laser systems will work to some extent. Topical and oral medications should be optimized and are generally continued during the initial phase of treatment with any of the devices. Occasionally, laser and light-based treatments may be used as first-line therapy, with or without topical and oral medications, in patients presenting with both active acne and acne scars who also want treatment of their scars.
The patient encounter In the initial evaluation of the patient, it is important to set realistic expectations. Although many patients see dramatic improvement with laser and light-based
TARGETING P.ACNES P. acnes produces and accumulates endogenous porphyrins, namely protoporphyrin, uroporphyrin, and coproporphyrin III,20,21 as part of its normal metabolic and reproductive processes. These porphyrins absorb light energy in the near-ultraviolet (UV) and blue regions of the spectrum, and can be visualized by Wood’s lamp (365 nm) examination, under which they fluoresce coral red.22 Porphyrins have two main absorption peaks, the Soret band (400–420 nm) and the Q-bands (500–700 nm), which make them susceptible to excitation by lasers and
07 Carniol-8028.qxd
72
8/23/2007
10:28 AM
Page 72
Clinical procedures in laser skin rejuvenation
Extinction coefficient Soret band > 2×105
Q-bands L mol−1 cm−1
400
600 Wavelength (nm)
Fig. 7.2 Excitation spectrum of protoporphyrins.The Soret band represents the highest peak of light absorption and thus sensitizer activation, while the Q-bands represent the several weaker absorptions at longer wavelengths. Because the highest peak of absorption of porphyrins is on the blue region (415 nm), this wavelength is used by several light source systems for acne treatment.
light sources emitting wavelengths in the visible light spectrum (400–700 nm) (Fig. 7.2). Once induced, these photosensitizers generate highly reactive freeradical species, which cause bacterial destruction23,24 (Fig. 7.3).The singlet oxygen formed in the reaction is a potent oxidizer that destroys lipids in the cell wall of P. acnes. Although absorption and photodynamic excitation are most efficient between the wavelengths of 400 and 430 nm, with enough light, the reaction may be initiated with a variety of different wavelengths. Porphyrin concentration, effective fluence, wavelength of the emitted photons, and temperature at which the reaction is carried out all play a role in P. acnes photoinactivation.25
Photoinactivation of P. acnes with visible light UVA/UVB After sunlight exposure, as many as 70% of patients report improvement in their acne.26 It is not known whether the UV or visible light component is primarily
Photons
NH
N
Basic porphyrin structure N
HN
Destruction of lipids in cell wall of P. acnes
Reactive oxygen free radicals
Excited porphyrin molecules
Fig. 7.3 Mechanism of P. acnes destruction by visible light interaction with porphyrins.When exposed to absorbed light wavelengths, porphyrins act as photosensitizers and generate highly reactive free-radical species, one of which is singlet oxygen.These radicals are potent oxidizers and destroy the lipids in the cell wall of P. acnes.
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 73
Lasers, light, and acne responsible for this effect. In vitro experiments have shown that P.acnes can be inactivated by low-dose nearUV radiation; however, given the potential carcinogenicity of UVA and UVB therapy, in vivo studies have not been able to justify this means of acne treatment, regardless of the treatment parameters.27,28
Conclusion: While anecdotal evidence of acne improvement over the summer has a rational basis, the potential side-effects of prolonged UV radiation are unacceptable risks, and other modalities should be sought.
Blue light The strongest porphyrin photoexcitation coefficient (407–420 nm) lies in the Soret band. It comes as no surprise, then, that irradiation of P. acnes colonies with blue light (415 nm) leads to bacterial destruction. In vitro, colony counts of P. acnes have decreased by four orders of magnitude 120 minutes after exposure to a metal halide lamp with a wavelength of 405–420 nm (ClearLight, Lumenis Ltd, Santa Clara, CA). Kawada et al29 used this light source on mild to moderate acne lesions in 30 patients and found a 64% mean acne lesion count reduction after 10 Clearlight treatments over a 5-week period with a one- to twoorder decrease in P. acnes colony count in correlated in vitro experiments.The study showed that papules and pustules improved more than comedones, but 10% of patients actually experienced an increase in acne. Another study utilizing the blue light source failed to show bacterial count changes by polymerase chain reaction (PCR) after therapy; however, damaged P. acnes were observed at the ultrastructural level.30 Shalita et al31 used the ClearLight to treat 35 patients with lesions on the face and back using 10-minute light exposures twice weekly over a 4-week period.There was an 80% improvement of noninflammatory and a 70% improvement of inflammatory lesions as assessed 2 weeks after the last treatment. Using the same device, Elman et al32 carried out a split-face double-blind controlled study (n =23) in which patients were treated a total of eight times for 15 minutes (420 nm, 90 mW/cm2). In this group, 87% of the treated sides showed at least a 20% reduction of inflammatory acne lesions with a 60% mean reduction of lesions in responders that remained steady at
73
2, 4, and 8 weeks post therapy. In the same trial, Elman et al32 treated 10 patients with papulopustular acne in a split-face dose-response study, exposing them to narrowband visible blue light (90 mW/cm2) for either 8 minutes or 12 minutes. Although there was a more than 50% decrease in inflammatory lesions in 83% of the treatment areas, there was little difference between 8- and 12-minute exposure times (a decrease of 65.9% versus 67.6%, respectively).32 Success in the treatment of acne vulgaris with the blue light may be dependent on the lesion morphology. For example, Tzung et al33 showed a 60% improvement in papulopustular lesions in skin phototypes III and IV with four biweekly treatments (F-36 W/Blue V, Waldmann, Villingen-Schwenningen, Germany) and worsening of nodulocystic acne in 20% of patients (n =28). Using a different blue light source (Blu-U, DUSA Pharmaceuticals, Inc., Wilmington, MA), Gold et al34 found an average 36% reduction in inflammatory acne lesion counts after 4 weeks of biweekly 1000-second light therapy sessions, compared with a 14% reduction in patients using 1% clindamycin solution twice daily. The authors of this study, however, acknowledge that a limiting factor in their trial was sample size (n =13 for the clindamycin arm and n = 12 for the light therapy arm), making it difficult to draw a conclusion regarding diligent topical antibiotic use versus blue light therapy alone. In fact, if all patients entered into the study are considered, there is no difference in the amount of clearing.
Conclusion: Blue light is effective for papules and pustules more than comedones, and carries the risk of worsening nodulocystic acne. It is effective in varying skin types.
Combination blue and red light One of the main restraints of blue light therapy for acne is that it is highly scattered in human skin and thus penetrates poorly. Red light, while less effective in photoactivating porphyrins,35 has increased depth of penetration into the epidermis to reach the porphyrins in the sebaceous follicles. Red light can also potentially induce anti-inflammatory effects by stimulating cytokine release from macrophages.36
07 Carniol-8028.qxd
74
8/23/2007
10:28 AM
Page 74
Clinical procedures in laser skin rejuvenation
In combination, red and blue light may act synergistically by exerting both antibacterial and anti-inflammatory effects. Papageorgiou et al37 compared the simultaneous use of red and blue light to treat acne vulgaris in a randomized single-blind control study with blue light phototherapy versus 5% benzoyl peroxide in a total of 140 patients with mild to moderate acne. After 84 consecutive treatments of 15 minutes (cumulative doses 320 J/cm2 for blue light and 202 J/cm2 for red light), the authors noted a final improvement of 76% in inflammatory lesions, which was significant compared with the results of blue light or benzoyl peroxide alone.
Conclusion: Combination blue and red light may act synergistically; however, the length of treatment requires patient compliance and diligence.
Yellow light Intense yellow light at 585 nm theoretically penetrates deeper than blue light, and, using the same principle of P. acnes porphyrin excitation, offers another alternative to laser devices. Edwards et al38 studied 30 patients with mild to moderate facial acne and exposed each side of their face to 3.0, 1.5, or 0.1 J/cm2 (sham) twice a week for 4 weeks.At 6 weeks after completion of therapy, patients who received 3.0 J/cm2 had a 23% improvement in Leeds acne score, with a 21% decrease in total lesion count. This system relies on a light-emitting diode (LED) and may offer some benefit to patients with mild acne.
Conclusion: Intense yellow light may improve mild acne, although alternatives exist in the blue light and combined blue and red light modalities that have shown greater efficacy than yellow light alone. Long-term efficacy data are not yet available for the LED.
Intense pulsed light Intense pulsed light sources emit a broad band of light with wavelengths generally ranging from 500 to 1200 nm. Although less selective by nature, these devices emit wavelengths of energy that are absorbed
by many chromophores and therefore can be used to treat a variety of conditions. The Palomar LuxVO (Palomar Co., Burlington, MA) handpiece provides wavelengths of 400–700 nm and 870–1200 nm. Gupta et al39 studied this device in 15 patients with Fitzpatrick skin phototypes I–V. Each patient received three to five treatments spaced 1–2 weeks apart (11 J/cm2, 60–100 ms pulse width, and three to four passes over the entire treatment area) and was followed up 3 months after completion of the last treatment. The authors found no significant difference in noninflammatory lesion counts, but did note a significant reduction in mean comedone, papule, and pustule counts as well as a significant improvement in global severity grade of acne. In the skin type V group, mild crusting associated with postinflammatory hyperpigmentation was noted, but resolved with time.
Conclusion: IPL may be an effective and safe treatment option for mild to moderate inflammatory acne lesions in a variety of skin types.
Pulsed light and heat Knowing that porphyrins have the highest excitation spectrum at lower wavelengths and yet in order to reach P. acnes a greater depth of penetration is required, which can only be accomplished through longer wavelengths, one of the dilemmas of lightbased therapy for acne vulgaris was how to combine these two properties. As a result, Radiancy Inc. designed proprietary technology for the simultaneous delivery of pulsed light and heat energy (LHE) through the ClearTouch system (430–1100 nm, 35 ms, 3–9 J/cm2, and spot size 22 mm × 55 mm). The LHE technology primarily rests on the principle that, like any other photochemical reaction, the efficiency of porphyrin induced P. acnes destruction is determined by the rate of production of excited porphyrins. The rate of porphyrin excitation is related to four factors: (1) the concentration of porphyrins; (2) the photon flux; (3) the temperature of the chemical reaction; and (4) the wavelength of the photons.40 One of the advantages of a pulsed light source compared with continuous-wave mode devices is the ability to provide many more photons at peak power.41 For
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 75
Lasers, light, and acne
a
75
b
Fig.7.4 Before (a) and after treatment (b) with the ClearTouch system (Radiancy Inc.),a device that emits wavelengths between 430 and 1100 nm in pulses of 35 ms and a low fluence (3–7.5J/cm2).This system,which combines light and heat damage to allow for deeper skin penetration and antibacterial effect for acne treatment,is used biweekly for 1 month with two passes during each therapy session.(Photographs courtesy of Dr Helena Regina de Brito Lima.) example, a 3.5 J/cm2 pulsed wave light source with a 35 ms pulse width delivers 10 000 times more photons than a continuous-wave 10 mW/cm2 light source.The disadvantage of using pulsed light is oxygen (ratelimiting) depletion and therefore rapid reaction saturation. Because the range of emitted wavelengths emitted by this device is broad, both antibacterial and anti-inflammatory effects are induced, since the peak absorption of endogenous porphyrins is covered as well as that of hemoglobin in blood vessels proximal to the inflamed acne papule. The efficacy of a combination of heat and light is also quantitatively justified through the Arrhenius equation, which states that the higher the temperature, the faster a given chemical reaction will proceed.42 Thus, the ability to deposit heat through conduction from a nonoptical, exogenous source may reduce inflammation and even speed up the photodynamic reactions. This was shown by Kjeldstad et al,23 who, using 330–410 nm near-UV light, found that in vitro photoinactivation of P. acnes increased as the temperature increased in intervals of 10°C, 20°C, and 37°C, with reciprocal increase in P. acnes colonies with decreased temperature. Elman and Lask43 studied the efficacy of the ClearTouch system (Radiancy Inc., Orangeburg, NY) in 19 acne treatment-naive patients with inflammatory and noninflammatory acne lesions. Each patient received a total of eight 10-minute treatments (two passes) over a period of 1 month (430–1100 nm, 3.5 J/cm2, 35 ms pulse, and 22 mm × 55 mm spot size). One month after treatment, noninflammatory
acne lesions were 79% ± 22% clear, while inflammatory lesions were 74% ± 20% clear.Two months after the last treatment, noninflammatory and inflammatory lesion counts were reduced by 85% and 87%, respectively. Gregory et al44 also studied the ClearTouch system in a multicenter blinded control trial of 50 patients suffering from mild to severe acne who discontinued all treatment 4 weeks prior to the start of the trial. Patients served as their own control and received two passes biweekly for 1 month. Four weeks later, the authors noted a mean 60% reduction in inflammatory lesion counts, compared with a 32% increase in the control phase, with erythema as the only reported side-effect (Fig. 7.4).
Conclusion:The technological basis of pulsed light and heat makes intuitive sense by allowing practitioners to target both P. acnes and the sebaceous gland. As a result, this device is successful in treating both inflammatory and noninflammatory acne vulgaris.
Laser 532 nm KTP laser The 532 nm (green) potassium titanyl phosphate (KTP) laser has as its target chromophores oxyhemoglobin and melanin.As such, it is typically used to treat telangiectasia and superficial pigmented lesions. However, since this laser has a greater optical penetration depth into skin than blue light, it has the innate
07 Carniol-8028.qxd
76
8/23/2007
10:28 AM
Page 76
Clinical procedures in laser skin rejuvenation
ability to activate bacterial porphyrins along with some nonspecific collateral thermal injury to sebaceous glands, and is generally well tolerated. Thus, it has also been trialed in the treatment of acne vulgaris. Baugh and Kucaba45 studied the effect of the Aura KTP laser (Laserscope, San Jose, CA) in 21 subjects with mild to moderate facial acne in a split-face singlecenter prospective trial. Patients who had been treated with systemic antibiotics in the 8 weeks prior, topical therapy in the 2 weeks prior, or oral retinoids in the 6 months prior to the start of the trial were excluded. Individual pulses of 12 J/cm2 with a 30–40 ms pulse width and a 1–5 Hz frequency were delivered with the use of a continuous contact cooling tip (Laserscope VersaStat I, which cools the skin to −4°C) twice a week for 2 weeks.The control area was treated with contact cooling alone. Results demonstrated the greatest improvement in acne papules (>45% reduction) at 1 week, which deteriorated by 4 weeks to just over 35% reduction, with no improvement in infiltrated lesions at 4 weeks. Acne pustules showed the most improvement at 4 weeks, while comedone improvement did not exceed 13% reduction at either 1 or 4 weeks post treatment. Total percent improvement in comedones, papules, pustules and infiltrated lesions was 25% 1 week after treatment and 21% 4 weeks after treatment. Subjectively, 47.6% of patients felt 70–79% overall satisfaction with the therapy. Of note, none of the subjects experienced post-treatment redness or irritation. Using the Aura (Iridex, Mountainview, CA) KTP laser (4 mm spot size, 7–9 J/cm2, 20 ms pulse, and 3–5 Hz), Bowes et al46 carried out a prospective splitface study involving 11 patients using 6–10 passes per half-face for 2 weeks. A moderate decrease in mild to moderate acne lesion count was noted after 1 month (36%), versus a 1.8% increase in the control group. Sebum production also decreased (28%), but there was minimal effect on P. acnes as measured by fluorescence photography. Subsequently, Lee47 reported on her experience with the Aura for facial and trunk acne by treating 25 patients with KTP alone, 25 patients with laser followed by topical medications and cleansers, and 125 patients with concomitant laser and topical treatment. A majority (90%) of the 125 patients treated
simultaneously with laser and topical agents had 80–95% improvement, which was similar to the group who followed their laser treatment with topical agents. Fifty percent of the 125 patients maintained results over 4 months without additional treatment. The laser-only group had more flares, less clearance, and slower response times in comparison. These data suggest that although the laser alone induces a limited response, it may be beneficial in combination therapy for acne treatment.
Conclusion: The KTP 532 nm laser can induce a reduction in inflammatory facial acne, although longterm suppression is variable. This laser is less successful in comedone treatment, and may be best used as an adjunctive therapeutic with topicals.
Pulsed dye laser: 585 nm Similar to the KTP, the chromophore for the flashlamp-pumped pulsed dye laser (PDL) is oxyhemoglobin, making it particularly suitable for reducing the ‘red’ component of clinically apparent acne lesions. In addition, as discussed earlier, 585 and 595 nm yellow light can be used to photoexcite porphyrins and reduce P. acnes. Seaton et al48 demonstrated a 49% reduction in inflammatory lesion counts (regardless of severity at baseline) versus 10% in controls 12 weeks after a single pass of the 585 nm PDL (5 mm spot size, 1.5–3.0 J/cm2, and 350 µs pulse; NLite System, ICN Pharmaceuticals Inc., Costa Mesa, CA). Other studies using the same device, however, were less encouraging. In a randomized blinded placebo-controlled trial of 26 patients with mild to moderate acne, Orringer et al49 showed only a trend towards improvement that was not statistically significant in mean papule counts, mean pustule counts, or mean comedone counts. Grading of serial photographs also showed no significant differences in Leeds scores for treated skin at baseline and at week 12 compared with untreated skin at the same time points.49 Although the two groups of investigators used the same device setting, the number of laser pulses used to treat each patient varied. Orringer et al48 used 385 per patient, while Seaton
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 77
Lasers, light, and acne
a
77
b
Fig. 7.5 a) Patient with acne and post acne erythema before treatment. b) Same patient 6 weeks later, following two treatments with the pulsed-dye laser.
et al50 used at least 500 pulses per patient, which may contribute in part to the difference in results.
In summary: targeting P. acnes
Pulsed dye laser: 595 nm Alam et al51 reported significant acne clearance in 25 subjects using a 595 nm PDL (7 mm spot size, 8–9 J/cm2, 6 ms pulse). These treatment parameters may be more suitable for acne, given the increased depth of penetration as well as longer pulse duration and higher fluence (Fig. 7.5).
The modalities thus far discussed directly or indirectly rely on the biological property of porphyrin as a photosensitizer to induce the destruction of P. acnes colonies in vivo and clinically improve acne vulgaris. Although light therapy in the 400–420 nm range coincides with porphyrin peak excitation, longer wavelengths allow for deeper dermal penetration. Unfortunately, since P. acnes is a rapid regenerator, acne clearance is generally short-lived (at most 3 months), and therefore treatments must be continued on an ongoing basis. Given this limitation, it is questionable whether these laser and light-based systems are a significant enough improvement over topical therapies to justify the expense and time needed to treat.
Conclusion: Because the pulsed dye laser is able to affect the ‘red’ component of acne and has a good depth of penetration, it may be suitable for patients with mildto-moderate inflammatory acne. However, the results have been widely variable – from no improvement to near 50% reduction.
07 Carniol-8028.qxd
78
8/23/2007
10:28 AM
Page 78
Clinical procedures in laser skin rejuvenation
Glycine + Succinyl CoA → ALA → Prophobilinogen → Hydoxymethylbilane → Uroporphyrinogen III → (Uroporphyrinogen) III → Protoporphyrinogen III → Protoporphyrin IX → Heme ↑ Ferrochelatase
Fig. 7.6 Devices using topical application of δ-aminolevulinic acid (ALA) are effective because they take advantage of the heme synthesis pathway, leading to protoporphyrin IX.When the protoporphyrin IX is photoactivated, the singlet oxygen and free radicals produced are not only cytotoxic to P. acnes but also damage the pilosebaceous unit itself.
TARGETING THE PILOSEBACEOUS UNIT The sebaceous gland is under many influences during adolescence.The ensuing increase in sebum production plays a primary role in acne formation. Although targeting P.acnes is one approach to ameliorating acne vulgaris, another involves targeting the pilosebaceous unit itself. By reducing the size, and therefore the sebum output, of the gland, or by straightening out the tubule by which it drains, several devices have been shown to significantly reduce acne for extended periods of time.
Photodynamic Therapy Photodynamic therapy (PDT) has recently been used in the treatment of acne vulgaris. This method uses a photosensitizer and low-intensity visible light that, together, produce cytotoxic oxygen radicals. One of the advantages of this method is that the photosensitizer can be selectively applied and illumination can be focused. In addition, this system is equally effective on all strains of P. acnes, regardless of antibiotic resistance.52
δ-Aminolevulinic acid Topical δ-aminolevulinic acid (ALA) is preferentially taken up by pilosebaceous units and incorporated into the heme synthesis pathway, resulting in the production of protoporphyrin IX. When photoactivated, protoporphyrin IX produces singlet oxygen molecules and free radicals, which are cytotoxic (Fig. 7.6). In addition, it has been shown that the addition of ALA
actually enhances intracellular porphyrin synthesis itself.53 PDT has also been used in combination with ALA in the treatment of nonmelanoma skin cancer, actinic keratoses, acne vulgaris, viral warts, and other dermatoses.54 The combination of topical ALA application followed by PDT results in cytotoxic free-radical production and death of P. acnes, as well as damage to the pilosebaceous unit itself. ALA application times as brief as 15–60 minutes followed by red, blue, or intense pulsed light, PDL, diode lasers, or LED sources have all been shown to be effective. ALA and red light In a study of 22 patients with chest and back acne, Hongcharu et al55 found that the majority of protoporphyrin IX production was localized in the sebaceous glands and hair follicles after three hours application of ALA under occlusion. Subsequently, these authors used a broad band 550–700 nm red light source at a fluence of 150 J/cm2, and were able to show a persistent decrease in acne lesion counts for 10–20 months following one to four treatments. Histology revealed damaged and even destroyed sebaceous glands. Sebum excretion rate, sebaceous gland size, and follicular bacterial counts also all decreased. Adverse effects, often typical of ALA–PDT treatment, included erythema, crusting, pain, and hyperpigmentation. Itoh et al56 reported an intractable case of acne vulgaris on the face that, after treatment with ALA–PDT (4-hour drug incubation, 635 nm), remained clear at 8-month follow-up. A subsequent study by the same group57
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 79
Lasers, light, and acne evaluated 13 subjects and demonstrated a reduction in new acne lesion counts at 1, 3, and 6 months following PDT treatment. ALA and blue light Pain-free treatments with few side-effects have been described with four weekly treatments using the blue light after short ALA incubation periods (15 minutes).58 In 15 patients with moderate to severe acne, the combination of 1-hour ALA incubation and blue light led to a continued reduction in acne lesion counts in responders up to 72% at 3 months after the last treatment.59 ALA and red light diode laser Pollock et al60 investigated the use of a red light diode laser (CeramOptec GmbH, Bonn, Germany) in combination with 20% ALA cream applied under occlusion for 3 hours. Ten patients with mild to moderate acne of the back were treated weekly for 3 weeks (635 nm, 25 mW/cm2, and 15 J/cm2) and assessed 3 weeks after the last treatment. ALA–PDT-treated areas demonstrated a significant reduction in acne lesion counts, but not in P. acnes concentration as assessed by P. acnes swabs or sebum excretion. It is possible, as Pollock et al60 suggest, that another mechanism of action may play a role in the response of acne to ALA–PDT. They also suggest that perhaps PDT, rather than destroying P. acnes, damages the bacterium so that it is unable to function normally.They speculate that when the bacterium is swabbed and put into an ideal culture environment, it grows normally, thus giving an inaccurate picture of what is occurring deep in the pilosebaceous unit. ALA and polychromatic visible light Oral ALA followed by exposure to polychromatic visible light from a metal halide lamp resulted in marked improvement based on a physician clinical assessment score in 61% of 51 patients treated for intractable acne on the body. Kimura et al61 administered the ALA at a dose of 10 mg/kg, which produced no liver dysfunction. However, adverse effects did occur, and consisted of slight discomfort, burning and stinging during the irradiation.
79
ALA and IPL Hwang and Seo62 compared two light spectra of IPL (Ellipse, DDD, Denmark), namely VL (555–950 nm) and HR (600–950 nm) with varying application times of ALA (1 hour vs 4 hours).They followed patients at 1, 4, 14 and 24 weeks after a single treatment, and found no difference in the number of comedones or inflammatory acne lesions when comparing 1-hour and 4-hour ALA incubation times. Of the two, the 600–950 nm applicator was more efficient than the 555–950 nm applicator in reduction of inflammatory acne. Given these data, and the risk of hyperpigmentation, Hwang and Seo62 concluded that ALA should be applied for a short time. Gold et al54 enrolled 15 patients who underwent four weekly treatments (ClearTouch, 3–9 J/cm2) after 1 hour incubation with ALA, and found a 71.8% reduction in inflammatory acne lesions at 12-week follow-up in 80% of the patients.This was an increase from a 68.5% reduction 1 month after treatment. Of note, none of the treated lesions recurred at 3-month follow-up. ALA and PDL In one of the few studies using patients with mild to severe acne including cystic and inflammatory lesions, Alexiades-Armenakas63 used a combination of ALA–PDT with the 595 nm PDL. Topical ALA was applied for 45 minutes on the face, followed by a single minimally overlapping pass with the long-pulsed PDL (595 nm, 7–7.5 J/cm2, 10 ms, 10 mm spot size, and dynamic cooling spray 30 ms) in 14 patients, who were then followed monthly for 13 months. Controls were treated with conventional therapy (oral antibiotics, oral contraceptives, or topicals) or PDL only. Complete clearance occurred in 100% of the patients in the PDL–PDT-treated group, with a mean of 2.9 treatments being required to achieve complete clearance. In the control groups, mean percent lesional clearance rate per treatment was 77%. The mean percent lesional clearance per treatment was 32% in the PDL-only group and 20% in the oral antibiotic and topical group, although the number of patients in these two control groups was small (n = 2 for each). Nonetheless, the PDT–laser combination was well tolerated, with minimal erythema lasting 1–2 days without evidence of crusting, blistering, or dyspigmentation. This pilot study demonstrated that PDL
07 Carniol-8028.qxd
80
8/23/2007
10:28 AM
Page 80
Clinical procedures in laser skin rejuvenation
Dynamic cooling device spray
Stratum corneum
Laser pulse
Epidermis
Dermis Hair
Sebaceous gland
follicle
Sebaceous gland
Dynamic cooling device pulse cools and protects the epidermis
Laser penetrates the skin to base of the sebaceous gland
Thermal injury to the sebaceous gland
Fig.7.7 Lasers at 1320,1450,and 1540 nm (mid-infrared) have shown impressive clearing of acne lesions.The lasers heat the dermis,in bulk,including the upper and mid-dermis,where sebaceous glands are primarily located.As a result,a potential reduction in the size and sebum output of the sebaceous gland,or a straightening of the infrainfundibular tubule,occurs and there is an improvement in acne.Side-effects associated with these lasers are pain,transient erythema and edema,and a risk of hyperpigmentation.
may be an efficacious combination with ALA to achieve clearance in patients with varying stages of acne from comedones to cysts.
Conclusion: Topical ALA application enhances the production of porphyrins and not only can induce cytotoxic effects on P. acnes but can also target sebaceous glands for destruction. The end-result is a decrease in acne, which varies depending on the light source used for illumination.
Indocyanine green Carotenoids are the natural chromophore in sebum, with an absorption range of 425–550 nm.The problem with using a laser in this wavelength range is the number of unintended components of the skin that will absorb this wavelength, resulting in unwanted side-effects such as blood coagulation.The ideal wavelength to use is in the ‘optical window’, which is 600–1300 nm.64 The only barrier is that local chromophores do not absorb in this wavelength. However, indocyanine green (ICG, a tricarbocyanine dye) is a chromophore with peak absorption at 805 nm, which can be applied topically and is known to be preferentially accumulated by sebaceous glands. In combination with diode lasers, ICG is thought to cause both photodynamic and photothermal effects within P. acnes and the pilosebaceous unit.
Tuchin et al65 treated 22 patients with inflammatory acne lesions on the back and face. An 803 nm (OPC-BO15-MMM-FCTS diode laser, Opto Power Corp., Tucson, AZ) or 809 nm (Palomar Medical Technologies, Inc., Burlington, MA) diode laser was used after occlusive ICG application for 5 or 15 minutes. The combination of ICG and laser produced less inflammation, lesion flattening, and reduction in P. acnes and sebum production compared with no treatment, ICG alone, and laser-only-treated areas. A subsequent pilot study for moderate to severe acne lesions showed that multiple treatments with ICG and a nearinfrared diode laser improved skin for as long as 1 month without side-effects when compared with a single ICG-laser treatment session.66 In one of the select studies to look at body acne, Lloyd and Mirkov67 treated patients with 5% ICG microemulsion for 24 hours under occlusion and then treated them with a 810 nm diode laser (4 mm spot size, 810 nm, 40 J/cm2, and 50 ms pulse; Cyanosure, Inc.). Histology showed evidence of selective necrosis of the sebaceous glands. Using these parameters, the group then treated 10 patients with back acne, and their preliminary clinical results showed a decrease in acne in the treatment area at 3-, 6-, and 10-month follow-up. It should be noted that treatment did not lead to immediate resolution of acne lesions, which cleared through the skin’s own healing process. However, the treated regions remained lesionfree for extended periods of time, leading Lloyd and
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 81
Lasers, light, and acne
a
81
b
Fig. 7.8 a) Patient with severe acne and acne scarring prior to laser treatment. b) Same patient 6 weeks later, following five treatments with a 595 nm pulsed-dye laser and 1450 nm infrared divide laser (Smoothbeam Laser, Candela Corp., Wayland MA).
Mirkov67 to speculate that ICG-diode laser treatment did cause thermal damage in the sebaceous gland.
Conclusion: ICG and long-pulsed diode lasers are an effective way to target sebaceous glands by applying an exogenous chromophore to the skin, however downsides include incubation time and pain during treatment due to collateral heating.
Infrared lasers Isotretinoin use is known to cause shrinkage of sebaceous glands, with a resultant reduction in sebum output. Interestingly, although sebum concentration returns to normal after therapy discontinuation, many patients remain clear of acne. This has led to the hypothesis that even a temporary alteration of sebaceous glands may be sufficient to induce long-term
acne clearance.The distribution of sebaceous glands is highly variable in the dermis; however, infrared lasers target water, which is the dominant chromophore in the sebaceous gland. Consequently, mid-infrared laser light, which has a depth of penetration into the superficial dermis, is able to produce a zone of injury in the superficial dermal layer that may injure sebocytes and arrest the overproduction of sebum and disrupt the pathogenesis of acne itself. Alternatively, infrared lasers may be affecting the infundibulum of the pilosebaceous unit and improving the sebum flow out of the gland (Fig. 7.7). In any event, infrared lasers have been shown to significantly clear acne for extended periods of time (Fig. 7.8). Infrared lasers encompass the 1320, 1450 and 1540 nm wavelength devices.
1450 nm In a multipart trial, Paithankar et al68 demonstrated that the 1450 nm diode laser with cryogen spray cooling
07 Carniol-8028.qxd
82
8/23/2007
10:28 AM
Page 82
Clinical procedures in laser skin rejuvenation
(Smoothbeam, Candela Corp., Wayland, MA) could induce thermal injury confined to the dermis histologically after irradiation of ex vivo human skin. Using rabbit ear skin as an in vivo model, treatment with the Smoothbeam produced histological alteration of sebaceous glands within the dermis at day 1 and day 3, with recovery from initial injury by day 7. Next, Paithankar et al68 conducted a human trial, using the 1450 nm diode laser (average fluence 18 J/cm2) for four treatments separated by 3 weeks each, and demonstrated a reduction of acne lesions in 14 of 15 patients at 6-month follow-up. Importantly, only 1 of the immediate post-treatment biopsies yielded sebaceous glands, indicating that selective targeting of the sebaceous gland is possible, as the histology demonstrated thermal coagulation of the sebaceous lobule and follicle with no epidermal alteration. Long-term biopsies taken at 2 and 6 months post treatment showed sebaceous glands that had returned to their pretreatment state. In a blinded multicenter study, 45 patients received four monthly treatments with the 1450 nm diode laser (14 J/cm2), of whom 26 had at least 65% improvement in lesion counts 1 month following treatment.69 At 6 months, 5 patients required no additional intervention. Mazer and Fayard70 reported 18-month remission rates in 29 patients who avoided any additional acne-modifying treatments such as laser or topical or oral therapy after four treatments with the 1450 nm diode laser (12–14 J/cm2, 35-dynamic cooling spray 35 ms, 6 mm spot size, and no overlapping whole-face treatment) every 4–6 weeks.They noted that initially there was an average 74.8% reduction in total acne lesion counts (maximum 88.5%, minimum 49.4%), which showed only a slight deterioration to 71.8% at 18 months (maximum 88.5%, minimum 47.9%). A pilot study demonstrated the safety of the 1450 nm laser in the treatment of inflammatory facial acne in 28 Indian patients with skin type IV or V.71 Each patient was treated with four sessions at 21-day intervals, alternating with glycolic acid peels on the 10th day after laser treatment. The control group of 28 patients was treated with glycolic acid peels only. The results demonstrated a reduction in lesion count of 40% after one treatment, 57% after two treatments, and 85% after four treatments, with recurrence in 7.1% of the group at 6 months. In comparison, lesion counts in the control group decreased by 17.9% after one peel and
51.8% after four peels. However, 96.4% of the patients in the control group experienced recurrence at 6 months. Postinflammatory hyperpigmentation was seen in only 3.6% of patients. This low incidence of postinflammatory hyperpigmentation may have been due to the concomitant use of glycolic acid peels. Jih et al72 compared the dose response of a 1450 nm diode laser (prototype laser supplied by Candela Corp., Wayland, MA) in 20 patients with skin phototypes II–VI and an age range of 18–39 years. Topical lidocaine (5% Ela-Max) was applied to the entire face 1 hour before laser treatment, and patients were evaluated via split face comparisons after treatment with either 14 or 16 J/cm2 for three treatments. At 12month follow-up, similar reductions in inflammatory acne lesion counts were observed (76.1% reduction using 14 J/cm2 vs 70.5% reduction using 16 J/cm2). One of the downsides of 1450 nm diode treatment is the level of discomfort reported by some patients. As a result, widespread use of this laser in younger populations has been limited. Bernstein73 reported his experience in six subjects with active papular acne who were treated in a split-face randomized trial monthly for 4 months. Half of the face was treated with a single pass (12–14 J/cm2), while the other half was treated with a double-pass at a lower energy (8 J/cm2), and subjects were evaluated 2 months after the final treatment. Bernstein73 reports a 78% reduction in acne counts on the single-pass-treated side and a 67% reduction on the half of the face treated with the lower energy. Importantly, patients had an average pain rating of 5.6 on a scale of 1 (minimum) to 10 (maximum) with the high-energy single pass and 1.3 with the lower-energy double pass.
The 1450 nm laser in combination with other therapies Using the 1450 nm laser as an adjunct in patients who were on oral and/or topical acne treatments, Friedman et al74 observed an 83% decrease in inflammatory facial acne lesion counts following three treatments at 4- or 6-week intervals. Side-effects were transient and local, including erythema, edema, and pain during treatment. Similarly, Astner et al75 used the SmoothBeam as an adjunct to conventional acne therapy in 13 patients who continued their
07 Carniol-8028.qxd
8/23/2007
10:28 AM
Page 83
Lasers, light, and acne
a
83
b
Fig. 7.9 a) Patient with significant acne and acne scarring prior to treatment. b) Same patient 6 weeks later, following four treatments with a 595 nm pulsed-dye laser and a 1450 nm infrared laser (Smoothbeam Laser, Candela Corp.,Wayland MA).
medications during four treatments spaced 4–6 weeks apart (12–14 J/cm2). They noted a mean 54.6% improvement in lesions counts which persisted for the 6-month follow-up period of the study. The 595 nm PDL has been used in combination with the 1450 nm diode laser in a study of 15 patients with inflammatory facial acne. First, patients were treated with the 595 nm PDL (10 mm spot size, 6.5–7.5 J/cm2, and 6–10 ms pulse; Vbeam, Candela Corp., Wayland, MA) followed by a single pass with the 1450 nm diode (6 mm spot size, 10–14 J/cm2, and dynamic cooling spray at 30–40 ms). Glaich et al76 reported a mean acne lesion count reduction of 52% after one treatment, 63% after two treatments, and 84% after three treatments. This combination may be successful due to the dual targeting of the sebaceous gland (1450 nm laser) and P.acnes (595 nm PDL) (Fig. 7.9). Wang et al77 carried out a study in which 19 patients with Fitzpatrick skin types